Quarterlytics / Technology / Computer Hardware / TransAct

TransAct

tact · NASDAQ Technology
Claim this profile
Ticker tact
Exchange NASDAQ
Sector Technology
Industry Computer Hardware
Employees 51-200
← All annual reports
FY2020 Annual Report · TransAct
Sign in to download
Loading PDF…
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K

(Mark One)
☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2020
or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission file number: 0-21121

TRANSACT TECHNOLOGIES INC

(Exact name of registrant as specified in its charter)

(State or other jurisdiction of incorporation or organization)

Delaware

One Hamden Center, 2319 Whitney Avenue, Suite 3B, Hamden, Connecticut

(Address of principal executive offices)

06-1456680

(I.R.S. Employer Identification No.)

06518
(Zip Code)

(203) 859-6800
(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act: None
Securities registered pursuant to Section 12(g) of the Act:

Title of each class
Common stock, par value $0.01 per share

Trading Symbol(s)
TACT

Name of each exchange on which registered
NASDAQ Global Market

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes   □   No   ⌧

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.  Yes   □   No   ⌧

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes   ⌧   No   □

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12
months (or for such shorter period that the registrant was required to submit such files).  Yes    ⌧   No   □

Indicate  by  check  mark  whether  the  registrant  is  a  large  accelerated  filer,  an  accelerated  filer,  a  non-accelerated  filer,  a  smaller  reporting  company  or  an  emerging  growth  company.    See  the
definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.  (Check one):

Large accelerated filer  □
Non-accelerated filer  ⌧

Accelerated filer  □
Smaller reporting company  ☒
Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards provided
pursuant to Section 13(a) of the Exchange Act.  □

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of internal control over financial reporting under Section
404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. □

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes   ☐   No   ⌧

The aggregate market value of the voting and non-voting common equity held by non-affiliates of the Registrant was approximately $33,500,000 based on the last sale price on June 30, 2020.

As of February 28, 2021, the number of shares outstanding of the Registrant’s common stock, $0.01 par value, was 8,960,535.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the Registrant’s Definitive Proxy Statement related to its 2021 Annual Meeting of Stockholders (the “Proxy Statement”) to be filed with the Securities and Exchange Commission 
within 120 days after the Registrant’s fiscal year end of December 31, 2020 are incorporated by reference into Part III of this Annual Report on Form 10-K.

 
 
 
 
 
 
 
 
 
 
 
 
Business

Item 1.
Item 1A. Risk Factors
Item 1B. Unresolved Staff Comments
Item 2.
Item 3.
Item 4. Mine Safety Disclosures

Properties
Legal Proceedings

TRANSACT TECHNOLOGIES INCORPORATED

INDEX

PART I.

PART II.

Selected Financial Data

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Item 6.
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
Item 8.
Item 9.
Item 9A. Controls and Procedures
Item 9B. Other Information

Financial Statements and Supplementary Data
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

Item 10. Directors, Executive Officers and Corporate Governance
Item 11. Executive Compensation
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Item 13. Certain Relationships and Related Transactions, and Director Independence
Item 14. Principal Accounting Fees and Services

PART III.

Item 15. Exhibits, Financial Statement Schedules
Item 16. Form 10-K Summary

PART IV.

SIGNATURES

Signatures

CONSOLIDATED FINANCIAL STATEMENTS

Index to Consolidated Financial Statements

1
8
17
17
17
17

18
18
18
28
28
28
28
29

30
30
30
30
30

31
32

33

F-1

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Smaller Reporting Company—Scaled Disclosure
Pursuant to Item 10(f) of Regulation S K promulgated under the Securities Act of 1933, as amended, as indicated herein, we have elected to comply with
certain scaled disclosure requirements applicable to “smaller reporting companies” in this Annual Report on Form 10-K (this “Form 10-K”).

PART I

Forward-Looking Statements
Certain statements included in this Form 10-K may include “forward-looking statements” within the meaning of the U.S. federal securities laws, including
the  Private  Securities  Litigation  Reform  Act  of  1995.  Forward-looking  statements  are  any  statements  other  than  statements  of  historical  fact.  Forward-
looking statements represent current views about possible future events and are often identified by the use of forward-looking terminology, such as “may,”
“will,”,,  “expect,”  “intend,”  “estimate,”  “anticipate,”  “believe,”  “project”  or  “continue”  or  the  negative  thereof  or  other  similar  words.    Forward-
looking statements are subject to certain risks, uncertainties and assumptions.  In the event that one or more of such risks or uncertainties materialize, or
one  or  more  underlying  assumptions  prove  incorrect,  actual  results  may  differ  materially  from  those  expressed  or  implied  by  the  forward-looking
statements.

Important factors and uncertainties that could cause actual results to differ materially from those expressed or implied by the forward-looking statements
include, but are not limited to, the following: the adverse effects of the COVID-19 pandemic on our business, operations, financial condition, results of
operations and capital resources, including as a result of supply chain disruptions, shutdowns and/or operational restrictions imposed on our customers,
an inability of our customers to make payments on time or at all, diversion of management attention, necessary modifications to our business practices and
operations, cost cutting measures we have made and may continue to make, a possible future reduction in the value of goodwill or other intangible assets,
inadequate manufacturing capacity or a shortfall or excess of inventory as a result of difficulty in predicting manufacturing requirements due to volatile
economic conditions, price increases or decreased availability of component parts or raw materials, exchange rate fluctuations, volatility of, and decreases
in,  trading  prices  of  our  common  stock  and  the  availability  of  needed  financing  on  acceptable  terms  or  at  all;  our  ability  to  successfully  develop  new
products that garner customer acceptance and generate sales, both domestically and internationally, in the face of substantial competition; our reliance on
an unrelated third party to develop, maintain and host certain web-based food service application software and develop and maintain selected components
of our downloadable software applications pursuant to a non-exclusive license agreement, and the risk that interruptions in our relationship with that third
party  could  materially  impair  our  ability  to  provide  services  to  our  food  service  technology  customers  on  a  timely  basis  or  at  all  and  could  require
substantial expenditures to find or develop alternative software products; our ability to successfully transition our business into the food service technology
market;  our ability to remediate the material weakness over internal control over financial reporting; risks associated with potential future acquisitions;
general economic conditions; our dependence on contract manufacturers for the assembly of a large portion of our products in Asia; our dependence on
significant  suppliers;  our  ability  to  recruit  and  retain  quality  employees  as  the  Company  grows;  our  dependence  on  third  parties  for  sales  outside  the
United States; marketplace acceptance of new products; risks associated with foreign operations; the availability of third-party components at reasonable
prices;  price  wars  or  other  significant  pricing  pressures  affecting  the  Company’s  products  in  the  United  States  or  abroad;  increased  product  costs  or
reduced customer demand for our products due to changes in U.S. policy that may result in trade wars or tariffs; our ability to protect intellectual property;
the effect of the United Kingdom’s withdrawal from the European Union; and other risk factors identified and discussed in Part I, Item 1A, Risk Factors,
and Part II, Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, of this Form 10-K and that may be detailed
from time to time in the Company’s other reports filed with the Securities and Exchange Commission (the “SEC”).

We  caution  readers  not  to  place  undue  reliance  on  forward-looking  statements,  which  speak  only  as  of  the  date  of  this  Form  10-K.    We  undertake  no
obligation to public publicly or otherwise revise any forward-looking statements, whether as a result of new information, future events or other factors,
except where we are expressly required to do so by law.

Item 1. Business.

The Company
TransAct Technologies Incorporated (together with its consolidated subsidiaries, “TransAct,” the “Company,” “we,” “us,” or “our”) was incorporated in
June  1996  and  began  operating  as  a  stand-alone  business  in  August  1996  as  a  spin-off  of  the  printer  business  that  was  formerly  conducted  by  certain
subsidiaries of Tridex Corporation.  We completed an initial public offering on August 22, 1996.

TransAct is a global leader in developing and selling software-driven technology and printing solutions for high growth markets including food service
technology, point of sale (“POS”) automation, casino and gaming, and oil and gas.  Our world-class products are designed from the ground up based on
market and customer requirements and are sold under the BOHA!™, AccuDate™, Epic®, EPICENTRAL™, Ithaca®, and Printrex® brand names.  During
2019, we launched a new line of products for the food service technology market, the BOHA! branded suite of cloud-based applications and companion
hardware solutions.  The new BOHA! software and hardware products help restaurants, convenience stores and food service operators of all sizes automate
the food production in the back-of-house operations.  Known and respected worldwide for innovative designs and real-world service reliability, our thermal
printers and terminals generate top-quality labels, coupons and transaction records such as receipts, tickets and other documents, as well as printed logging
and plotting of data.  We sell our technology to original equipment manufacturers (“OEMs”), value-added resellers, select distributors, as well as directly to
end-users.    Our  product  distribution  spans  across  the  Americas,  Europe,  the  Middle  East,  Africa,  Asia,  Australia,  New  Zealand,  Latin  America,  the
Caribbean Islands and the South Pacific. We also offer world-class service, support, labels, spare parts, accessories and printing supplies to our growing
worldwide base of products currently in use by our customers. Through our TransAct Services Group (“TSG”), we provide a complete range of supplies
and  consumables  used  in  the  printing  activities  of  customers  in  the  restaurant  and  hospitality,  retail,  casino  and  gaming,  government  and  oil  and  gas
exploration  markets.    Through  our  webstore,  www.transactsupplies.com,  and  our  direct  selling  team,  we  address  the  demand  for  these  products.  Our
primary operating, hardware research and development, and U.S. service center is located in Ithaca, New York.  In addition, we have a casino and gaming
sales  headquarters  and  software  research  and  development  in  Las  Vegas,  Nevada;  a  European  sales  and  service  center  at  our  subsidiary  in  the  United
Kingdom (“UK”); and a sales office located in Macau, China.  Our executive offices are located at One Hamden Center, 2319 Whitney Avenue, Suite 3B,
Hamden, Connecticut, 06518, with a telephone number of (203) 859-6800.

1

Impact of the COVID-19 Pandemic
In  December  2019,  a  novel  strain  of  coronavirus  and  the  disease  it  causes,  commonly  known  as  COVID-19,  was  first  reported  in  China  and  has  since
widely impacted the global public health and economic environment.  In March 2020, the World Health Organization declared COVID-19, including all
additional  variations  and  strains  thereof,  a  global  pandemic.    Our  business  trends  through  the  first  two  months  of  2020  were  in  line  with  internal
expectations;  however,  the  challenges  posed  by  the  COVID-19  pandemic  on  the  United  States  and  global  economy  increased  significantly  as  the  first
quarter of 2020 progressed and continued throughout the remainder of 2020.  Unfortunately, the massive economic and social disruptions across the world
persist due to COVID-19 and the measures implemented to mitigate its spread.  The food service, casino and gaming, and oil and gas industries have been
particularly affected by the pandemic, and we expect such disruptions to continue to negatively impact our overall business for the foreseeable future.

As a result of the COVID-19 pandemic and measures implemented to mitigate its spread, we experienced decreased demand for our products and lower
than anticipated sales beginning in the second half of March 2020 and continuing through the end of 2020, particularly in our food service technology and
casino and gaming markets.  We experienced some improvement in demand during the second half of 2020 compared to the second quarter of 2020, as
some state and local governments lifted certain measures implemented earlier in 2020 to mitigate the spread of the virus, however demand remained lower
than 2019, and we expect this trend to continue through at least the first half of 2021.  Below is a discussion of the impact of COVID-19 that we have
experienced, and that we believe we will continue to experience for the foreseeable future in each of our markets.

Food  service  technology  and  POS  automation.    In  both  our  food  service  technology  and  POS  automation  markets,  many  restaurants  and  food  service
establishments that were closed during much of the second quarter of 2020 started to reopen as state and local governments began to ease restrictions put in
place in response to the pandemic.  Many of our customers have opened under restrictions that limit them to providing drive through, take-out or delivery
service without dine-in options, as well as limiting the volume of customers and employees on site at any one time.  During the third and fourth quarters of
2020, we experienced sales improvement compared to the second quarter of 2020, as these food service customers reopened for business.  However, during
the fourth quarter of 2020, restaurants were again impacted by a resurgence of the pandemic.  Notwithstanding the gradual resumption of limited operations
that began in the third quarter of 2020, our food service technology and POS automation customers continue to recover from the financial impact of being
closed  for  several  months  and  we  expect  new  capital  expenditures  to  be  a  lower  priority  for  them  in  the  near  term,  which  we  believe  will  continue  to
negatively impact sales of BOHA! hardware, software and label products, as well as sales of POS printers.  However, food service providers have been and
are likely to continue to be required to develop and implement new or enhanced policies and operating procedures regarding cleaning, sanitizing and social
distancing to ensure the safety of their employees and customers.  We believe that our BOHA! hardware, software and label products could prove to be
helpful to our food service customers in efficiently and effectively managing and complying with these new procedures, especially as many establishments
are and will likely continue to be operating with reduced staff levels.

Casino and gaming.   In the casino and gaming market, most casinos and other gaming establishments were closed worldwide during most of the second
quarter  of  2020.    Many  casinos  began  to  reopen  in  late  May  and  early  June  2020,  but  similar  to  restaurants,  casino  openings  were  slow  and  measured,
starting with reduced capacity and limited game play based on social distancing guidelines.  During the fourth quarter of 2020, some casinos re-closed due
to a resurgence of the pandemic.  We anticipate that casinos will continue to limit capacity in the near term and will progressively increase capacity over
time.  As casinos gradually recover from the financial impact of being closed for several months, we expect that casinos’ appetite for purchases of new slot
machines will be diminished, which we believe is likely to negatively impact sales of casino and gaming printers purchased by slot manufacturers for use in
slot machines at casinos during 2021.

Lottery.  We exited the lottery market at the end of 2019 and IGT made a final purchase of our lottery printer during the second quarter of 2020.  Therefore,
COVID-19 has not had an impact our lottery printer sales, and we do not anticipate that it will have an impact on our future lottery printer sales.

Printrex.  The oil and gas market has been negatively impacted by the decline in worldwide oil prices attributable to the COVID-19 pandemic.  Due to the
uncertainty of current and future market conditions, we believe sales of our Printrex oil and gas printers will continue to be negatively impacted until oil
and gas prices recover.

TSG.  Due to closures and reduced operating capacity of restaurants, food service establishments, casinos and other gaming establishments resulting from
the COVID-19 pandemic, sales of spare parts, service and consumable products have declined, and we expect such sales to remain at reduced levels, due to
lower usage while the pandemic persists.

Our gross margin has been negatively impacted and we expect our gross margin to continue to be negatively impacted by the COVID-19 pandemic.  As a
result  of  an  expected  significantly  lower  sales  level,  we  believe  our  gross  margin  will  decline  due  to  fixed  manufacturing  overhead  expenses  (such  as
facility costs, depreciation, etc.) that cannot be reduced or eliminated even with the lower sales level.

We  have  also  experienced  supply  chain  disruptions,  including  delayed  product  shipments  from  our  two  contract  manufacturers  located  in  China  and
Thailand that conduct almost all of our printer and terminal manufacturing, due to reduced operations and parts shortages at these facilities.  To date, these
disruptions have only minimally impacted deliveries to customers due to our high inventory levels and reduced demand for our products.  However, if the
delays are sustained or additional disruptions from the pandemic occur, we may have insufficient inventory levels and our ability to deliver products to our
customers on time or at all may be impaired.

2

While it is difficult to predict the magnitude of the ultimate impact that the pandemic and the responsive measures will have on our customers and our
business, we took several actions during 2020 to manage our expenses during these turbulent and uncertain times.  Such steps included:

● a  reduction  of  our  workforce  starting  in  July  2020  by  approximately  20%  through  a  combination  of  employee  terminations  and  temporary
furloughs.  During the fourth quarter, we brought back all furloughed employees.  As of December 31, 2020 our overall headcount was reduced by
approximately 16% when compared to December 31, 2019;

● a 10% reduction in the salaries of all salaried, non-commissioned employees, including executive officers, starting in March 2020.  From May 1,
2020 until early July 2020, employees below the vice president level were paid their full salary as a result of the receipt of the PPP Loan proceeds
(defined below).  All employee full salaries were reinstated on January 1, 2021;

● a reduction in sales commissions for all commissioned employees starting in March 2020 through the end of 2020;

● a 10% reduction of cash retainer fees for all non-employee directors starting in March 2020 through the end of 2020; and

● the elimination of discretionary spending wherever possible starting in March 2020, which has continued into the first quarter of 2021.

In addition, we took measures to increase liquidity, including the following:

● Public Offering – On October 16, 2020, the Company raised net proceeds of $8.7 million, after deducting underwriting discounts, commissions
and offering expenses, through an underwritten public offering (the “Offering”) and sold an aggregate of 1,380,000 shares of common stock.

● PPP Loan – On May 1, 2020 (the “Loan Date”), the Company was granted a $2.2 million loan (the “PPP Loan”) under the Paycheck Protection
Program (the “PPP”) administered by the Small Business Administration (“SBA”) established under Division A, Title I of the Coronavirus Aid,
Relief,  and  Economic  Security  (“CARES”)  Act,  which  enabled  us  to  return  our  furloughed  employees  to  full  time  employment  and  to  restore
certain pay cuts until the PPP Loan proceeds were exhausted.

● New Credit Facility – On March 13, 2020, we entered into a new credit facility with Siena Lending Group LLC that provides a revolving credit

line of up to $10.0 million, subject to a borrowing base.

● Reduced Capital Expenditures – We limited capital expenditures during 2020.

Since the onset of the pandemic, our top priority has been to ensure the health and safety of our employees while continuing to provide our customers with
high-quality, personalized service. On March 20, 2020, we instituted work-from-home practices for the majority of our employees to reduce the spread of
COVID-19  and  to  comply  with  government  mandates.  Because  most  of  our  employees  already  had  laptop  computers  with  remote  access  into  our  IT
systems, we have experienced only minor reductions in productivity and minimal costs related to the implementation of our work-from-home practices.  In
addition, even with the move to a work-from-home environment, our existing internal control structure remained operational and unchanged.

Our distribution centers, deemed an essential service, have remained operational throughout the pandemic.  We implemented a new COVID-19 policy to
specifically address health and safety guidelines for employees to adhere to and follow when at work or returning to work.  This policy was based on the
COVID-19 safety guidelines recommended by the Centers for Disease Control and Prevention and implements the following operations procedures:

● staggered shifts and a rotational or flexible work schedule to minimize the number of employees at any particular facility at a single time;
● mandated use of protective equipment, such as masks and gloves, when in common areas, which is provided to employees;
● spaced seating in workspaces such as manufacturing cells, lunch/break rooms, conference rooms and other common areas to comply with social

distancing guidelines;

● employees who (i) show symptoms of COVID-19 or (ii) have been exposed to someone who shows symptoms or has tested positive for COVID-

19 are prohibited from reporting to work for 10 days;

● visitors are prohibited from entering all facilities;
● cleaning and disinfecting protocols at all facilities; and
● daily temperature checks of all employees before entering all facilities.

We have evaluated the recoverability of the assets on our Consolidated Balance Sheet as of December 31, 2020 in accordance with relevant authoritative
accounting literature. We considered the disruptions caused by the COVID-19 pandemic, including lower than previously forecasted sales and customer
demand,  a  decline  in  the  price  of  our  common  stock  and  macroeconomic  factors  potentially  impacting  accounts  receivable,  inventory,  investments,
intangible  assets,  goodwill  and  other  assets  and  liabilities.    Where  forward-looking  estimates  are  required,  we  made  a  good-faith  estimate  based  on
information available as of the balance sheet date. We have continued to monitor for indicators of impairment through the date of this Report and reflected
accordingly in the accompanying condensed consolidated financial statements.

Notwithstanding the foregoing, there is no assurance that the actions we have taken in response to the pandemic are sufficient or adequate, and we may be
required  to  take  additional  preventive  or  responsive  measures,  as  the  ultimate  extent  of  the  effects  of  the  COVID-19  pandemic  on  the  Company,  our
financial condition, results of operations, liquidity, and cash flows are uncertain and are dependent on evolving developments which cannot be predicted at
this time.  See Part I, Item 1A, Risk Factors, of this Form 10-K for further discussion of risks related to COVID-19.

3

Products, Services and Distribution Methods

Printers, terminals and other hardware: TransAct designs, develops and markets a broad array of transaction-based and specialty printers and terminals
utilizing  thermal  printing  technology  for  applications,  primarily  in  the  food  service  technology,  POS  automation,  casino  and  gaming,  and  oil  and  gas
printing markets.  Our printers and terminals are configurable and offer customers the ability to choose from a variety of features and functions.  Options
typically include interface configuration, mounting configuration, paper cutting devices, paper handling capacities and cabinetry color.  Our food service
technology  terminals  also  offer  software  configurable  menu  options.    Our  food  service  technology  market  also  includes  sales  of  hardware  products
including handheld devices, tablets, temperature probes and temperature sensors and gateways.

Food Service Technology: The primary offering in the food service technology market is our BOHA! ecosystem, which combines our latest generation
terminal, cloud-based software applications and related hardware into a unique solution to automate back-of-house operations in restaurants, convenience
stores and food service operations.  The software component of BOHA! consists of a suite of software-as-a-service (“SaaS”)-based applications, including
applications  for  inventory  management,  temperature  monitoring  of  food  and  equipment,  timers,  food  safety  labeling,  food  recalls,  checklists  and
procedures, equipment service management, and delivery management.  Any and all these applications can be chosen by our customer and packaged into a
single platform with the associated hardware, which includes the BOHA! terminal, handheld devices, tablets, temperature probes and temperature sensors
and gateways. The BOHA! terminal combines the software and hardware components in a device that includes an operating system, touchscreen and one or
two  thermal  print  mechanisms  that  print  easy-to-read  food  rotation  labels,  grab-and-go  labels  for  prepared  foods,  nutritional  labels  and  “enjoy  by”  date
labels.  The BOHA! terminal is equipped with the TransAct Enterprise Management System to ensure that only approved applications and functions are
available on the device and allows over-the-air updates to the applications and operating system.  BOHA! helps food service establishments and restaurants
(including  fine  dining,  casual  dining,  fast  casual  and  quick-serve  restaurants,  convenience  stores,  hospitality  establishments  and  contract  food  service
providers) effectively manage food safety and grab-and-go initiatives, as well as automate and manage back-of-house operations.  Recurring revenue from
BOHA! is generated by software sales, including software subscriptions that are charged to customers upfront on a per-application basis, as well as sales of
labels, extended warranty and service contracts, and technical support services.  In the food service technology market, we use an internal sales force to
solicit sales directly from end users.

POS automation: In the POS market, we sell several models of printers utilizing thermal printing technology.  Our POS printers are used primarily by
quick-serve restaurants located either at the checkout counter or within self-service kiosks to print receipts for consumers or print on linerless labels.  In the
POS market, we primarily sell our products through a network of domestic and international distributors and resellers.  We use an internal sales force to
manage sales through our distributors and resellers, as well as to solicit sales directly from end-users.  Prior to 2020, revenue in this market included sales
of inkjet printers used by banks, credit unions and other financial institutions to print deposit or withdrawal receipts and/or validate checks at bank teller
stations.  We exited the banking market during 2018 and therefore do not expect any future sales. In the banking market, we primarily sold our products
directly to end-user banks and financial institutions through our internal sales force and, to a lesser extent, resellers.

Casino and gaming:  We sell several models of printers used in slot machines and video lottery terminals (“VLTs”) and other gaming machines that print
tickets or receipts instead of issuing coins (“ticket-in, ticket-out” or “TITO”) at casinos, racetracks and other gaming venues worldwide.  These printers
utilize thermal printing technology to print tickets and receipts in monochrome and offer various other features such as jam resistant bezels and a dual port
interface  that  enables  casinos  to  print  coupons  and  promotions.    In  addition,  we  sell  printers  using  thermal  roll-fed  printing  technology  for  use  in
international non-casino establishments, including game types such as Amusements with Prizes, Skills with Prizes, Fixed Odds Betting Terminals, sports
betting  establishments  and  other  off-premise  gaming  type  machines  around  the  world.    We  sell  our  casino  and  gaming  products  primarily  (1)  to  slot
machine manufacturers, who incorporate our printers into slot machines and, in turn, sell completed slot machines directly to casinos and other gaming
establishments and (2) through distributors.  We also maintain a dedicated internal sales force to solicit sales from slot machine manufacturers and casinos,
and to manage sales through our distributors.

We  also  offer  a  software  solution,  the  EPICENTRAL™  Print  System,  including  annual  software  maintenance,  that  enables  casino  operators  to  create
promotional coupons and marketing messages and to print them in real time at the slot machine. With EPICENTRAL™, casinos can utilize the system to
create multiple promotions and incentives to either increase customer time spent on the casino floor or encourage additional visits to generate more revenue
to the casinos.  In 2019, we introduced EPICENTRAL 4.0, which uses the new Acres 4.0 technology that provides EPICENTRAL with true real time slot
machine play data.

Lottery:    Our  lottery  printers  are  designed  for  high-volume,  high-speed  printing  of  lottery  tickets  for  various  lottery  applications.    We  primarily  supply
lottery printers to International Gaming Technology and its subsidiaries (“IGT”), our largest customer and the world’s largest provider of lottery terminals. 
During 2019, we decided to exit this business and we expect no future sales beyond 2020.  Sales of our lottery products were made directly to IGT and
were managed by an internal sales representative before we exited the business in 2019.

Printrex:  Printrex printers include wide format, desktop and rack-mounted and vehicle-mounted black and white thermal printers used by customers to log
and plot oil field, seismic and down hole well drilling data in the oil and gas exploration industry.  The Printrex® brand of printers also includes high-speed
color  inkjet  desktop  printers  used  by  oil  and  gas  field  service  companies  to  print  logs  at  data  centers  of  the  oil  and  gas  field  service  companies.    We
primarily sell our Printrex® products directly to oil field service and drilling companies and OEM’s, as well as through regional distributors in the United
States, Europe, Canada and Asia.

TSG:  Through TSG, we proactively market the sale of consumable products (including POS receipt paper, inkjet cartridges, ribbons and other printing
supplies), replacement parts, maintenance and repair services, refurbished printers, and shipping and handling charges.  Our maintenance services include
the sale of extended warranties, multi-year maintenance contracts, a 24-hour guaranteed replacement product service called TransAct Xpress™ and other
repair  services  for  our  printers  and  terminals.    Within  the  United  States,  we  provide  repair  services  through  our  service  center  in  Ithaca,  New  York. 
Internationally, we provide repair services through our European service center located in Doncaster, UK, and through partners strategically located around
the world.

4

We  also  provide  customers  with  telephone  sales  and  technical  support,  and  a  personal  account  representative  to  handle  orders,  shipping  and  general
information.  Technical and sales support personnel receive training on all our manufactured products and services.  In addition to personalized telephone
and technical support, we also market and sell consumable products 24 hours a day, seven days a week, via our webstore, www.transactsupplies.com.

Sources and Availability of Raw Materials
We design our products to optimize product performance, quality, reliability and durability.  These designs combine cost efficient materials, sourcing and
assembly methods with high standards of workmanship.  Almost all of our printers and terminals are produced by two third-party manufacturers located in
China  and  Thailand.    A  small  portion  of  our  products  are  assembled  in  our  Ithaca,  New  York  facility  largely  on  a  configure-to-order  basis  using
components and subassemblies that have been sourced from vendors and contract manufacturers around the world.

We  procure  component  parts  and  subassemblies  for  use  in  the  assembly  of  our  hardware  products  in  Ithaca,  New  York.    Critical  component  parts  and
subassemblies  include  thermal  print  heads,  printing/cutting  mechanisms,  power  supplies,  motors,  injection  molded  plastic  parts,  LCD  screens,  circuit
boards  and  electronic  components,  which  are  obtained  from  domestic  and  foreign  suppliers  at  competitive  prices.    As  a  result  of  the  majority  of  our
production being performed by our contract manufacturers, the majority of our purchases consist of fully-assembled printers and terminals produced by our
contract  manufacturers  and,  to  a  much  lesser  extent,  component  parts.    We  typically  strive  to  maintain  more  than  one  source  for  our  component  parts,
subassemblies and fully assembled printers and terminals to reduce the risk of parts shortages or unavailability.  However, we could experience temporary
disruption if certain suppliers ceased doing business with us, as described below.

We currently buy a majority of our thermal print mechanisms, an important component of our thermal printers, and fully assembled printers for several of
our printer and food service technology terminal models, from one foreign contract manufacturer in China and to a lesser extent, one other foreign contract
manufacturer  in  Thailand.    Although  we  believe  that  other  contract  manufacturers  could  provide  similar  thermal  print  mechanisms  or  fully  assembled
printers and terminals, on comparable terms, a change in contract manufacturers could cause a delay in manufacturing and possible loss of sales, which
may have a material adverse effect on our operating results.  Although we do not have supply agreements with our foreign contract manufacturers, our
relationship  with  both  remain  strong  and  we  have  no  reason  to  believe  that  either  will  discontinue  their  supply  of  thermal  print  mechanisms  or  fully
assembled printers to us during 2021 or that their terms to us will be substantially less favorable than they have been historically.  Due to the impact from
the  Chinese  tariff  starting  in  2019,  during  2020  we  increasingly  transferred  production  from  our  largest  contract  manufacturer  in  China  to  our  contract
manufacturer in Thailand.  We plan to continue transferring production to our contract manufacturer during 2021.

We currently buy a majority of our thermal print mechanisms, an important component of our thermal printers, and fully assembled printers for several of
our printer and food service technology terminal models, from a foreign contract manufacturer in China and a foreign contract manufacturer in Thailand. 
Although  we  believe  that  other  contract  manufacturers  could  provide  similar  thermal  print  mechanisms  or  fully  assembled  printers  and  terminals,  on
comparable terms, a change in contract manufacturers could cause a delay in manufacturing and possible loss of sales, which may have a material adverse
effect on our operating results.  Although we do not have supply agreements with our foreign contract manufacturers, our relationship with both remain
strong and we have no reason to believe that either will discontinue their supply of thermal print mechanisms or fully assembled printers to us during 2021
or that their terms to us will be substantially less favorable than they have been historically.  Due to the impact from the Chinese tariff starting in 2019,
during 2020 we increasingly transferred production from our contract manufacturer in China to our contract manufacturer in Thailand.  We plan to continue
transferring production to our contract manufacturer in Thailand during 2021.

Patents and Proprietary Information
TransAct relies on a combination of trade secrets, patents, employee and third-party nondisclosure agreements, copyright laws and contractual rights to
establish and protect its proprietary rights in its products.  As of February 28, 2021, we hold 35 United States and 36 foreign patents and have 5 United
States and 3 foreign patent applications pending pertaining to our products.  The duration of these patents ranges from 1 to 19 years.  The expiration of any
individual patent would not have a significant negative impact on our business.  We regard certain manufacturing processes and designs to be proprietary
and  attempt  to  protect  them  through  employee  and  third-party  nondisclosure  agreements  and  similar  means.    It  may  be  possible  for  unauthorized  third
parties  to  copy  certain  portions  of  our  products  or  to  reverse  engineer  or  otherwise  obtain  and  use,  to  our  detriment,  information  that  we  regard  as
proprietary.  Moreover, the laws of some foreign countries do not afford the same protection to our proprietary rights as do the laws of the United States.
There  can  be  no  assurance  that  legal  protections  we  rely  upon  to  protect  our  proprietary  position  will  be  adequate  or  that  our  competitors  will  not
independently develop technologies that are substantially equivalent or superior to our technologies.

Trademarks, Service Marks and Copyrights
We own or have rights to trademarks, service marks, trade names and copyrights that we use in connection with the operation of our business, including our
corporate  names,  logos  and  website  names.  Other  trademarks,  service  marks  and  trade  names  appearing  in  this  Annual  Report  on  Form  10-K  are  the
property  of  their  respective  owners.    The  trademarks  we  own  include  TransAct®,  BOHA!TM,  AccuDate™,  Epic,  EPICENTRAL™,  Ithaca®  and
Printrex®. Solely for convenience, some of the trademarks, service marks, trade names and copyrights referred to in this annual report on Form 10-K are
listed without the ©, ® and ™ symbols, but we will assert, to the fullest extent under applicable law, our rights to our trademarks, service marks, trade
names and copyrights.

Seasonality
Restaurants typically reduce purchases of equipment in the fourth quarter due to the increased volume of transactions during the holiday period, which may
negatively impact sales of our food service technology products or POS printers.

Working Capital
Inventory,  accounts  receivable,  and  accounts  payable  levels,  payment  terms,  and  where  applicable,  return  policies  are  in  accordance  with  the  general
practices of the industry and standard business procedures.  See also Item 7. Management’s Discussion and Analysis of Financial Condition and Results of
Operations.

5

Certain Significant Customers
IGT is our most significant customer and has been since 1995.  We sell both on-line lottery printers and casino and gaming printers to IGT.  On May 29,
2015,  we  signed  an  agreement  with  IGT  to  sell  on-line  lottery  and  casino  printers  to  IGT  on  a  non-exclusive  basis  through  December  31,  2019.      We
decided not to renew the agreement upon its expiration and to exit the on-line lottery market.  Although we no longer have an agreement with IGT, we
expect to continue selling casino and gaming printers to IGT, as well as spare parts for our remaining, but declining, installed base of lottery printers, in the
future but no longer expect to sell on-line lottery printers beyond 2020.

Sales to IGT represented 15% and 14% of our total net sales for the years ended December 31, 2020 and 2019, respectively.

Backlog
Our  backlog  of  firm  orders  was  approximately  $3.4  million  as  of  February  28,  2021,  compared  to  $5.7  million  as  of  February  29,  2020.    Based  on
customers’ current delivery requirements, we expect to fill and recognize as revenue $2.7 million of our current backlog during 2021, $0.4 million during
2022 and the remaining balance of the amount during 2023.

Competition
The market for transaction-based and specialty printers and food service technology terminals is extremely competitive, and we expect such competition to
continue in the future.  However, we experience less competition for EPICENTRALTM software due to the highly customized nature of the product.  We
compete with a number of companies, many of which have greater financial, technical and marketing resources than TransAct.  We believe our ability to
compete successfully depends on a number of factors both within and outside our control, including durability, reliability, quality, design capability, product
customization,  price,  customer  support,  success  in  developing  new  products,  manufacturing  expertise  and  capacity,  supply  of  component  parts  and
materials, strategic relationships with suppliers, the timing of new product introductions by us and our competitors, general market, economic and political
conditions and, in some cases, the uniqueness of our products.

In the food service technology market, we primarily compete with Avery Dennison Corporation, Ecolab Inc., ITD Food Safety, CMC Daymark, Integrated
Control  Corp,  Digi  International,  Squadle  Inc.,  Jolt  Software  and  Zenput.    We  compete  in  this  market  based  largely  on  our  ability  to  provide  highly
specialized  software  and  purpose-built  products  and  ongoing  technical  support.    We  rely  upon  third-party  developed  software  and  hosting  services
combined  with  our  own  proprietary  hardware  and  software  to  offer  a  unique  BOHA!  branded  solution  to  support  back-of-house  operations  in  the  food
service  industry.    Our  competitors  or  others  may  develop,  or  may  establish  relationships  with  developers  with  the  capability  to  develop,  software  and
services  that  are  similar  to  or  competitive  with  ours,  which  may  be  disadvantageous  to  our  competitive  position.    Certain  portions  of  our  food  service
technology software are licensed from a third-party developer on a non-exclusive basis through 2031 and are subject to a revenue sharing arrangement with
the  developer.  We  are  reliant  upon  the  third-party  developer  to  further  develop  and  maintain  their  developed  software,  and  the  developer  controls  the
software source code. The license agreement does not preclude the developer from working with others on similar products. Also, the third party developer
hosts the web-based applications.  Therefore, presently, we are highly dependent upon this third-party developer for continued service to our customers and
the further development of our food service technology software products.

In the POS automation market, we primarily compete with Epson America, Inc., which holds a dominant market position.  We also compete, to a much
lesser extent, with Star Micronics America, Inc. and Citizen -- CBM America Corporation.  Certain competitors of ours have greater financial resources
and lower costs attributable to higher volume production which enables them to occasionally offer lower prices than us.  However, we will continue to
deemphasize efforts in the POS automation market going forward as we have shifted our focus toward our higher-value, technology enabled food service
technology and casino and gaming products.

In the casino and gaming market (consisting principally of slot machine printing, VLT transaction printing and promotional coupon printing), we compete
with several companies including JCM Global, Nanoptix, Inc., Custom Engineering SPA, Eurocoin and others.  Certain of our products sold for casino and
gaming applications compete based upon our ability to provide highly specialized products, custom engineering and ongoing technical support.

In  the  lottery  market  (consisting  principally  of  on-line  lottery  transaction  printing),  we  competed  with  other  lottery  printer  providers  such  as  Custom
Engineering  SPA,  Star  Micronics  and  Wincor  Nixdorf.    However,  we  exited  the  lottery  market  in  2019  and  shifted  our  focus  toward  our  higher-value,
technology enabled food service technology and casino and gaming products.

In the oil and gas market, our Printrex® products compete primarily with the products of Imaging Systems Group, Inc. and Neuralog Inc.  We compete in
this market based largely on our ability to provide specialized, custom-engineered products.

The  market  in  which  TSG  competes  is  highly  fragmented,  and  we  compete  with  numerous  competitors  of  various  sizes,  including  POS  and  internet
resellers and paper converters depending on the geographic area.

Our strategy for competing in our markets is to continually develop and/or license new products (hardware and software), such as our launch of BOHA!TM
in 2019, and product line extensions that are technologically advanced and provide differentiated features and functions, to increase our market penetration,
to take advantage of strategic relationships, and to lower the cost of our products by sourcing certain products overseas.  Although we believe that our
products,  operations  and  relationships  provide  a  competitive  foundation,  there  can  be  no  assurance  that  we  will  compete  successfully  in  the  future.    In
addition,  our  products  utilize  certain  thermal  printing  technologies  and  licensed  software.    If  new  technologies  are  introduced,  or  existing  technologies
evolve,  we  may  be  required  to  incorporate  these  technologies  into  our  products.    Alternatively,  if  such  technologies  were  to  become  available  to  our
competitors, our products could become obsolete, which could have a significant negative impact on our business.

Environmental Compliance
Our compliance with federal, state and local laws and regulations relating to environmental protection and discharge of hazardous materials has not had a
material impact on our capital expenditures, earnings or competitive position, and we do not anticipate any material impact from such compliance in the
future.

6

Available Information
We make available free of charge through the “Investor Relations” tab on our Internet website, www.transact-tech.com, our Annual Report on Form 10-K,
quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements and all amendments to those reports and statements as soon as reasonably
practicable  after  such  material  is  electronically  filed  with  or  furnished  to  the  SEC  pursuant  to  Sections  13(a)  or  15(d)  of  the  Exchange  Act.    The  SEC
maintains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC at http;//www.sec.gov. 
The content on any website referred to in this Form 10-K is not incorporated by reference in this Form 10-K unless expressly noted.

Employees
As  of  December  31,  2020,  TransAct  and  our  subsidiaries  employed  112  persons,  all  of  whom  were  full-time  employees.    None  of  our  employees  are
unionized, and we consider our relationships with our employees to be good.

Information about our Executive Officers

The following is a list of the names and ages of all executive officers of the registrant, indicating all positions and offices with the registrant held by each
such person and each person’s principal occupations and employment during at least the past five years.

Name
Bart C. Shuldman
Steven A. DeMartino
Donald E. Brooks
Tracey S. Chernay
Andrew J. Hoffman
David B. Peters
Brent Richtsmeier
Raymond T. Walsh, Jr.

Age
63
51
68
61
63
42
56
35

  Position
  Chairman of the Board and Chief Executive Officer
  President, Chief Financial Officer, Treasurer and Secretary
  Senior Vice President, Engineering
  Senior Vice President, Casino, Gaming and Lottery Sales
  Senior Vice President, Operations
  Vice President and Chief Accounting Officer
  Senior Vice President, Software Engineering
  Senior Vice President, Global Sales

Bart C. Shuldman has been Chief Executive Officer and a Director of the Company since its formation in June 1996.  In February 2001, Mr. Shuldman was
elected Chairman of the Board.  Mr. Shuldman served as President of the Company from its formation until June 2010, when he relinquished the President
title, to focus on new products and markets, international expansion and potential acquisitions.

Steven A. DeMartino was named as TransAct’s President, Chief Financial Officer, Treasurer and Secretary on June 1, 2010.  Previously, Mr. DeMartino
served  as  Executive  Vice  President,  Chief  Financial  Officer,  Treasurer  and  Secretary  from  June  2004  to  May  2010,  Senior  Vice  President,  Finance  and
Information  Technology  from  October  2001  to  May  2004,  Vice  President  and  Corporate  Controller  from  January  1998  to  October  2001,  and  Corporate
Controller from August 1996 to December 1997.  Mr. DeMartino is a certified public accountant.

Donald E. Brooks was appointed Senior Vice President of Engineering in April 2012.  Previously, Mr. Brooks served as Vice President, Engineering from
September  2004  to  April  2012,  Senior  Project  Engineer  from  February  1998  to  September  2004,  Project  Engineer  from  June  1997  to  February  1998,
Director of Electrical Engineering from March 1986 to June 1997 and Manager of Electronic Development from December 1983 to March 1986.

Tracey  S.  Chernay  was  appointed  Senior  Vice  President,  Casino  and  Gaming  Sales  and  Marketing  in  June  2010,  with  responsibility  for  the  sales  and
marketing of all casino and gaming products.  Previously, Ms. Chernay served as Senior Vice President, Sales and Marketing from June 2007 to May 2010,
Senior Vice President, Marketing and Sales, POS and Banking with the Company from July 2006 to June 2007, and joined TransAct in May of 2005 as
Senior Vice President, Marketing.  Prior to joining TransAct, Ms. Chernay was employed with Xerox Corporation where she held the role of Manager,
Worldwide Marketing since 2003, and Manager, Sales Operations from 2000 to 2002.  She joined Xerox Corporation in 1983.

Andrew J. Hoffman was appointed Senior Vice President, Operations for TransAct worldwide in November 2004.  He served as Vice President, Operations
from September 1994 to November 2004.

David  B.  Peters  was  appointed  Vice  President  and  Chief  Accounting  Officer  on  March  1,  2018.    Previously,  Mr.  Peters  served  as  Director,  SEC  and
Financial Reporting since joining TransAct in March 2014.  Prior to joining TransAct, Mr. Peters was employed with United Technologies Corporation
from November 2006 to March 2014 where he served in various financial management positions.  Mr. Peters is a certified public accountant.

Brent Richtsmeier was hired as Senior Vice President, Software Engineering on December 9, 2019 and appointed as an officer of the Company on January
11, 2021.  Prior  to  joining  TransAct,  Mr.  Richtsmeier  was  employed  with  Samsung  as  the  VP  of  Development  where  he  was  responsible  for  software
strategy, software development at scale and business development.

Raymond T. Walsh, Jr. was appointed Senior Vice President, Global Sales on February 27, 2019.  Previously, Mr. Walsh served as Vice President, Global
Sales since 2018.  Mr. Walsh joined TransAct in 2006 and has held several sales positions of increasing responsibility with the Company.  Prior to joining
TransAct, Mr. Walsh served as the Senior Manager of Business Development at Nerac.

There are no family relationships between any of our executive officers and there is no arrangement or understanding between any of such officers and any
other person pursuant to which he or she was selected as an officer.  Each of our executive officers was elected by the Board of Directors to hold office
until his or her successor is elected and qualified or until his or her earlier resignation or removal.

7

 
 
 
 
 
 
 
 
 
Item 1A. Risk Factors

Investors  should  carefully  consider  the  risks,  uncertainties  and  other  factors  described  below,  as  well  as  other  disclosures  in  Item  7.  Management’s
Discussion and Analysis of Financial Condition and Results of Operations, because they could have a material adverse effect on our business, financial
condition, operating results, and growth prospects.  The risks described below are not the only ones facing our Company.  Additional risks and uncertainties
not  presently  known  to  us,  or  that  we  currently  believe  to  be  immaterial,  may  also  impair  our  business  operations.      In  the  event  that  such  risks  or
uncertainties materialize, our business, financial condition, and results of operations could be materially adversely affected.

We assume no obligation (and specifically disclaim any such obligation) to update these Risk Factors or any other forward-looking statements contained in
this Form 10-K to reflect actual results, changes in assumptions or other factors affecting such forward-looking statements, except as required by law.

Risks Related to our Business

We experienced a net loss in 2020, anticipate increasing expenses in the future, and we may not be able to achieve, maintain or increase profitability in
the future.
We incurred a net loss of $5.6 million in 2020, we anticipate increasing expenses in the future, and we may not be able to achieve, maintain or increase
profitability in the future. We expect our costs will increase over time and our losses to continue as we expect to invest significant additional funds towards
growing our food service technology business and transitioning away from other lines of business. We have expended and expect to continue to expend
substantial financial and other resources on developing our food service technology business, including expanding our offerings, developing or acquiring
new products and services and increasing our sales and marketing efforts. These efforts may be more costly than we expect and may not result in increased
revenue or growth in our food service technology business. Any failure to increase our revenue sufficiently to keep pace with our investments and other
expenses  could  prevent  us  from  achieving,  maintaining  or  increasing  profitability  or  positive  cash  flow  on  a  consistent  basis.  If  we  are  unable  to
successfully  address  these  risks  and  challenges  as  we  encounter  them,  our  business,  financial  condition,  and  results  of  operations  could  be  adversely
affected.  If we are unable to generate adequate revenue growth and manage our expenses, we may continue to incur significant losses in the future and
may not be able to achieve, maintain or increase profitability

Our operating results and financial condition may fluctuate.
Our operating results and financial condition may fluctuate from quarter-to-quarter and year-to-year and are likely to continue to vary due to a number of
factors, many of which are not within our control.  If our operating results do not meet the expectations of securities analysts or investors, who may derive
their expectations by extrapolating data from recent historical operating results, the market price of our common stock will likely decline.  Fluctuations in
our  operating  results  and  financial  condition  may  be  due  to  a  number  of  factors,  including,  but  not  limited  to,  those  identified  throughout  this  “Risk
Factors” section:

● delays  between  our  expenditures  to  develop  and  market  new  or  enhanced  products  and  consumables  and  the  generation  of  sales  from  those

products;

● the geographic distribution of our sales and our supply chain;
● market acceptance of our products, both domestically and internationally;
● development of new competitive products by others;
● our responses to price competition;
● our level of research and development activities;
● changes in the amount that we spend to develop, acquire or license new products, consumables, technologies or businesses;
● changes in the amount we spend to promote our products and services;
● changes in the cost of satisfying our warranty obligations and servicing our installed base of products;
● availability of third-party components at reasonable prices;
● general  economic  and  industry  conditions,  including  changes  in  interest  rates  affecting  returns  on  cash  balances  and  investments,  that  affect

customer demand;

● fluctuations of world-wide oil and gas prices;
● the dependence of our supply chain on a few, foreign third-party manufacturers and suppliers;
● severe weather events, public health crises, and other external events out of our control that can disrupt our operations or the operations of our

customers’ or suppliers’ facilities; and

● changes in accounting rules.

Due to all of the foregoing factors, and the other risks discussed in this Form 10-K, quarter-to-quarter comparisons of our operating results may not be an
indicator of future performance.

8

The  COVID-19  pandemic  has  had,  and  is  likely  to  continue  to  have,  an  adverse  impact  on  our  business,  operations,  financial  condition,  results  of
operations and capital resources, as well as on the operations and financial performance of many of our suppliers and customers. We are unable to
predict  the  ultimate  extent  to  which  the  pandemic  and  related  effects  will  adversely  impact  our  business,  operations,  financial  condition,  results  of
operations, capital resources and the achievement of our strategic objectives.
As a result of the COVID-19 pandemic and the numerous disease control measures being taken to limit the spread of COVID-19, we have experienced, and
can be expected to continue to experience, disruptions to our business, our operations, the delivery of our products and customer demand for our products,
including the following:

● operating  losses  in  excess  of  those  we  anticipated  in  transitioning  our  business  focus  toward  the  food  service  technology  market,  which,  in
addition to the factors discussed below, may require us to seek to obtain additional capital through debt or equity financings or other arrangements
to fund operations, or if such arrangements are not available, to take additional significant cost-cutting measures;

● supply  chain  disruptions,  including  delayed  product  shipments  from  two  contract  manufacturers  located  in  China  and  Thailand  that  conduct
substantially all of our printer and terminal manufacturing, which, if sustained, could lead to insufficient inventory levels and harm our ability to
deliver products to our customers on time or at all;

● continuing or new restrictions on the  operations of our customers in the casino industry and food service industry, including, in some cases, partial
or  complete  business  shutdowns,  which  have  resulted  in,  and  are  likely  to  continue  to  result  in,  reduced  demand  for  our  products  in  the  two
primary markets that we serve;

● an inability of our customers to make payments in a timely fashion or at all, which may continue even after operating restrictions are lifted in the

event that the downturn in economic conditions persist;

● devotion of significant time, management attention and resources to monitoring the COVID-19 pandemic and its impacts, and anticipated impacts,
on our business, and seeking to mitigate the effects of the pandemic on our business and workforce, which diverts management’s attention and
resources away from strategic initiatives, new business opportunities, the transition of our business toward the food service and casino and gaming
markets, and the overall profitability of our  business;

● necessary modifications to our business practices and operations, including suspension of employee travel, cancellation of physical participation in
meetings, events and conferences and social distancing measures, including work-from-home policies, and such further actions as may be required
by government authorities or that we determine are in the best interests of our employees, customers and suppliers, which may adversely impact
efficiency  and  productivity  and  may  increase  operational  risks,  including  cybersecurity  risks,  and  have  affected  the  way  that  we  conduct  our
product development, marketing, customer support and other activities;

● a permanent reduction in workforce, furlough of workers and an across-the-board 10% salary reduction, as well as other cost-cutting measures we
have taken to help mitigate the impact of the COVID-19 crisis on our business, which may, along with any additional such measures that may be
taken in the future, impair our ability to operate and have a negative effect on employee loyalty and our reputation and, if furloughed employees
do not return following the crisis, or if employees seek higher-paying jobs, may limit our ability to restart operations following the crisis and to
grow our food service technology business as planned;

● a possible future reduction in the value of goodwill or other intangible assets causing the carrying value of such assets to exceed their fair value,

which could require us to recognize asset impairment;

● difficulty  predicting  our  manufacturing  requirements  accurately  due  to  volatile  economic  conditions  and  uncertainty  as  to  when  our  customers
may resume operations, which could result, in the case of an underestimate, in inadequate manufacturing capacity or inventory, interruptions in
production  and  delayed  deliveries  to  customers  (with  resulting  losses  in  orders  or  customers  lowering  our  net  sales),  or  in  the  case  of  an
overestimate, in an excess inventory of component parts or manufactured products;

● increases in prices and/or decreases in availability of component parts and raw materials needed to produce our products;
● foreign exchange rate fluctuations due to volatile global economic conditions, which could negatively affect earnings and the value of our assets

held outside the United States, and if we increase prices to absorb a portion of the currency impact, could cause demand to decrease;

● volatility of, and decreases in, trading prices of our common stock; and
● the possibility that we may need to raise additional capital through an equity or debt financing to support operations but are unable to do so due to,
among other things, global economic conditions, conditions in the global financing markets, trading prices of our common stock and the outlook
for the industries that we serve, all of which could be negatively impacted by the COVID-19 pandemic, such that there can be no assurance that
such financing would be available to us.

If we issue equity or debt securities to raise additional funding, our existing shareholders may experience dilution and we may incur significant financing
costs.  If we issue debt securities or otherwise incur additional debt, we would have additional debt service obligations, could become subject to additional
restrictions limiting our ability to operate our business, and may be required to further encumber our assets.

The COVID-19 pandemic continues to evolve rapidly, and additional material impacts and disruptions may occur. The factors described above, which may
worsen, have had and, along with other factors that we cannot predict, can be expected to continue to have, a material adverse impact on our business,
operations, financial condition, results of operations and capital resources.  The ultimate impact of the COVID-19 pandemic on the Company is highly
uncertain and subject to change and will depend on future developments, which cannot be accurately predicted, including the duration of the pandemic,
additional  or  modified  government  actions,  new  information  that  may  emerge  concerning  the  severity  and  impact  of  the  COVID-19  pandemic,  newly
identified strains of COVID-19, the rollout and effectiveness of vaccines and treatments and the actions taken to contain COVID-19 or address its impact in
the short and long term, among others. We do not yet know and cannot predict the full extent of potential impacts on our business, operations, financial
condition, results of operations and capital resources.

In addition, any of the risks and uncertainties set forth in this Form 10-K can be expected to be further heightened by the COVID-19 pandemic and have a
material adverse effect on the Company’s business, prospects, financial condition, results of operations and capital resources and the achievement of our
strategic objectives

9

Our revenue and profitability depend on our ability to continue to develop or license, on a timely basis, new products and technologies which are free
from hardware or software anomalies and cannot be fraudulently manipulated, and customer acceptance of such products.
Our success depends upon our and our development partners’ ability to timely adapt our capabilities and processes to meet the demands of producing new
and innovative products.  Because our newer products contain software and generally are more technologically sophisticated than those we have produced
in the past, we must continually refine our capabilities to meet the needs of our product innovation.  If we cannot efficiently adapt our infrastructure to meet
the needs of our product innovations in a timely manner, our business could be negatively impacted.

In addition, even if we, or developers on our behalf, successfully develop such products, there is no assurance that our innovations will be accepted by our
customers.  Developing and marketing new products, such as our BOHA! ecosystem, is costly, and our business could be materially adversely affected if
we are unable to generate sales of such products or if our existing or new customers do not quickly accept such products.  Customer acceptance is crucial
because new products typically have very little competition and market penetration due to their novelty.  Although we develop new products with the input
of our customers, which has contributed to the early success of BOHA!, customer acceptance is never assured and may take time to materialize.  Further,
technological innovation often results in unintended consequences such as bugs, vulnerabilities, and other system failures. Any such bug, vulnerability, or
failure,  especially  in  connection  with  a  significant  technical  implementation  or  change,  could  result  in  lost  business,  harm  to  our  brand  or  reputation,
consumer  complaints,  and  other  adverse  consequences,  any  of  which  could  materially  adversely  affect  our  business,  results  of  operations,  and  financial
condition.

We rely on an unrelated third party to develop, maintain and host certain portions of our food service technology software, and any disruption in the
relationship with that third party, or any defects in the software provided by that third party, could have a material adverse effect on our reputation,
business, financial condition and results of operations.
We rely upon third-party developed software and hosting services combined with our own proprietary hardware and software to offer our unique BOHA!
branded  solution  to  support  back-of-house  operations  in  the  food  service  industry.    Certain  web-based  food  service  application  software  and  selected
components of our downloadable software applications are licensed from a third-party developer on a non-exclusive basis through 2031 and are subject to a
revenue sharing arrangement with the developer. We are reliant upon the third-party developer to further develop and maintain their developed software,
and the developer controls the software source code.  Therefore, presently, we are highly dependent on this third-party developer for continued service to
our customers and the further development of our food service technology software products.    If the software provider were to terminate operations or
otherwise  be  unavailable  to  provide  maintenance,  hosting  and  development  services  to  us  and  our  customers,  the  availability  or  usage  of  our  software
products could be disrupted and our customers could be adversely affected.  In any such case, we may need to seek comparable software and services from
other  third  parties  or  develop  it  internally,  which  could  require  significant  time  and  expense.  There  can  be  no  assurance  that  such  software  or  services
would be available from other sources, or that if available, it would be of comparable quality and cost.  Moreover, any efforts to develop new software,
whether  internal  or  by  third  parties,  would  require  significant  lead  time,  and  there  could  be  an  interruption  in  service  during  any  period  in  which  the
software  provider  ceases  to  provide  products  and  services  and  new  products  remain  under  development.  Any  such  occurrence  could  materially  and
adversely impact our business, financial condition and results of operations.

Any errors or defects in, or failures of, third-party software or applications could result in errors or defects in or failures of our food service technology
products and services, which could be costly to correct and have a material adverse effect on our reputation, business, financial condition and results of
operations

We compete in highly competitive markets, which are likely to become more competitive. Competitors may be able to respond more quickly to new or
emerging technology and changes in customer requirements.
We  face  significant  competition  in  developing  and  selling  our  printers,  terminals,  software,  consumables  and  services.    Our  principal  competitors  have
substantial marketing, financial, development and personnel resources.  To remain competitive, we believe we must continue to provide:

● technologically advanced products that satisfy the user demands;
● superior customer service;
● high levels of quality and reliability; and
● dependable and efficient distribution networks.

We  cannot  ensure  we  will  be  able  to  compete  successfully  against  current  or  future  competitors.    Increased  competition  may  result  in  price  reductions,
lower gross profit margins and loss of market share, and could require increased spending on research and development, sales and marketing and customer
support.  Some competitors may make strategic acquisitions or establish cooperative relationships with suppliers or companies that produce complementary
products, which may include relationships with our software developer.  Any of these factors could reduce our earnings.

Our success will depend on our ability to sustain and manage growth.
As  part  of  our  business  strategy,  we  intend  to  pursue  a  growth  strategy.    Assuming  this  growth  occurs,  it  will  require  the  expansion  of  customer
relationships in international markets, the successful development and marketing of new products for our existing and new markets, expanded internal sales
and  marketing,  customer  service  and  support,  and  the  continued  implementation  and  improvement  of  our  operational,  financial  and  management
information systems.

To the extent that we seek growth through acquisitions, our ability to manage our growth will also depend on our ability to integrate businesses that have
previously  operated  independently.    We  may  not  be  able  to  achieve  this  integration  without  encountering  difficulties  or  experiencing  the  loss  of  key
employees,  customers  or  suppliers.    It  may  be  difficult  to  design  and  implement  effective  financial  controls  for  combined  operations  and  differences  in
existing controls for each business may result in weaknesses that require remediation when the financial controls and reporting functions are combined.  As
we pursue acquisitions, we may incur legal, accounting and other transaction related expenses for unsuccessful acquisition attempts that could adversely
affect our results of operations in the period in which they are incurred.

There can be no assurance that we will be able to successfully implement our growth strategy, or that we can successfully manage expanded operations, if
they occur.  As we expand, we may from time to time experience constraints that will adversely affect our ability to satisfy customer demand in a timely
fashion.  Failure to manage growth effectively could adversely affect our results of operations and financial condition.

10

Material weaknesses in our internal control over financial reporting have been identified, and if we are unable to implement and maintain effective
internal control over financial reporting, or our independent registered public accounting firm is unable to provide an unqualified report thereon, we
could be materially adversely affected.
Material weaknesses in our internal control over financial reporting existed as of December 31, 2018 and 2019 regarding our internal controls over user
access to ensure appropriate segregation of duties and to adequately restrict user access to appropriate personnel.  Specifically, the provisioning and user
recertification  controls  are  not  designed  to  ensure  users  maintain  proper  segregation  of  duties  and  therefore  could  have  inappropriate  access  rights. 
Additionally,  we  identified  a  material  weakness  in  controls  over  key  spreadsheets  supporting  our  accounting  records  as  of  December  2018  and  2019. 
Specifically, we did not design adequate controls to address the completeness and accuracy of information included in key spreadsheets.  During 2020, we
remediated the material weakness related to the provisioning and user recertification controls, but the material weakness related to key spreadsheets still
exists as of December 31, 2020.  As a result of the remaining key spreadsheet material weaknesses, management concluded that our internal control over
financial reporting was not effective as of December 31, 2020.

Unless  and  until  the  material  weakness  has  been  remediated  or  should  new  material  weaknesses  arise  or  be  discovered  in  the  future,  a  material
misstatement could occur and go undetected in our interim or annual consolidated financial statements. As a result, we may experience delays in fulfilling
our reporting obligations or complying with federal securities laws, which could result in investigations and sanctions by regulatory authorities, including,
but not limited to, the SEC, and may result in defaults or accelerations under our credit facility in the event that we are unable to timely file reports with the
SEC, to the extent that in such an event, we are unable to obtain waivers from our lender. Any of these results could adversely affect our business and the
value of our common stock.

We are dependent on sales to one large customer; the loss of this customer or reduction in orders from this customer could materially affect our sales.
Casino and gaming sales and lottery spare part sales to IGT represent a material percentage of our net sales.  A reduction, delay or cancellation in orders
from this customer, including reductions or delays due to market, economic, or competitive conditions in the industries in which we serve, could have a
material adverse effect upon our results of operations.

General economic conditions could have a material adverse effect on our business, operating results and financial condition.
Our  business  is  subject  to  general  economic  conditions.    Uncertainty  or  negative  trends  in  U.S.  or  international  economic  and  investment  climates,
including the impact of Brexit and recent developments in U.S.-China trade relations (discussed separately below), could adversely affect our business.  For
example, customers or potential customers could reduce or delay orders, key suppliers could become insolvent, which could result in production delays,
and  our  customers  may  become  insolvent  or  be  unable  to  obtain  credit.    Any  of  these  possible  effects  could  impact  our  ability  to  effectively  manage
inventory levels and collect receivables, create unabsorbed costs due to lower net sales, and ultimately decrease our net sales and profitability including
write-downs of assets.

Fluctuations in oil and gas prices could adversely affect drilling and exploration activities by oil and gas companies and our revenue in our Printrex
market.  If oil and gas prices remain volatile, or if oil or gas prices decline, the demand for our Printrex products could be adversely affected.
The demand for our Printrex products depends on the level of spending by oil and gas companies for drilling and exploratory activities, which are affected
by short-term and long-term trends in oil and gas prices, including current and anticipated oil and gas prices.  Oil and gas prices, as well as the level of
drilling and exploration, historically have been extremely volatile and are expected to continue to be highly volatile.  Further, oil prices may be impacted by
continuing  political  and  social  attention  to  the  issue  of  climate  change,  state  regulation  of  greenhouse  gas  emissions,  and  executive  orders,  regulatory
actions and/or legislation that the current presidential administration may pursue in furtherance of its stated priority to address climate change.  If oil and
gas prices decline, or if there is a reduction in drilling and exploration activities, the demand for our Printrex products could be materially and adversely
affected.

If market conditions deteriorate or future results of operations are less than expected, a valuation allowance may be required for all or a portion of our
deferred tax assets.
We currently have deferred tax assets, which may be used to reduce taxable income in the future.  We assess the realization of these deferred tax assets on a
quarterly basis, and if we determine that it is more likely than not that some portion of these assets will not be realized, an income tax valuation allowance
is  recorded.    If  market  conditions  deteriorate  or  future  results  of  operations  are  less  than  expected,  or  there  is  a  change  to  applicable  tax  rules,  future
assessments may result in a determination that it is more likely than not that some or all of our net deferred tax assets are not realizable.  As a result, we
may need to establish a valuation allowance for all or a portion of our net deferred tax assets, which may have a material adverse effect on our business,
results of operations and financial condition.

We rely on distributors and resellers to sell our products and services.
We use a variety of distribution channels, including OEMs and distributors, to market and sell our products and services.  We may be adversely impacted
by any conflicts that could arise between and among our various sales channels.

Our dependence upon distributors and resellers exposes us to numerous risks, including:

● loss of channel and the ability to bring new products to market;
● concentration of credit risk, including disruption in distribution should the distributors and / or resellers’ financial condition deteriorate;
● reduced visibility to end user demand and pricing issues which makes forecasting more difficult;
● distributors or resellers leveraging their buying power to change the terms of pricing, payment and product delivery schedules; and
● direct competition should a distributor or reseller decide to manufacture printers internally or source printers from a competitor.

We cannot guarantee that resellers will not reduce, delay or eliminate purchases from us, which could have a material adverse effect upon the business,
consolidated results of operations and financial condition.

11

We are dependent upon two manufacturers located in China and Thailand for the manufacturing and assembly of our printers and terminals, and their
operations were disrupted by the outbreak of COVID-19. The disruption adversely affected the Company’s business, financial conditions and results of
operations, and any further or future disruption in their businesses or operations, such as those caused by political, social or economic instability, trade
restrictions or tariffs, severe weather, additional public health crises and other events out of our control, could materially adversely affect our business,
financial condition and results of operations.
In  an  effort  to  achieve  additional  cost  savings  and  operation  benefits,  we  have  outsourced  substantially  all  of  the  manufacturing  and  assembly  of  our
printers and terminals to two contract manufacturers located in China and Thailand.  As a result, we are dependent on them for the manufacturing of our
products,  and  any  disruption  in  such  manufacturing  or  the  export  of  products  from  these  manufacturers  to  the  U.S.  may  adversely  affect  our  business,
financial condition and results of operations.

Risks affecting the businesses and operations of our two manufacturers in Asia include: political and regional strife; war; labor shortages; severe weather
and  natural  disasters  such  as  earthquakes,  hurricanes,  fires,  and  floods;  lengthy  power  outages;  increased  pricing,  financial  instability  and  capacity
constraints of shippers; and concerns with or threats of public health crises, contagious diseases or health epidemics.  The risk to our business posed by any
disruption in manufacturing is exacerbated by the concentration of our manufacturing operations in two manufacturers both located in Asia.

In response to COVID-19, the Chinese government placed restrictions on travel and mandated business closures. Such restrictions and closures disrupted
our supply chain by delaying product shipments from our contract manufacturers during 2020.

The  ultimate  impact  of  COVID-19  on  our  operations  will  depend  on  future  developments,  which  are  highly  uncertain  and  cannot  be  predicted  with
confidence, including the duration of the outbreak and any resurgences, new information which may emerge concerning the severity of COVID-19 and
newly  identified  strains,  the  rollout  and  effectiveness  of  vaccines  and  treatments  and  the  actions  to  contain  the  virus  or  treat  its  impact,  among  others. 
Without the contract manufacturers continuing to manufacture our products and the continuing operation of the contract manufacturers’ facilities, we will
have  limited  means  for  the  final  assembly  of  a  majority  of  our  products  until  we  are  able  to  secure  the  manufacturing  capability  at  another  facility  or
develop an alternative manufacturing facility, which could be costly and time consuming and have a material adverse effect on our operating and financial
results.

We may also incur increased business continuity and reputational risks to the extent that we continue to outsource the manufacturing and assembly of our
products  to  foreign  third-party  service  providers.    For  example,  outsourcing  of  manufacturing  prevents  us  from  exercising  control  over  the  assembly  of
certain  of  our  products  and  related  operations  or  processes,  including  the  internal  controls  associated  with  operations  and  processes  conducted  and  the
quality of our products assembled by contract manufacturers.  If we are unable to effectively manage and oversee our outsourcing strategy, we may not
realize cost structure efficiencies and our operating and financial results could be materially adversely affected.  Outsourcing also exposes us to increased
risk of infringement or misappropriation of our intellectual property, to which our manufacturers have access.  Because our manufacturers are located in
Asia,  there  is  no  guarantee  that  our  intellectual  property  rights  will  be  protected  or  enforced  to  the  same  extent  as  under  U.S.  federal  and  state  laws.
Consequently, we may not be able to prevent third-parties from developing or selling products made using our technologies.

Overestimates or underestimates in our manufacturing forecasts could cause us to hold excess inventory or result in delays in the manufacturing and
delivery of our products, which could cause us to lose orders or customers.
If we fail to predict our manufacturing requirements accurately, we could incur additional costs or experience manufacturing delays, which could cause us
to lose orders or customers and result in lower net sales. We currently use a rolling 12-month forecast based primarily on our anticipated product orders and
our product order history to help determine our requirements for components and materials. It is very important that we accurately predict both the demand
for our products and the lead-time required to obtain the necessary components and raw materials.

Lead times for materials and components that we order vary significantly and depend on factors such as the specific supplier, the size of the order, contract
terms,  and  demand  for  each  component  at  a  given  time.  If  we  underestimate  our  requirements,  we  may  have  inadequate  manufacturing  capacity  or
inventory, which could interrupt manufacturing of our products and result in delays in shipments and net sales. If we overestimate our requirements, we
could  have  excess  inventory  of  parts  and  finished  products.  In  addition,  delays  in  the  manufacturing  of  our  products  could  cause  us  to  lose  orders  or
customers.

We purchase component parts and consumable products from third-party and sole source suppliers, and any interference with this supply chain may
impact our ability to manufacture and sell our products.
We rely on third-party or sole source suppliers to provide certain key components for our products including BOHA! labels.  We do not have guaranteed
supply  contracts  with  any  of  our  component  suppliers,  and  our  suppliers  could  delay  shipments,  increase  prices  or  cease  manufacturing  or  selling  such
components to us at any time.  A disruption in the supply of such component parts and consumable products could delay our production and/or the release
of our new products and hinder our ability to meet our commitments to customers.  If we are unable to obtain a sufficient quantity of these components on
commercially reasonable terms or in a timely manner, or if we are unable to obtain alternative sources for the components, sales of our products could be
delayed or halted entirely or we may be required to redesign our products.  Any of these events could result in lost sales, reduced gross margins or damage
to our end-customer relationships, which would have a material adverse effect on our operations and financial results.

In addition to maintaining offices in the UK and Macau, we sell and ship a significant portion of our products internationally and rely on third parties
that make up our global salesforce.  The international nature of our operations may expose us to certain risks associated with doing business outside of
the U.S., including risks posed by the UK’s withdrawal from the European Union, tariffs, and changes in trade relations.
We  sell  a  significant  amount  of  our  products  to  customers  outside  the  United  States.  Shipments  to  international  customers  are  expected  to  continue  to
account for a material portion of net sales. In addition, our manufacturers and suppliers are largely located in Asia.  As a result, our products are largely
exported to one of our facilities in the United States, which makes our operations vulnerable to disruptions in trade that could adversely affect our business
results.

12

Our international operations, including our reliance on manufacturers and suppliers located in Asia, our worldwide sales team, and our sales to customers
located outside the United States, expose us to disruptions in trade and other associated risks such as:

● the imposition of additional duties, tariffs, quotas, taxes, trade barriers, capital flow restrictions and other charges on imports and exports by the

United States or the governments of the countries in which we or our manufacturers and suppliers operate;

● delays in the delivery of cargo due to port security considerations, labor disputes such as dock strikes, and our reliance on a limited number of
shipping and air carriers, which may experience capacity issues that adversely affect our ability to ship inventory in a timely manner or for an
acceptable cost;

● fluctuations  in  the  value  of  the  U.S.  Dollar  against  foreign  currencies,  which  could  restrict  sales,  or  increase  costs  of  purchasing,  in  foreign

countries;

● economic or political instability in any of the countries in which we or our manufacturers or suppliers operate, which could result in a reduction in

demand for our products due to political and economic instability or impair our foreign assets;

● a reduced ability or inability to sell in or purchase from certain markets as a result of export or import restrictions;
● potentially limited intellectual property protection in certain countries, such as China, may limit recourse against infringing products or cause us to

refrain from selling in certain geographic territories;

● reliance on a limited number of shipping and air carriers who may experience capacity issues that adversely affect our ability to ship inventory in a

timely manner or for an acceptable cost; and

● economic uncertainties and adverse economic conditions (including inflation and recession).

Although we carry business interruption insurance to cover lost revenue and profits in an amount we consider adequate, this insurance does not cover all
possible situations.  In addition, the business interruption insurance would not compensate us for the loss of opportunity and potential adverse impact, both
short-term and long-term, on relations with our existing customers resulting from our inability to produce products for them.

Our  business  could  be  adversely  affected  by  actual  or  threatened  terrorist  attacks  or  the  related  heightened  security  measures,  military  actions  and
other efforts to combat terrorism.
Our business could be adversely affected by actual or threatened terrorist attacks or the related heightened security measures, military actions and other
efforts  to  combat  terrorism.    It  is  possible  that  terrorist  attacks  could  be  directed  at  important  locations  for  the  gaming  industry.    Heightened  security
measures and other efforts to combat terrorism may also have an adverse effect on the gaming industry by reducing tourism.  Any of these developments
could  also  negatively  affect  the  general  economy  and  consumer  confidence.    Any  downturn  in  the  economy  in  general,  or  in  the  gaming  industry  in
particular  could  result  in  a  reduced  demand  for  our  products  and  could  adversely  affect  our  business  and  results  of  operations.    In  addition,  heightened
security measures may cause certain governments to restrict the import or export of goods, which may have an adverse effect on our ability to buy and sell
goods.

We depend on key personnel, the loss of which could materially impact our business.
Our future success will depend in significant part upon the continued service of certain key management and other personnel and our continuing ability to
attract and retain highly qualified managerial, technical and sales and marketing personnel.  There can be no assurance that we will be able to recruit and
retain such personnel.  The loss of either Bart C. Shuldman, the Company’s Chairman of the Board and Chief Executive Officer, or Steven A. DeMartino,
the Company’s President, Chief Financial Officer, Treasurer and Secretary, or the loss of certain groups of key employees, could have a material adverse
effect on our results of operations.

The inability to protect our intellectual property rights could harm our reputation, damage our business or interfere with our competitive position, and
infringement on the intellectual property rights of others, or claims thereof, could put us at a competitive disadvantage, and any related litigation could
be time consuming and costly.
Our intellectual property is valuable and provides us with certain competitive advantages.  Copyrights, patents, trademarks, service marks, trade secrets,
technology licensing agreements, nondisclosure agreements and contracts are used to protect these proprietary rights. Despite these precautions, it may be
possible for third parties to copy aspects of our products or, without authorization, to obtain and use information which we regard as trade secrets.

In addition, prosecuting and defending infringement lawsuits is very expensive.  We are committed to aggressively asserting and defending our technology
and related intellectual property rights, which we have spent a significant amount of money to develop.  Similarly, third-parties may claim, from time to
time, that we have violated their intellectual property rights. To the extent of a violation of a third-party’s patent or other intellectual property right, we may
be  prevented  from  operating  our  business  as  planned  and  may  be  required  to  pay  damages,  to  obtain  a  license,  if  available,  or  to  use  a  non-infringing
method, if possible, to accomplish our objectives. Any such claims could result in costly litigation and, if successful, could result in costly judgments or
settlements.

The expense of prosecuting or defending any future infringement lawsuits could have a material adverse effect on our business, financial condition and
results of operations.  Intellectual property litigation is generally complex, costly, protracted, and highly disruptive to business operations by diverting the
attention and energies of management and key technical personnel.

13

We currently rely on third-party service providers to host our food service technology software and deliver certain services, and any interruptions or
delays in services from these third parties could impair the delivery of our products and services, and our business, results of operations, and financial
condition could be materially adversely affected.
We rely on a third-party service provider to host our food service technology software. Third parties also provide services to key aspects of our operations,
including Internet connections and networking, data storage and processing, trust and safety and security infrastructure.  We do not control the operation,
physical security, or data security of any of these third-party providers. Our efforts to use commercially reasonable diligence in the selection and retention
of such third-party providers may be insufficient or inadequate to prevent or remediate such operational and security risks. Our third-party providers may
be subject to intrusions, computer viruses, denial-of-service attacks, sabotage, acts of vandalism, acts of terrorism or other misconduct. They are vulnerable
to damage or interruption from power loss, telecommunications failures, fires, floods, earthquakes, hurricanes, tornadoes, and similar events, and they may
be subject to financial, legal, regulatory, and labor issues, each of which may impose additional costs or requirements on us or prevent these third parties
from  providing  services  to  us  or  our  customers  on  our  behalf.  In  addition,  these  third  parties  may  breach  their  agreements  with  us,  disagree  with  our
interpretation of contract terms or applicable laws and regulations, refuse to continue or renew these agreements on commercially reasonable terms or at all,
fail  to  or  refuse  to  process  transactions  or  provide  other  services  adequately,  take  actions  that  degrade  the  functionality  of  our  platform  and  services,
increase  prices,  impose  additional  costs  or  requirements  on  us  or  our  customers,  or  give  preferential  treatment  to  our  competitors.  If  we  are  unable  to
procure  alternatives  in  a  timely  and  efficient  manner  and  on  acceptable  terms,  or  at  all,  we  may  be  subject  to  business  disruptions,  losses,  or  costs  to
remediate any of these deficiencies. The occurrence of any of the above events could result in reputational damage, legal or regulatory proceedings, loss of
customers or other adverse consequences, any of which could materially adversely affect our business, results of operations, and financial condition.

Our  food  service  technology  business  depends  substantially  on  our  customers  renewing  their  subscriptions  with  the  Company.  Any  decline  in  our
customer renewals would harm our food service technology business, results of operations and financial condition.
Our subscription offerings are term-based, and in order for us to maintain or improve our results of operations, it is important that our customers renew
their subscriptions with us when the existing subscription term expires and renew on the same or more favorable quantity and terms. Our customers have
no obligation to renew their subscriptions and we may not be able to accurately predict customer renewal rates. Customers may elect not to renew their
subscriptions with us for a variety of reasons, including as a result of changes in their strategic priorities, budgets and costs and, in some instances, due to
competing  solutions.  Our  retention  rate  may  also  decline  or  fluctuate  as  a  result  of  a  number  of  other  factors,  including  our  customers’  satisfaction  or
dissatisfaction  with  our  solutions,  the  increase  in  the  contract  value  of  subscription  and  support  contracts  from  new  customers,  the  effectiveness  of  our
customer support services, our pricing, the prices of competing products or services, global economic conditions and the other risk factors described herein.
As  a  result,  there  can  be  no  assurance  that  our  food  service  technology  customers  will  renew  subscriptions.    If  our  customers  do  not  renew  their
subscriptions or renew on less favorable terms, our business, results of operations and financial condition may be adversely affected.

If we fail to offer high quality support, our business and reputation could suffer.
Our  customers  rely  on  us  and  our  third-party  service  providers  for  support  of  our  software  and  services  included  in  our  food  service  technology
subscription  packages.  High-quality  support  is  important  for  the  renewal  and  expansion  of  our  agreements  with  existing  customers.  The  importance  of
high-quality  support  will  increase  as  we  expand  our  business  and  pursue  new  customers.  If  we  or  our  third-party  service  providers  do  not  help  our
customers  quickly  resolve  issues  and  provide  effective  ongoing  support,  our  ability  to  sell  new  food  service  technology  products  to  existing  and  new
customers could suffer and our reputation and relationships with existing or potential customers could be harmed.

Cyber-security and privacy breaches, cyber-attacks, or other disruptions could expose us to liability, affect our business, and damage our reputation.
We  are  increasingly  dependent  on  our  information  technology  systems  and  infrastructure  for  our  business.  We  collect,  store,  and  transmit  sensitive
information including intellectual property, proprietary business information and personal information in connection with business operations. The secure
maintenance of this information is critical to our operations and business strategy. Some of this information could be an attractive target of criminal attack
by  third  parties  with  a  wide  range  of  motives  and  expertise,  including  organized  criminal  groups,  disgruntled  current  or  former  employees,  and  others.
Cyber-attacks are of ever-increasing levels of sophistication, and despite our extensive security measures, our information technology and infrastructure
may be vulnerable to such attacks or may be breached, including due to employee error or malfeasance.  Any such breach could compromise our networks
and the information stored there could be accessed, publicly disclosed, lost or stolen. If our systems become compromised, we may not promptly discover
the intrusion. Like other companies in our industry, we have experienced attacks to our data and systems, including malware and computer viruses that we
have been able to detect and eliminate. If our systems fail or are breached or disrupted, we could lose product sales, and suffer reputational damage and loss
of customer confidence. Such incidents would require notification to affected individuals and may result in legal claims or proceedings and liability under
federal  and  state  laws  that  protect  the  privacy  and  security  of  personal  information.  Any  one  of  these  events  could  cause  our  business  to  be  materially
harmed and our results of operations to be adversely impacted.

We cannot provide any assurance that current laws, or any laws enacted in the future, will not have a material adverse effect on our business.
Our  operations  are  subject  to  laws,  rules,  regulations,  including  environmental  regulations,  government  policies  and  other  requirements  in  each  of  the
jurisdictions  in  which  we  conduct  business.    Changes  in  such  laws,  rules,  regulations,  policies  or  requirements  could  result  in  the  need  to  modify  our
products  and  could  affect  the  demand  for  our  products,  which  may  have  an  adverse  impact  on  our  future  operating  results.    If  we  do  not  comply  with
applicable laws, rules and regulations we could be subject to costs and liabilities and our business may be adversely impacted.

14

Risks Related to our Indebtedness

The agreement governing our credit facility contains restrictions and limitations that could significantly affect our ability to operate our business, as
well as significantly affect our liquidity.
The  loan  and  security  agreement  (the  “Loan  Agreement”)  governing  the  Siena  Credit  Facility  contains  a  number  of  significant  covenants  that  could
adversely affect our ability to operate our business, our liquidity, and our results of operations. These covenants restrict, among other things, our ability, and
the ability of any future domestic subsidiary, to:

● merge, consolidate, form subsidiaries or dispose of assets;
● acquire assets outside the ordinary course of business;
● enter into other transactions outside the ordinary course of business;
● sell, transfer, return or dispose of collateral;
● make loans to or investments in, or enter into transactions with, affiliates;
● incur or guarantee indebtedness, incur liens;
● redeem equity interests while borrowings are outstanding under the credit facility;
● change our capital structure; or;
● dissolve, divide, change our line of business or cease or suffer a disruption to all or a material portion of our business.

Additionally, the Loan Agreement requires us to comply with a minimum EBITDA covenant, the amount of which is based on financial forecasts provided
to the lender. The breach of any covenants or obligations in the Loan Agreement, if not otherwise waived or amended, could result in a default under the
Loan Agreement and could trigger acceleration of our obligations thereunder and permit the lender to foreclose on the collateral securing our obligations
under the Loan Agreement and exercise other rights of secured creditors.

Availability under the Siena Credit Facility is subject to a borrowing base, which is based on eligible accounts receivable and inventory. To the extent that
our  eligible  accounts  receivable  and  inventory  decline  in  value,  our  borrowing  base  will  decrease,  and  the  availability  under  the  Siena  Credit  Facility
currently is and may continue to be less than its stated amount and may decrease. In addition, if at any time the amount of outstanding borrowings and
letters of credit under that facility exceeds the borrowing base, we are required to prepay borrowings and/or cash collateralize letters of credit sufficient to
eliminate the excess.

Our ability to comply with the covenants under the Loan Agreement or to maintain our borrowing base may be affected by events beyond our control,
including deteriorating economic conditions and consequences of the COVID-19 crisis. For example, the minimum EBITDA covenant, as applicable to
periods through March 31, 2021, is based on financial projections prepared before most COVID-19-related operating restrictions were put in place in the
United States, and our actual EBITDA for any of those periods may be substantially less than projected in such forecasts. In such event, we may not be able
to comply with the covenant. In addition, reductions in the value of accounts receivable and inventory have occurred and are likely to continue to occur due
to  decreases  in  sales  and  production  that  have  occurred  as  a  result  of  the  COVID-19  pandemic.  Further,  certain  slow-moving  inventory  and  accounts
receivable  that  remain  unpaid  for  a  specified  period  of  time  are  excluded  from  the  borrowing  base  calculation.  Thus,  a  decline  in  economic  conditions
and/or  a  decline  in  the  financial  condition  of  customers  in  the  industries  we  serve,  such  as  the  decline  that  has  occurred  in  the  casino  and  food  service
industries in connection with the COVID-19 pandemic, has impacted and may continue to negatively impact the borrowing base both by decreasing the
value  of  existing  accounts  and  reducing  the  number  and  amount  of  new  accounts.  If  we  overestimate  our  inventory  needs  due  to  the  uncertainty
surrounding  the  COVID-19  pandemic  and  the  duration  of  its  impact  on  customer  closures  and  economic  conditions,  we  may  have  inventory  that  is
considered slow-moving and thus excluded from the borrowing base calculation, and any reduction in production in response to decreased demand would
also result in a lower inventory value and thus a lower borrowing base.

Any of these events could require us to seek waivers or amendments of covenants or alternative sources of financing or to reduce expenditures. We cannot
assure you that such waivers, amendments or alternative financing could be obtained, or if obtained, would be on terms acceptable to us, or that we would
be able to reduce expenditures enough to offset any decrease in the borrowing base, or that we could make such reductions without a material negative
impact on our business.

We may not be entitled to forgiveness of our PPP Loan.
On May 1, 2020, the Company was granted the $2.2 million PPP Loan. The PPP Loan is unsecured and is evidenced by a note a dated the Loan Date (the
“Note”)  issued  by  the  Company  in  favor  of  Berkshire  Bank,  as  the  lender  (the  “PPP  Lender”).  The  Note  has  a  two-year  term.  The  PPP  provides  for
forgiveness of up to the full amount borrowed as long as the Company uses the loan proceeds during the covered period following disbursement for eligible
purposes as described in the CARES Act and related guidance. Under the CARES Act, loan forgiveness is generally available to the extent the PPP Loan
was  used,  during  the  covered  period,  for  payroll  costs  and  costs  to  continue  group  health  care  benefits,  as  well  as  for  interest  on  mortgage  obligations
incurred before February 15, 2020, rent under lease agreements in effect before February 15, 2020, utilities for which service began before February 15,
2020,  and  interest  on  debt  obligations  incurred  before  February  15,  2020  (“qualifying  expenses”),  subject  to  conditions  and  limitations  provided  in  the
CARES Act. We maximized usage of the proceeds from the PPP Loan for qualifying expenses during the applicable period. As of the date of this filing, we
have not yet submitted an application for forgiveness.

Under the revised rules for the PPP, if we submit a forgiveness application within 10 months after the end of the covered period, we will not have to begin
principal and interest payments before the date on which the SBA remits the loan forgiveness amount to the PPP Lender (or notifies the PPP Lender that no
loan forgiveness is allowed). If no loan forgiveness is allowed, the Company will be required to pay the PPP Lender equal monthly payments of principal
and  interest  based  on  the  principal  amount  outstanding  on  the  PPP  Loan,  plus  interest  outstanding  at  the  end  of  the  deferment  period,  and  taking  into
account any reductions in the principal amount due to forgiveness, if any. We cannot provide any assurance that we will be eligible for loan forgiveness or
that any amount of the PPP Loan will ultimately be forgiven by the SBA.

15

General Risk Factors

Our stock price may fluctuate significantly.
The market price of our common stock could fluctuate significantly in response to variations in quarterly operating results and other factors, such as:

● prevailing  domestic  and  international  market  and  economic  conditions,  and  conditions  in  the  industries  we  serve,  including  current  market
volatility and the economic impact of COVID-19 and resulting shutdowns on the casino and food service industries and on the U.S. and global
economies;

● adverse business conditions faced by customers, or bankruptcies or store closures of our customers resulting from adverse economic conditions

due to COVID-19 or otherwise;

● changes in our business, operations or prospects;
● developments in our relationships with our customers or strategic partners;
● announcements of new products or services by us or by our competitors;
● announcement or completion of acquisitions by us or by our competitors;
● changes in existing or adoption of additional government regulations; and
● unfavorable or reduced analyst coverage.

In  addition,  the  stock  market  may  experience  significant  price  fluctuations  year-to-year.    Broad  market  fluctuations,  general  economic  conditions  and
specific conditions in the industries in which we operate may adversely affect the market price of our common stock.

Limited trading volume and a reduction in analyst coverage of our common stock may contribute to its price volatility.
The limited trading volume of our common stock may contribute to its price volatility. The trading market for our common stock also relies in part on the
research and reports that industry or financial analysts may publish about us, our business, our markets and our competitors. We currently  have limited
analyst coverage. If securities analysts do not cover our common stock in the future, the lack of research coverage may adversely affect the market price of
our common stock. Furthermore, if one or more of the analysts who cover us downgrade our stock, or if those analysts issue other unfavorable commentary
about us or our business, our stock price may decline.

Our common stock is traded on the Nasdaq Global Market.  During the year ended December 31, 2020 the average daily trading volume for our common
stock as reported by the Nasdaq Global Market was approximately 29,000 shares.  We are uncertain whether a more active trading market in our common
stock will develop.  In addition, many investment banks no longer find it profitable to provide securities research on micro-cap and small-cap companies. 
As a result, relatively small trades may have a significant impact on the market price of our common stock, which could increase the volatility and depress
the price of our common stock.

Our common stock is thinly traded, and investors may be unable to sell their shares at their desired prices, or at all, and sales of large blocks of shares
may adversely affect the price of our common stock.
Our common stock has historically been sporadically or “thinly traded,” meaning that the number of persons interested in purchasing shares of our common
stock at prevailing prices at any given time may be relatively small. This could lead to wide fluctuations in our share price. Investors may be unable to sell
their  common  stock  at  or  above  their  purchase  price,  which  may  result  in  substantial  losses.  As  a  consequence  of  this  lack  of  liquidity,  the  trading  of
relatively small quantities of shares by our stockholders may disproportionately influence the price of shares of our common stock in either direction. The
price of shares of our common stock could, for example, decline precipitously in the event a large number of shares of our common stock are sold on the
market  without  commensurate  demand,  while  an  issuer  with  a  more  robust  daily  trading  volume  for  its  common  stock  might  better  absorb  those  sales
without an adverse impact on its share price.

If we raise additional capital in the future, existing shareholder ownership interest in the Company could be diluted or otherwise adversely impacted,
and future sales of our common stock or other financing arrangements may cause our stock price to decline.
In the future, we may sell additional shares of our common stock in public or private offerings, or we may obtain funds through a credit facility or by
issuing debt or preferred securities. We may also issue additional shares of our common stock to finance future acquisitions. Shares of our common stock
are also available for future issuance and sale pursuant to stock options and other equity awards that we have granted to our employees, and in the future,
we may grant additional stock options, restricted stock units and other forms of equity compensation to our employees. Any issuance of equity we may
undertake in the future to raise additional capital could cause the price of our common stock to decline, or require us to issue shares at a price that is lower
than that paid by holders of our common stock in the past, which would result in those newly issued shares being dilutive. Sales of our common stock or
the perception that such sales could occur may adversely affect prevailing market prices for shares of our common stock and could impair our ability to
raise capital through future offerings. The lenders under our existing debt agreements have rights that are senior to your rights as a common stockholder,
and if we obtain funds in the future through a credit facility or through the issuance of debt or preferred securities, the lenders of such facility or the holders
of such securities would likely also have rights senior to the rights of our common stockholders, which could impair the value of our common stock.

We take advantage of specified scaled disclosure requirements applicable to a “smaller reporting company” under Regulation S-K, and the information
that we provide to stockholders may therefore be different than they might receive from other public companies. If some investors find our shares of
common stock less attractive as a result of this scaled disclosure, there may be a less active trading market for our shares of common stock, which may
increase the volatility of the market price of our common stock.
We are a “smaller reporting company,” as defined in Item 10(f)(1) of Regulation S-K. As a smaller reporting company, we take advantage of specified
scaled disclosure and other requirements that are otherwise applicable generally to public companies.

We intend to continue to take advantage of certain of the scaled disclosure requirements of smaller reporting companies and may continue to do so until we
are no longer a smaller reporting company. We will cease to be a smaller reporting company if we have (i) more than $250 million in market value of our
shares held by non-affiliates as of the last business day of our second fiscal quarter or (ii) more than $100 million of annual revenues in our most recent
fiscal  year  completed  before  the  last  business  day  of  our  second  fiscal  quarter  and  a  market  value  of  our  shares  held  by  non-affiliates  more  than  $700
million as of the last business day of our second fiscal quarter. We choose to take advantage of some but not all of these scaled disclosure requirements;
therefore, the information that we provide stockholders may be different than one might get from other public companies. Further, if some investors find
our shares of common stock less attractive as a result, there may be a less active trading market for our shares of common stock and the market price of
such shares of common stock may be more volatile.

16

Item 1B. Unresolved Staff Comments.
Not applicable.

Item 2. Properties.
Our principal facilities as of December 31, 2020 are listed below.  We believe that all facilities generally are in good condition, adequately maintained and
suitable for their present and currently contemplated uses.

Location
Hamden, Connecticut

Ithaca, New York

Las Vegas, Nevada
Doncaster, UK
Macau, China

Operations Conducted

Executive offices and sales office

  Hardware design and development, assembly and

service facility
Software design and development and casino and
gaming sales office
Sales office and service center
Sales office

Size
(Approx. Sq. Ft.)  
11,100 

Owned
or Leased
Leased

  Lease Expiration

Date
April 30, 2027

73,900 

Leased

May 31, 2025

19,600 
6,000 
180 

110,780   

Leased
Leased
Leased

October 31, 2022
August 26, 2026
June 30, 2021

Item 3. Legal Proceedings.
The Company may, in the ordinary course of business, become a party to litigation involving collection matters, contract claims and other legal proceedings
relating to the conduct of its business.  As of December 31, 2020, we are unaware of any material legal proceedings pending or threatened against us, or
any material legal proceedings contemplated by governmental authorities.

Item 4. Mine Safety Disclosures.
Not applicable.

17

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
Our common stock is traded on the Nasdaq Global Market under the symbol TACT.  As of February 28, 2021, there were 251 holders of record of the
common stock.

Issuer Purchases of Equity Securities
During the fourth quarter of 2020, we did not repurchase any shares of our common stock.

Dividend Policy
In 2012, our Board of Directors initiated a quarterly cash dividend program subject to the Board’s approval each quarter.  Dividends declared and paid on
our common stock totaled $2.7 million or $0.36 per share in 2019.  On January 23, 2020, our Board of Directors announced the cessation of our quarterly
cash dividend on the Company’s common stock to accelerate the investment in sales and marketing, continued product development and infrastructure of
the BOHA! ecosystem.  The final dividend payment was made in December 2019.

Sales of Unregistered Securities
None.

Item 6. Selected Financial Data
Not required.

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
This discussion should be read in conjunction with the Consolidated Financial Statements and notes thereto.

Overview
The year ended December 31, 2020 was a very challenging year, as the COVID-19 pandemic unexpectedly occurred and significantly impacted our and our
customers’  businesses.    The  pandemic  caused  us  to  quickly  react  and  take  actions  and  measures  to  reduce  costs,  increase  liquidity  and  protect  our
employees.  The good news is that TransAct persevered and made it through these difficult times.  Even with the pandemic raging, we continued to focus
our  efforts  on  the  sales  execution  and  growing  revenue  of  BOHA!  software-as-a-service  (“SaaS”)-based  software  and  hardware  ecosystem  launched  in
2019.    BOHA!  is  a  comprehensive  ecosystem  of  cloud-based  SaaS  software  applications  and  hardware  designed  to  help  restaurant  and  food  service
companies  automate  their  back-of-house  operations.    BOHA!  represents  the  first  single-vendor  solution  to  allow  customers  to  choose  from  any
combination  of  applications  for  inventory  management,  temperature  monitoring  of  food  and  equipment,  food  safety  labeling,  food  recalls,  checklists  &
procedures,  equipment  service  management,  timers  and  delivery  management.    Despite  the  negative  impact  from  the  COVID-19  pandemic  explained
above, food service technology sales increased in 2020 compared to 2019 due primarily to sales of our BOHA! software, labels and other recurring revenue
to both new customers and our existing installed base of BOHA! terminals.

During 2020, sales in all markets other than food service technology decreased primarily due to the negative impact from the COVID-19 pandemic.  POS
automation  and  banking  sales  declined  primarily  due  to  lower  sales  of  our  Ithaca  9000  printer  to  McDonald’s  in  2020  compared  to  2019.    Casino  and
gaming sales were lower in 2020 due to casino closures and gradual reopenings in the second half of 2020 in response to the COVID-19 pandemic.  Sales
for our lottery market decreased as we exited the lottery market in 2019 and completed our final sale of lottery printers in 2020.  Printrex sales declined
primarily  due  to  the  negative  impact  from  lower  worldwide  oil  prices  largely  attributable  to  the  COVID-19  pandemic.    TSG  sales  decreased  in  2020
compared to 2019 primarily due to lower sales of our legacy consumable products and service sales due to the exit of the banking market in 2018.

During the year ended December 31, 2020, our total net sales decreased 33% to approximately $30.6 million compared to the year ended December 31,
2019.  See the table below for a breakdown of our sales by market:

(In thousands, except percentages)
Food service technology
POS automation and banking
Casino and gaming
Lottery
Printrex
TSG

Year Ended
December 31, 2020

Year Ended
December 31, 2019

$ Change

    % Change

  $

  $

7,734     
3,770     
10,979     
817     
300     
6,995     
30,595     

25.3%  $
12.3%   
35.9%   
2.7%   
1.0%   
22.8%   
100.0%  $

6,104     
5,758     
21,529     
1,291     
1,166     
9,900     
45,748     

13.3%  $
12.6%   
47.1%   
2.8%   
2.6%   
21.6%   
100.0%  $

1,630     
(1,988)    
(10,550)    
(474)    
(866)    
(2,905)    
(15,153)    

26.7%
(34.5%)
(49.0%)
(36.7%)
(74.3%)
(29.3%)
(33.1%)

Sales of our food service technology products increased 27% in the year ended December 31, 2020 compared to the year ended December 31, 2019.  In the
food  service  technology  market,  we  focus  on  providing  hardware  products,  which  include  terminals,  handheld  devices,  tablets,  temperature  probes  and
temperature sensors; in addition to cloud-based software applications, labels and other recurring revenue items.  In 2019, we launched our BOHA! solution,
which  combines  our  latest  generation  terminal,  cloud-based  software  applications  and  hardware  into  a  unique  solution  to  automate  the  back-of-house
operations in restaurants and food service operations. Food service technology sales increased in 2020 primarily due to a 96% increase in recurring revenue
attributable to sales of BOHA!, which sales reflect subscriptions for the related software applications, as well as sales of labels, extended warranty and
service contracts, and technical support services.

18

 
 
 
 
   
 
 
 
 
 
 
 
   
   
   
   
   
 
Sales of our POS automation and banking products decreased 35% in the year ended December 31, 2020 compared to the year ended December 31, 2019. 
In the POS market, we focus primarily on supplying printers that print receipts or linerless labels for customers in the restaurant and quick serve markets. 
During the year ended December 31, 2020, sales of our Ithaca 9000 printer to McDonald’s decreased.  We believe the decrease is a result of the COVID-19
pandemic.  In the banking market, which we exited at the end of 2018, we focused mainly on supplying printers for use in bank teller stations at banks and
financial institutions primarily in the U.S. We exited the banking market in order to shift focus to our food service technology market and we do not expect
any future sales of these legacy products.

Sales of our casino and gaming products decreased 49% in 2020 compared to 2019.  In our casino and gaming market, our focus lies primarily in supplying
printers  worldwide  for  use  in  slot  machines  at  casinos  and  racetracks,  as  well  as  in  other  electronic  gaming  devices  that  print  tickets  or  receipts.
Additionally,  we  supplement  these  printer  sales  with  revenue  from  EPICENTRAL™,  our  promotional  printing  system  that  enables  casino  operators  to
create  promotional  coupons  and  marketing  messages  and  print  them  in  real  time  at  the  slot  machine.    The  decrease  of  casino  and  gaming  printers  was
driven by industry-wide weakness resulting in lower sales to our OEMs that were impacted by casino closures in response to the COVID-19 pandemic,
which were in place for most of the second quarter of 2020 before gradually reopening at reduced capacities during the second half of 2020. 

During the year ended December 31, 2020, total lottery printer sales decreased approximately 37% due to lower sales to IGT.  On December 31, 2019, we
ended our non-exclusive agreement with IGT and exited the lottery market as we shifted our focus to our higher-value, technology-enabled market for food
service technology and casino and gaming products.  During 2020 IGT made a final purchase of lottery printers and we expect no future sales of our lottery
printer.

Sales of our Printrex branded printers include wide format, rack-mounted and vehicle-mounted thermal printers used by customers to log and plot oil field
and  down  hole  well  drilling  data  in  the  oil  and  gas  exploration  industry.    During  the  year  ended  December  31,  2020,  we  experienced  a  74%  decline  in
Printrex oil and gas printer sales as a result of lower worldwide oil prices as a result of the COVID-19 pandemic.  Although we will continue to fulfill
orders  from  existing  customers  during  2021,  we  have  shifted  our  focus  away  from  this  market  and  towards  our  higher  value,  technology  enabled  food
service technology terminals and casino and gaming products.

TSG, which sells service, replacement parts and consumable products, including receipt paper, ribbons and inkjet cartridges, continues to offer a recurring
revenue stream from mostly our legacy products.  TSG sales decreased 29% in 2020 from 2019 primarily due to lower sales of consumable products for
our legacy banking printers and lower service sales primarily related to a service contract with a banking customer that is expected to end in 2021.  We
expect TSG sales to continue to decline in 2021 due to the ending of the service contract and lower expected sales of our lottery printer spare parts to IGT
for our legacy lottery printer.

Operationally, our gross margin was 42.3% in 2020, a decrease of 560 basis points from 2019 due to the 33% sales decline during 2020 and the impact of
fixed manufacturing overhead on lower sales volume as a result of the impact of the COVID-19 pandemic.

During 2020, our operating margin declined  from 0.7% in 2019 to negative 26.7% in 2020 due to the 33% decline in sales and 560 basis point decrease in
gross margin.  Operating expenses decreased by 2% due to cost saving initiatives implemented in March 2020 and maintained through 2020 in response to
the negative impact from the COVID-19 pandemic.  During 2021, we expect operating expenses to increase significantly compared to 2020, as we resume
our investment in selling and marketing to take advantage of the opportunities we see in the food service technology market.

We reported a net loss of $5.6 million and net loss per diluted share of $0.72 for 2020, compared to net income of $0.5 million and net income per diluted
share of $0.07 for 2019.  In terms of cash flow, for 2020 we used $3.5 million of cash in operating activities.  During 2020, we completed an underwritten
public offering (the “Offering”) which raised net proceeds of $8.7 million and the Company was granted the $2.2 million PPP Loan.  We ended the year
with cash and cash equivalents of $10.4 million on our Consolidated Balance Sheet at December 31, 2020.

Critical Accounting Policies and Estimates
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates, judgments
and assumptions that affect both Balance Sheet items and Statement of Operations categories.  Such estimates and judgments are based upon historical
experience and certain assumptions that are believed to be reasonable in the particular circumstances.  We evaluate our assumptions on an ongoing basis by
comparing actual results with our estimates.  Actual results may differ from the original estimates.

The  following  accounting  policies  are  those  that  we  believe  to  be  most  critical  in  the  preparation  of  our  financial  statements.    These  items  utilize
assumptions and estimates about the effect of future events that are inherently uncertain and are therefore based on our judgment.  Please refer to Note 2 –
Summary of significant accounting policies in the accompanying Consolidated Financial Statements for a complete listing of our significant accounting
policies.

Revenue  Recognition  –  We  account  for  revenue  in  accordance  with  the  Financial  Accounting  Standards  Board  (“FASB”)  Accounting  Standards
Codification  (“ASC”)  606,  “Revenue  from  Contracts  with  Customers  (“ASC  606”).    We  adopted  ASC  606  effective  January  1,  2018  and  elected  the
modified retrospective approach.  In accordance with ASC 606, a performance obligation is a promise in a contract with a customer to transfer a distinct
good  or  service  to  the  customer.  Some  of  our  contracts  with  customers  contain  a  single  performance  obligation,  while  other  contracts  contain  multiple
performance obligations (most commonly when contracts include a hardware product, software and extended warranties).  A contract’s transaction price is
allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.

The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring services to the customer. 
To  the  extent  the  transaction  price  includes  variable  consideration,  such  as  price  protection,  reserves  for  returns  and  other  allowances,  the  Company
estimates the amount of variable consideration that should be included in the transaction price utilizing either the “expected value” method or the “most
likely  amount”  method  depending  on  the  nature  of  the  variable  consideration.    Variable  consideration  is  included  in  the  transaction  price  if,  in  the
Company’s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur.

19

For a majority of our revenue, which consists of printers, terminals, consumables, and replacement parts, the Company recognizes revenue as of a point of
time.    The  transaction  price  is  recognized  upon  shipment  of  the  order  when  control  of  the  goods  is  transferred  to  the  customer  and  at  the  time  the
performance obligation is fulfilled.  We also sell a software solution in our casino and gaming market, EPICENTRAL™, that enables casino operators to
create promotional coupons and marketing messages and to print them in real time at the slot machine.  EPICENTRALTM is primarily comprised of both a
software component, which is licensed to the customer, and a hardware component.  EPICENTRAL™ software and hardware are integrated to deliver the
system’s  full  functionality.    The  transaction  prices  from  EPICENTRAL™  software  license  and  hardware  are  recognized  upon  installation  and  formal
acceptance by the customer when control of the license is transferred to the customer.  For out-of-warranty repairs, the transaction price is recognized after
the  repair  work  is  completed  and  the  printer  or  terminal  is  returned  to  the  customer,  as  control  of  the  product  is  transferred  to  the  customer  and  our
performance obligation is completed.

Performance obligations are satisfied over time if the customer receives the benefits as we perform work, if the customer controls the asset as it is being
produced, or if the product being produced for the customer has no alternative use and we have a contractual right to payment.  For our separately priced
extended warranty, BOHA! cloud-based software applications, technical support for our food service technology terminals and maintenance agreements
(including  free  one-year  maintenance  received  by  customers  upon  completion  of  EPICENTRAL™  installation)  revenue  is  recognized  over  time  as  the
customer receives the benefit.  The transaction price from the maintenance services is recognized ratably over time, using output methods, as control of the
services is transferred to the customer.  Our cloud-based BOHA! software allows customers to use hosted software over the contract period without taking
possession  of  the  software  and  are  provided  on  a  subscription  basis  and  is  recognized  ratably  over  the  contract  period.    For  extended  warranties,  the
transaction price is recognized ratably over the warranty period, using output methods, as control of the services is transferred to the customer.

When  there  is  more  than  one  performance  obligation  in  a  customer  arrangement,  the  Company  typically  uses  the  “standalone  selling  price”  method  to
determine the transaction price to allocate to each performance obligation. The Company sells the performance obligations separately and has established
standalone  selling  prices  for  its  products  and  services.  In  the  case  of  an  overall  price  discount,  the  discount  is  applied  to  each  performance  obligation
proportionately based on standalone selling price. To determine the standalone selling price for initial EPICENTRAL™ installations, the Company uses the
adjusted market assessment approach.

Accounts Receivable – We have standardized credit granting and review policies and procedures for all customer accounts, including: credit reviews of all
new  customer  accounts;  ongoing  credit  evaluations  of  current  customers;  credit  limits  and  payment  terms  based  on  available  credit  information;  and
adjustments to credit limits based upon payment history and the customer’s current creditworthiness.  We also provide an estimate of doubtful accounts
based on historical experience and specific customer collection issues.  Our allowance for doubtful accounts as of December 31, 2020 was $220 thousand,
or 6.1% of outstanding accounts receivable, which we believe is appropriate considering the overall quality of our accounts receivable.  Although credit
losses  have  historically  been  within  expectations  and  the  reserves  established,  there  is  no  assurance  that  our  credit  loss  experience  will  continue  to  be
consistent with historical experience.

Inventories – Our inventories are stated at the lower of cost (principally standard cost, which approximates actual cost on a first-in, first-out basis) or net
realizable value. We review net realizable value based on estimated selling prices in the ordinary course of business less estimated costs of completion,
disposal  and  transportation,  historical  usage  and  estimates  of  future  demand.  Assumptions  are  reviewed  at  least  quarterly  and  adjustments  are  made,  as
necessary,  to  reflect  changing  market  conditions.  Based  on  these  reviews,  inventory  write-downs  are  recorded,  as  necessary,  to  reflect  estimated
obsolescence,  excess  quantities  and  net  realizable  value.  Should  circumstances  change  and  we  determine  that  additional  inventory  is  subject  to
obsolescence, additional write-downs of inventory could result in a charge to income.

Goodwill  and  Intangible  Assets  –  We  acquire  businesses  in  purchase  transactions  that  result  in  the  recognition  of  goodwill  and  intangible  assets.  The
determination  of  the  value  of  intangible  assets  requires  management  to  make  estimates  and  assumptions.  In  accordance  with  ASC  350-20  “Goodwill,”
acquired goodwill is not amortized but is subject to impairment testing at least annually and when an event occurs or circumstances change that indicate it
is  more  likely  than  not  an  impairment  exists.    We  perform  a  fair  value-based  impairment  test  to  the  carrying  value  of  goodwill  and  indefinite-lived
intangible assets on an annual basis (as of December 31) and, if certain events or circumstances indicate that an impairment loss may have been incurred,
on  an  interim  basis.    The  Company  utilizes  the  option  to  first  assess  qualitative  factors  to  determine  whether  it  is  necessary  to  perform  the  Step  1
quantitative  goodwill  impairment  test  in  accordance  with  the  applicable  accounting  standards.  Under  the  qualitative  assessment,  management  considers
relevant events and circumstances including, but not limited to, macroeconomic conditions, industry and market considerations, Company performance,
and events directly affecting the Company. If the Company determines that the Step 1 quantitative impairment test is required, management estimates the
fair value of the reporting unit primarily using the income approach, which reflects management’s cash flow projections, and also evaluates the fair value
using the market approach. Factors considered that may trigger an interim period impairment review of either acquired goodwill or intangible assets are:
significant underperformance relative to expected historical or projected future operating results; significant changes in the manner of use of acquired assets
or the strategy for the overall business; significant negative industry or economic trends; and significant decline in market capitalization relative to net book
value. Finite lived intangible assets are amortized and are tested for impairment when appropriate.

During the three months ended March 31, 2020, our stock price declined to the lowest price since 2009. We determined that the significant decline in our
market capitalization and broader economic downturn arising from the COVID-19 pandemic was a triggering event and an indicator that it was more likely
than not that the carrying value of goodwill exceeded fair value. Therefore, we concluded that quantitative analyses were required to be performed due to
the triggering event occurring during the first quarter of 2020.  We utilized an implied market value method under the market approach to calculate the fair
value  of  the  Company  as  of  March  31,  2020,  which  we  determined  was  the  best  approximation  of  fair  value  in  the  current  social  and  economic
environment.  Based on our interim impairment assessment as of March 31, 2020, we determined that no goodwill or intangible asset impairment occurred
and the fair value of goodwill was substantially higher than our carrying value.

As  of  December  31,  2020,  upon  the  completion  of  our  annual  assessment  for  impairment,  we  have  determined  that  no  goodwill  or  intangible  asset
impairment has occurred and the fair value of goodwill was substantially higher than our carrying value.

20

Income Taxes – In preparing our Consolidated Financial Statements, we are required to estimate income taxes in each of the jurisdictions in which we
operate.  This involves estimating the actual current tax exposure together with assessing temporary differences between the tax basis of certain assets and
liabilities and their reported amounts in the financial statements, as well as net operating losses, tax credits and other carryforwards.  These differences
result in deferred tax assets and liabilities, which are reflected in our Consolidated Balance Sheets.  We then assess the likelihood that the deferred tax
assets will be realized from future taxable income, and to the extent that we believe that realization is not likely, we establish a valuation allowance.

Significant judgment is required in determining the provision for income taxes and, in particular, any valuation allowance or tax reserves with respect to
our deferred tax assets and uncertain tax positions.  On a quarterly basis, we evaluate the recoverability of our deferred tax assets based upon historical
results and forecasted taxable income over future years, and match this forecast against the basis differences, deductions available in future years and the
limitations allowed for net operating loss and tax credit carryforwards to ensure that there is adequate support for the realization of the deferred tax assets.
Although  we  have  considered  future  taxable  income  and  ongoing  prudent  and  feasible  tax  planning  strategies  in  assessing  the  need  for  a  valuation
allowance, in the event we were to determine that we would not be able to realize all or part of our deferred tax assets in the future, an adjustment to the
valuation allowance or tax reserves would be charged as a reduction to income in the period such determination was made.  Likewise, should we determine
that we would be able to realize future deferred tax assets in excess of its net recorded amount, an adjustment to the valuation allowance would increase net
income in the period such determination was made.

We  account  for  income  taxes  in  accordance  with  ASC  740,  “Income  Taxes”  (“ASC  740”)    Among  other  things  this  provision  prescribes  a  minimum
recognition  threshold  that  an  income  tax  position  must  meet  before  it  is  recorded  in  the  reporting  entity’s  financial  statements.  It  also  requires  that  the
effects  of  such  income  tax  positions  be  recognized  only  if,  as  of  the  balance  sheet  reporting  date,  it  is  “more  likely  than  not”  (i.e.,  more  than  a  50%
likelihood) that the income tax position will be sustained based solely on its technical merits.  When making this assessment, management must assume
that the responsible taxing authority will examine the income tax position and have full knowledge of all relevant facts and other pertinent information. 
The accounting guidance also clarifies the method of accruing for interest and penalties when there is a difference between the amount claimed, or expected
to be claimed, on a company’s income tax returns and the benefits recognized in the financial statements.

Warranty  –  We  generally  warrant  our  products  for  up  to  24  months  and  record  the  estimated  cost  of  such  product  warranties  at  the  time  the  sale  is
recorded.  Estimated warranty costs are based upon actual past experience of product repairs and the related estimated cost of labor and material to make
the necessary repairs.  If actual future product repair rates or the actual costs of material and labor differ from the estimates, adjustments to the accrued
warranty liability and related warranty expense would be made.

Share-Based Compensation  –  We  calculate  share-based  compensation  expense  in  accordance  with  ASC  718,  “Compensation  –  Stock  Compensation”
using the Black-Scholes option-pricing model to calculate the fair value of share-based awards.  The key assumptions for this valuation method include the
expected term of an option grant, stock price volatility, risk-free interest rate, and dividend yield.  We account for forfeitures as they occur.

Results of Operations: Year Ended December 31, 2020 Compared to Year Ended December 31, 2019

Net Sales.  Net sales, which include printer, terminal and software sales as well as sales of replacement parts, consumables and maintenance and repair
services, by market for the years ended December 31, 2020 and 2019 are detailed in the below table.

(In thousands, except percentages)
Food service technology
POS automation and banking
Casino and gaming
Lottery
Printrex
TSG

International*

  $

  $

  $

Year Ended
December 31, 2020

Year Ended
December 31, 2019

$ Change

    % Change

7,734     
3,770     
10,979     
817     
300     
6,995     
30,595     

25.3%  $
12.3%   
35.9%   
2.7%   
1.0%   
22.8%   
100.0%  $

6,104     
5,758     
21,529     
1,291     
1,166     
9,900     
45,748     

13.3%  $
12.6%   
47.1%   
2.8%   
2.6%   
21.6%   
100.0%  $

1,630     
(1,988)    
(10,550)    
(474)    
(866)    
(2,905)    
(15,153)    

26.7%
(34.5%)
(49.0%)
(36.7%)
(74.3%)
(29.3%)
(33.1%)

5,862     

19.2%  $

10,416     

22.8%  $

(4,554)    

(43.7%)

*

International sales do not include sales of products made to domestic distributors or other customers who in turn ship those products to international
destinations.

Net sales for 2020 decreased $15.2 million, or 33%, from 2019.  Printer, terminal and other hardware sales volume decreased by 44% to approximately
62,000 units, due to volume decreases in almost all our markets except for a slight increase in food service technology terminal sales. The volume decrease
in 2020 was driven primarily by a 52% decrease in unit volume from the casino and gaming market and, to a lesser extent, a 28% decrease in the POS
automation and banking market and 50% decrease in the lottery market. The average selling price of our printers, terminals and other hardware increased
2% during 2020 compared to 2019 primarily due to a lower level of POS automation and banking printer sales, which sell at a lower price than our other
products.  The sales volume decreases were partially offset by a $1.9 million, or 96%, increase in software, labels and other recurring revenue from our
food service technology market.

International sales for 2020 decreased $4.6 million, or 44%, compared to 2019, primarily due to a 51% decrease of international casino and gaming sales.

21

 
 
 
 
   
 
 
 
 
 
 
 
   
   
   
   
   
 
 
   
      
  
   
      
  
   
      
  
Food service technology:  Our  primary  offering  in  the  food  service  technology  market  is  our  BOHA!  ecosystem,  which  combines  our  latest  generation
terminal, cloud-based software applications and related hardware into a unique solution to automate back-of-house operations in restaurants, convenience
stores and food service operations.  The software component of BOHA! consists of a suite of software-as-a-service (“SaaS”)-based applications, including
applications  for  inventory  management,  temperature  monitoring  of  food  and  equipment,  timers,  food  safety  labeling,  food  recalls,  checklists  and
procedures,  equipment  service  management,  and  delivery  management.    These  applications  are  combined  into  a  single  platform  with  the  associated
hardware, which includes the BOHA! terminal, handheld devices, tablets, temperature probes and temperature sensors. The BOHA! terminal combines the
software and hardware components in a device that includes an operating system, touchscreen and one or two thermal print mechanisms that print easy-to-
read food rotation labels, grab and go labels for prepared foods, and “enjoy by” date labels.  The BOHA! terminal is equipped with the TransAct Enterprise
Management System to ensure that only approved applications and functions are available on the device and allows over-the-air updates to the applications
and  operating  system.    BOHA!  helps  food  service  establishments  and  restaurants  (including  fine  dining,  casual  dining,  fast  casual  and  quick-serve
restaurants, convenience stores, hospitality establishments and contract food service providers) effectively manage food safety and grab-and-go initiatives,
as  well  as  automate  and  manage  back-of-house  operations.    Recurring  revenue  from  BOHA!  is  generated  by  software  sales,  including  software
subscriptions  that  are  charged  to  customers  upfront  on  a  per-application  basis,  as  well  as  sales  of  labels,  extended  warranty  and  service  contracts,  and
technical support services.  Sales of our worldwide food service technology products for the years ended December 31, 2020 and 2019 is as follows:

(In thousands, except percentages)
Domestic
International

(In thousands, except percentages)
Hardware
Software, 
revenue

labels  and  other 

recurring

Year Ended
December 31, 2020

Year Ended
December 31, 2019

$ Change

    % Change

6,956     
778     
7,734     

89.9%  $
10.1%   
100.0%  $

5,522     
582     
6,104     

90.5%  $
9.5%   
100.0%  $

1,434     
196     
1,630     

26.0%
33.7%
26.7%

Year Ended
December 31, 2020

Year Ended
December 31, 2019

$ Change

    % Change

3,938     

3,796     
7,734     

50.9%  $

49.1%   
100.0%  $

4,169     

1,935     
6,104     

68.3%  $

31.7%   
100.0%  $

(231)    

1,861     
1,630     

(5.5%)

96.2%
26.7%

  $

  $

  $

  $

The increase in food service technology sales in 2020 compared to 2019 was driven primarily by sales of our BOHA! software, labels and other recurring
revenue.    Sales  of  BOHA!  software  recognized  on  a  SaaS  subscription  basis,  labels  and  other  recurring  revenue  increased  by  96%,  primarily  due  to
increased label sales and, to a lesser extent,  increased software sales, compared to the prior year period.  Sales for the prior year period were significantly
lower due to the launch of BOHA! not occurring until March 2019.  The large increase of label sales in 2020 was primarily due to an initial stocking order
to a distributor of a large convenience store chain as well as increased usage by existing customers as the installed terminal base continued to increase. 
Hardware  sales  in  2020  decreased  6%  compared  to  2019  primarily  due  to  the  impact  from  the  COVID-19  pandemic  that  resulted  in  widespread  store
closings and substantially reduced customer operations.

POS automation and banking:  Revenue from the POS automation and banking market includes sales of thermal printers used primarily by quick serve
restaurants located either at the checkout counter or within self-service kiosks to print receipts for consumers or print on linerless labels.  Prior to 2020,
revenue included sales of inkjet printers used by banks, credit unions and other financial institutions to print deposit or withdrawal receipts and/or validate
checks at bank teller stations.  We exited the banking market during 2018. A summary of sales of our worldwide POS automation and banking products for
the years ended December 31, 2020 and 2019 is as follows:

(In thousands, except percentages)
Domestic
International

Year Ended
December 31, 2020

Year Ended
December 31, 2019

$ Change

    % Change

  $

  $

3,763     
7     
3,770     

99.8%  $
0.2%   
100.0%  $

5,714     
44     
5,758     

99.2%  $
0.8%   
100.0%  $

(1,951)    
(37)    
(1,988)    

(34.1%)
(84.1%)
(34.5%)

The decrease in both domestic and international POS automation and banking sales in 2020 compared to 2019 was primarily driven by a 33% decrease in
domestic and international sales of our Ithaca® 9000 printer largely attributable to fewer sales to McDonald’s which we believe resulted from the  COVID-
19 pandemic.

22

 
 
 
 
   
 
 
 
 
 
 
 
   
 
 
 
 
 
   
 
 
 
 
 
 
 
   
 
 
 
 
 
   
 
 
 
 
 
 
 
   
 
Casino and Gaming: Revenue from the casino and gaming market includes sales of thermal ticket printers used in slot machines, video lottery terminals,
and other gaming machines that print tickets or receipts instead of issuing coins at casinos and racetracks and other gaming venues worldwide.  Revenue
from  this  market  also  includes  sales  of  thermal  roll-fed  printers  used  in  the  international  off-premise  gaming  market  in  gaming  machines  such  as
Amusement with Prizes, Skills with Prizes and Fixed Odds Betting Terminals at non-casino gaming and sports betting establishments. Revenue from this
market also includes royalties related to our patented casino and gaming technology.  In addition, casino and gaming market revenue includes sales of the
EPICENTRAL™ print system, our software solution (including annual software maintenance), that enables casino operators to create promotional coupons
and marketing messages and to print them in real time at the slot machine.  A summary of sales of our worldwide casino and gaming products for the years
ended December 31, 2020 and 2019 is as follows:

(In thousands, except percentages)
Domestic
International

Year Ended
December 31, 2020

Year Ended
December 31, 2019

$ Change

    % Change

  $

  $

6,852     
4,127     
10,979     

62.4%  $
37.6%   
100.0%  $

13,076     
8,453     
21,529     

60.7%  $
39.3%   
100.0%  $

(6,224)    
(4,326)    
(10,550)    

(47.6%)
(51.2%)
(49.0%)

The decrease in domestic sales of our casino and gaming products during 2020 compared to 2019 was primarily due to a 50% decrease in domestic sales of
our thermal casino printer, driven by industry-wide weakness resulting in lower sales to our OEMs that were impacted by casino closures in response to the
COVID-19 pandemic, which were in place for most of the second quarter of 2020 before gradually reopening at reduced capacities during the second half
of 2020.  This decrease was partially offset by a 73% increase in EPICENTRAL™ sales to an existing EPICENTRAL™ customer that expanded their slot
machine floor. There were no new EPICENTRAL™ software installations during 2020 or 2019.  Sales of domestic EPICENTRALTM are project based,
and as a result, may fluctuate significantly quarter-to-quarter and year-to-year.

The decrease in international casino and gaming sales during 2020 compared to 2019 was primarily due to a 46% decline in sales of our thermal casino
printers and a 64% decline in international sales of our off-premise gaming printers attributable to the negative impacts of the COVID-19 pandemic on the
international casino and gaming industry.

Lottery:  Revenue from the lottery market includes sales of thermal on-line and other lottery printers primarily to IGT and, to a lesser extent, other lottery
system companies for various lottery applications.  A summary of sales of our worldwide lottery printers for the years ended December 31, 2020 and 2019
is as follows:

(In thousands, except percentages)
Domestic
International

Year Ended
December 31, 2020

Year Ended
December 31, 2019

$ Change

    % Change

  $

  $

817     
–     
817     

100.0%  $
0.0%   
100.0%  $

1,290     
1     
1,291     

99.9%  $
0.1%   
100.0%  $

(473)    
(1)    
(474)    

(36.7%)
(100.0%)
(36.7%)

On December 31, 2019, we allowed our non-exclusive agreement to provide lottery terminal printers to IGT to expire, as we decided to exit the lottery
market and shift our focus towards our higher-value, technology enabled food service technology and casino and gaming products.  As a result, IGT made a
final purchase of our lottery printers during the second quarter of 2020 and we do not expect any further lottery printer sales in the future.

Printrex:  Printrex branded printers are sold into markets that include wide format, desktop and rack mounted and vehicle mounted black/white thermal
printers used by customers to log and plot oil field, seismic and down hole well drilling data in the oil and gas exploration industry.  It also includes high-
speed color inkjet desktop printers used to print logs at the data centers of the oil and gas field service companies. A summary of sales of our worldwide
Printrex printers for the years ended December 31, 2020 and 2019 is as follows:

(In thousands, except percentages)
Domestic
International

Year Ended
December 31, 2020
83     
217     
300     

  $

  $

Year Ended
December 31, 2019

$ Change

    % Change

27.7%  $
72.3%   
100.0%  $

961     
205     
1,166     

82.4%  $
17.6%   
100.0%  $

(878)    
12     
(866)    

(91.4%)
5.9%
(74.3%)

The  decrease  in  sales  of  Printrex  printers  in  2020  compared  to  2019  resulted  primarily  from  lower  domestic  sales  in  the  oil  and  gas  market  which  was
negatively impacted by the decline in worldwide oil prices largely attributable to the COVID-19 pandemic.

23

 
 
 
 
   
 
 
 
 
 
 
 
   
 
 
 
 
 
   
 
 
 
 
 
 
 
   
 
 
 
 
 
   
 
 
 
 
 
 
 
   
 
TSG:  Revenue  generated  by  TSG  includes  sales  of  consumable  products  (POS  receipt  paper,  inkjet  cartridges,  ribbons  and  other  printing  supplies),
replacement parts, maintenance and repair services, testing services, refurbished printers, and shipping and handling charges.  A summary of sales in our
worldwide TSG market for the years ended December 31, 2020 and 2019 is as follows:

(In thousands, except percentages)
Domestic
International

Year Ended
December 31, 2020

Year Ended
December 31, 2019

$ Change

    % Change

  $

  $

6,262     
733     
6,995     

89.5%  $
10.5%   
100.0%  $

8,769     
1,131     
9,900     

88.6%  $
11.4%   
100.0%  $

(2,507)    
(398)    
(2,905)    

(28.6%)
(35.2%)
(29.3%)

The decrease in domestic TSG sales for 2020 as compared to 2019 was primarily due to a 72% decline in consumable sales resulting largely from lower
sales of legacy HP inkjet cartridges used in our banking printers, as we exited the banking market at the end of 2018, and to a lesser extent, lower sales of
legacy  POS  receipt  paper.    In  addition,  we  experienced  32%  lower  service  sales  primarily  related  to  a  service  contract  with  a  banking  customer  that  is
expected to end in 2021.  We expect TSG sales to decrease in 2021 compared to 2020 due to lower expected sales of lottery printer spare printer parts to
IGT and lower service sales related to the service contract with a banking customer that is expected to end in 2021.

Internationally,  TSG  sales  decreased  during  2020  compared  to  2019  primarily  due  to  a  49%  decrease  in  sales  of  replacement  parts  and  accessories  to
international casino and gaming customers.

Gross Profit.  Gross profit information for the years ended December 31, 2020 and 2019 is summarized below (in thousands, except percentages):

Year Ended December 31,

2020

2019

Percent
Change

Percent of
Total Sales - 2020

Percent of
Total Sales - 2019

$

12,929 

  $

21,935 

(41.1%)  

42.3%  

47.9%

Gross  profit  is  measured  as  revenue  less  cost  of  sales,  which  includes  primarily  the  cost  of  all  raw  materials  and  component  parts,  direct  labor,
manufacturing overhead expenses, cost of finished products purchased directly from our contract manufacturers, expenses associated with installations and
support of our EPICENTRALTM print system and BOHA! ecosystem and royalty payments to third parties, including to the third party licensor of our food
service technology software products.  Gross profit decreased $9.0 million, or 41% in 2020 compared to 2019 primarily due to a 33% sales decrease in
2020 compared to 2019.  Gross margin decreased 560 basis points to 42.3% during 2020 compared to 47.9% in 2019 primarily due to the impact of fixed
manufacturing overhead expenses on lower sales volume as a result of the effects of the COVID-19 pandemic, partially offset by cost savings measures
implemented in late March 2020 and maintained through the end of 2020 in response to the COVID-19 pandemic.

Operating Expenses - Engineering, Design and Product Development.  Engineering, design and product development information for the years ended
December 31, 2020 and 2019 is summarized below (in thousands, except percentages):

Year Ended December 31,

2020

2019

Percent
Change

Percent of
Total Sales - 2020

Percent of
Total Sales - 2019

$

5,703 

  $

4,393 

29.8%  

18.6%  

9.6%

Engineering, design and product development expense primarily includes salary and payroll related expenses for our hardware and software engineering
staff,  depreciation  and  design  expenses  (including  prototype  printer  expenses,  outside  design,  development  and  testing  services,  supplies  and  contract
software  development  expenses).    Engineering,  design  and  product  development  expenses  increased  $1.3  million,  or  30%,  in  2020  compared  to  2019
primarily  due  to  continued  expanded  development  for  our  food  service  technology  products.    We  expect  engineering,  design  and  product  development
expense to increase in 2021 compared to 2020 related to accelerated investments planned for our food service technology products.

Operating Expenses - Selling and Marketing.  Selling and marketing information for the years ended December 31, 2020 and 2019 is summarized below
(in thousands, except percentages):

Year Ended December 31,

2020

2019

Percent
Change

Percent of
Total Sales - 2020

Percent of
Total Sales - 2019

$

6,144 

  $

8,033 

(23.5%)  

20.1%  

17.6%

Selling  and  marketing  expense  primarily  includes  salaries  and  payroll  related  expenses  for  our  sales  and  marketing  staff,  sales  commissions,  travel
expenses,  expenses  associated  with  the  lease  of  sales  offices,  advertising,  trade  show  expenses,  public  relations,  e-commerce  and  other  promotional
marketing expenses.  Selling and marketing expenses decreased $1.9 million, or 24%, in 2020 compared to 2019 primarily due to cost saving measures
implemented in late March 2020 and maintained through 2020 in response to the COVID-19 pandemic, which more than offset the increase in sales and
marketing expenses resulting from the new and expanded marketing programs and promotions to support our food service technology products that were
implemented  during  the  first  quarter  of  2020  prior  to  the  COVID-19  outbreak.  We  expect  selling  and  marketing  expenses  to  increase  in  2021  as  we
gradually return to more normalized pre-COVID-19 spending levels as well as  make substantial strategic investments in our food service technology sales
and marketing groups that were deferred from 2020 due to the pandemic.

24

 
 
 
 
   
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Operating  Expenses  -  General  and  Administrative.    General  and  administrative  information  for  the  years  ended  December  31,  2020  and  2019  is
summarized below (in thousands, except percentages):

Year Ended December 31,

2020

2019

Percent
Change

Percent of
Total Sales - 2020

Percent of
Total Sales - 2019

$

9,255 

  $

9,166 

1.0%  

30.3%  

20.0%

General and administrative expenses primarily include salaries, incentive compensation, and other payroll related expenses for our executive, accounting,
human  resources,  business  development  and  information  technology  staff,  expenses  for  our  corporate  headquarters,  professional  and  legal  expenses,
telecommunication expenses, and other expenses related to being a publicly-traded company.  General and administrative expenses increased $0.1 million,
or 1%, in 2020 compared to 2019 primarily due to higher compensation expense almost entirely offset by a decrease in professional fees and discretionary
spending resulting from cost saving initiatives implemented in the first quarter of 2020 in response to the COVID-19 pandemic.  We expect general and
administrative expenses to increase in 2021 as we gradually return to more normalized pre-COVID-19 spending levels.

Operating (Loss) Income.    Operating  (loss)  income  information  for  the  years  ended  December  31,  2020  and  2019  is  summarized  below  (in  thousands,
except percentages):

Year Ended December 31,

2020

2019

Percent
Change

Percent of
Total Sales – 2020

Percent of
Total Sales – 2019

$

(8,173)   $

343 

(2,482.8%)  

(26.7%)  

0.7%

Our operating income decreased $8.5 million during 2020 compared to 2019 primarily due to the 33% decrease in sales and the 560 basis point decrease in
gross margin in 2020 compared to 2019.

Interest.  We recorded net interest expense of $52 thousand in 2020 compared to $11 thousand in 2019.  The increase in interest expense was primarily due
to  interest  on  borrowings  under  the  Siena  Credit  Facility  in  the  second  quarter  of  2020  and  higher  fees  for  unused  borrowings  under  the  Siena  Credit
Facility as compared to no borrowings and lower fees for unused borrowings under the TD Bank revolving line of credit during 2019.

Other, net.  We recorded other income of $56 thousand in 2020 compared to $35 thousand in 2019 primarily due to foreign exchange gains recorded by our
UK  subsidiary.    Going  forward,  we  may  continue  to  experience  more  foreign  exchange  gains  or  losses  depending  on  the  level  of  sales  to  European
customers through our UK subsidiary and the fluctuation in exchange rates of the Euro and Pound Sterling against the U.S. Dollar, which may be impacted
by volatility in global economic conditions due to the COVID-19 pandemic.

Income Taxes.  We recorded an income tax benefit during the year ended 2020 of $2.5 million at an effective tax rate of 31.1%, compared to an income tax
benefit during the year ended 2019 of $149 thousand at an effective tax rate of (40.6%).  The effective tax rate for 2020 included the impact of the net
operating loss (“NOL”) that we expect to carry back to prior years.  The CARES Act permits NOLs incurred in 2018, 2019 and 2020 to be carried back to
each of the five preceding taxable years to generate a refund of previously paid income taxes.  We generated an NOL for 2020 which we will carry back to
tax years that had a federal statutory tax rate of 34% compared to 21% in 2020.  The income tax benefit for 2019 was unusually high primarily due to the
impact of  research and development (R&D) credits on a relatively low level of taxable income.

Net Income.  We reported a net loss for the year ended 2020 of $5.6 million, or $(0.72) per diluted share, compared to net income of $0.5 million, or $0.07
per diluted share, in 2019.

Liquidity and Capital Resources
We assess our liquidity in terms of our ability to generate cash to fund our operating, investing and financing activities.  Significant factors affecting the
management of liquidity are cash flows from operating activities, capital expenditures, access to bank lines of credit and our ability to attract long-term
capital with satisfactory terms.

Internal cash generation together with currently available cash and cash equivalents, available borrowing facilities and an ability to access credit lines, if
needed, are expected to be sufficient to fund operations, capital expenditures, and any increase in working capital that would be required to accommodate a
higher  level  of  business  activity.    We  may  actively  seek  to  expand  by  acquisition  as  well  as  through  the  growth  of  our  current  business.    A  significant
acquisition may require additional debt and/or equity financing.

25

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash Flow
During 2020 our cash balance increased $6.2 million, or 146%, from December 31, 2019 due to financing activities providing $11 million of cash primarily
from the completion of the Offering and the funds received from the PPP Loan.  We had $10.4 million in cash and cash equivalents as of December 31,
2020, of which $0.5 million was held by our UK subsidiary.

Operating activities: The following significant factors primarily affected our cash used in operating activities of $3.5 million in 2020 as compared to cash
provided by operating activities of $4.8 million in 2019. During 2020:

● We reported a net loss of $5.6 million.
● We recorded depreciation and amortization of $1.3 million and share-based compensation expense of $0.9 million.
● Accounts receivable decreased $3 million, or 47%, primarily due to lower sales volume during the fourth quarter of 2020 compared to the fourth

quarter of 2019 due to the pandemic.

● Inventories decreased $0.9 million, or 7%, primarily due to the utilization of inventory on hand to fulfill sales in response to the pandemic.
● Prepaid income taxes increased $2.2 million due to an expected income tax refund related to the net operating loss reported for 2020 that will be

carried back to prior years as permitted by the CARES Act.

● Other current and long-term assets increased $0.2 million, or 19%, due primarily to recording a contract asset related to a long term BOHA! sales
contract  which  was  partially  offset  by  the  recognition  of  royalty  expense  that  was  prepaid  in  2019  to  a  technology  partner  for  food  service
technology.

● Accounts  payable  decreased  $1.3  million,  or  43%,  due  to  inventory  purchases  made  towards  the  end  of  the  fourth  quarter  of  2019  that  were

subsequently paid in the first quarter of 2020 and a lower level of inventory purchases during 2020 due to the pandemic.

● Accrued liabilities and other liabilities increased $0.2 million, or 3%, due primarily to an increase in accrued inventive compensation.

During 2019:

● We reported a net income of $0.5 million.
● We recorded depreciation and amortization of $1.4 million and share-based compensation expense of $0.7 million.
● Accounts receivable decreased $1.6 million, or 20%, primarily due to strong collections on receivables during the fourth quarter of 2019.
● Inventories decreased $0.8 million, or 6%, primarily due to the utilization of inventory on hand to fulfill sales.
● Prepaid income taxes decreased $0.6 million, or 71%, primarily due to an income tax refund received in the fourth quarter of 2019.
● Other current and long-term assets increased $0.3 million, or 47%, due primarily to an advanced payment of royalty fees to a technology partner

for food service technology.

● Accounts payable decreased $0.5 million, or 15%, primarily due to the utilization of inventory on hand to fulfill sales requiring a lower level of

inventory purchases during the second half of 2019.

● Accrued liabilities and other liabilities increased $0.4 million, or 11%, due primarily to an increase in deferred revenue related to our food service

technology service contracts and software subscriptions.

Investing activities:    Our  capital  expenditures,  including  capitalized  software  costs,  were  $0.7  million  and  $1.4  million  in  2020  and  2019,  respectively. 
Expenditures for 2020 were primarily for new product tooling equipment, leasehold improvements at our Las Vegas facility and computer and networking
equipment.    Expenditures  in  2019  were  primarily  for  new  product  tooling  equipment,  and,  to  a  lesser  extent,  computer  and  networking  equipment. 
Additionally, during the first quarter of 2020, prior to widespread shutdowns in the United States in response to the COVID-19 pandemic, we loaned an
additional $0.6 million to a third party software developer from whom we license our food service technology software.

Capital expenditures and additions to capitalized software for 2021 are expected to be approximately $1.4 million, primarily for new product tooling, new
computer software and computer and networking equipment to support our food service technology market.

Financing activities:    Financing  activities  provided  $11.0  million  of  cash  during  2020  primarily  from  the  completion  of  the  Offering  which  raised  net
proceeds of $8.7 million, after deducting underwriting discounts, commissions and offering expenses, and the $2.2 million in funds received from the PPP
Loan and, to a lesser extent, proceeds of $0.4 million from stock option exercises.  These increases were partially offset by the payment of financing costs
associated with signing our Siena Credit Facility.  During 2019, we used $2.9 million of cash from financing activities to pay dividends of $2.7 million and
$0.2 million related to the relinquishment of shares to pay for withholding taxes on stock issued from our stock compensation plan.

Resource Sufficiency
Given the unprecedented uncertainty related to the impact of the COVID-19 pandemic on the food service and casino industries, the Company is closely
monitoring its cash generation, usage and preservation including the management of working capital to generate cash. The Company does not currently
anticipate requiring any additional credit facilities within the next twelve months beyond our Siena Credit Facility and the PPP Loan, which are discussed
above, nor does it anticipate a material change in the terms or covenants pertaining to its current facilities.

We believe that our cash and cash equivalents on hand, our expected cash flows generated from operating activities, proceeds raised through the Offering
on  October  16,  2020,  borrowings  available  under  our  Siena  Credit  Facility,  and  savings  from  the  cost  reduction  actions  discussed  above  will  provide
sufficient resources to meet our working capital needs, finance our capital expenditures and meet our liquidity requirements through at least the next twelve
months.  Notwithstanding this belief, the duration and extent of the pandemic remain uncertain and its ultimate impact unknown.  As a result, continue to
evaluate several different strategies to enhance our liquidity position as a result of the significant financial and operational impacts due to the COVID-19
pandemic.  These strategies may include, but are not limited to, seeking to raise additional capital through an equity or debt financing and applying for
additional relief through other programs established under the CARES Act.

26

Credit Facility and Borrowings
On March 13, 2020, we entered into the Siena Credit Facility with Siena Lending Group LLC and terminated our credit facility with TD Bank N.A..  The
Siena Credit Facility provides for a revolving credit line of up to $10 million expiring on March 13, 2023.  Borrowings under the Siena Credit Facility bear
a floating rate of interest equal to the greatest of (i) the prime rate plus 1.75%, (ii) the federal funds rate plus 2.25%, and (iii) 6.50%.  The total deferred
financing costs related to expenses incurred to complete the Siena Credit Facility were $245 thousand.  We also pay a fee of 0.50% on unused borrowings
under  the  Siena  Credit  Facility.    Borrowings  under  the  Siena  Credit  Facility  are  secured  by  a  lien  on  substantially  all  the  assets  of  the  Company. 
Borrowings under the Siena Credit Facility are subject to a borrowing base based on (i) 85% of eligible accounts receivable plus the lesser of (a) $5 million
and (b) 50% of eligible raw material and 60% of finished goods inventory.

The  Siena  Credit  Facility  imposes  a  quarterly  financial  covenant  on  the  Company  and  restricts,  among  other  things,  our  ability  to  incur  additional
indebtedness  and  the  creation  of  other  liens.    The  three  month  period  from  April  1,  2020  to  June  30,  2020  was  the  first  period  we  were  subject  to  the
financial covenant, which required the Company to maintain a minimum EBITDA.  As of December 31, 2020, we had no outstanding borrowings under the
Siena Credit Facility and were in compliance with our financial covenant.  The following table demonstrates our compliance with the financial covenant at
December 31, 2020.

Financial Covenant
EBITDA

Requirement
Minimum of $(6,631)

Calculation for the period from April 1, 2020 to
December 31, 2020
$(4,899)

On  May  1,  2020,  the  Company  entered  into  the  PPP  Loan  with  Berkshire  Bank  in  the  aggregate  amount  of  $2.2  million,  pursuant  to  the  PPP  which  is
administered by the SBA and was established under Division A, Title I of the CARES Act, enacted March 27, 2020.

The PPP Loan, which is evidenced by a Note dated the Loan Date issued by the Company (the “Note”), matures on May 1, 2022 and bears interest at a
fixed rate of 1.0% per annum, accruing from the Loan Date and payable monthly. No payments are due on the PPP Loan for six months from the date of
first disbursement, and if a loan forgiveness application is submitted to the SBA within 10 months after the end of the covered period, no payments are due
until the date on which the SBA remits the loan forgiveness amount to the PPP Lender (or notifies the PPP Lender that no loan forgiveness is allowed), but
interest will continue to accrue during the deferment period.  If no loan forgiveness is allowed, the Company will be required to pay the PPP Lender equal
monthly  payments  of  principal  and  interest  based  on  the  principal  amount  outstanding  on  the  PPP  Loan,  plus  interest  outstanding  at  the  end  of  the
deferment period, and taking into account any reductions in the principal amount due to forgiveness, if any.  The Note is unsecured and guaranteed by the
SBA.  The Note may be prepaid by the Company at any time prior to maturity with no prepayment penalties.  The Note provides for customary defaults,
including  failure  to  make  payment  when  due  or  to  fulfill  the  Company’s  obligations  under  the  Note  or  related  documents,  reorganizations,  mergers,
consolidations or other changes to the Company’s business structure, and certain defaults on other indebtedness, bankruptcy events, adverse changes in
financial condition or civil or criminal actions.  The PPP Loan may be accelerated upon the occurrence of a default.

Under  the  terms  of  the  PPP,  the  PPP  Loan  may  be  forgiven  to  the  extent  that  funds  from  the  PPP  Loan  are  used  for  qualifying  expenses,  subject  to
conditions and limitations provided in the CARES Act.  At least 60% (as amended) of the proceeds of the PPP Loan must be used for eligible payroll costs
for  the  PPP  Loan  to  be  forgivable.  The  Company  has  maximized  the  use  of  the  PPP  Loan  proceeds  for  qualifying  expenses  and  intends  to  apply  for
forgiveness of the PPP Loan in accordance with the terms of the CARES Act, as amended by the Paycheck Protection Program Flexibility Act of 2020. 
Whether  forgiveness  will  be  granted  and  in  what  amount  is  subject  to  an  application  to,  and  approval  by,  the  SBA  and  may  also  be  subject  to  further
requirements  in  any  regulations  and  guidelines  the  SBA  may  adopt.    The  PPP  Loan  is  classified  as  “Long-term  debt”  in  the  Condensed  Consolidated
Balance Sheet until the forgiveness determination has been made by the SBA.

Shareholder Dividend Payments
In 2012, our Board of Directors initiated a quarterly cash dividend program which is subject to the Board’s approval each quarter.  Dividends declared and
paid on our common stock totaled $2.7 million or $0.36 per share in 2019.  On January 23, 2020, our Board of Directors announced the cessation of our
quarterly  cash  dividend  on  the  Company’s  common  stock  to  accelerate  the  investment  in  sales  and  marketing,  continued  product  development  and
infrastructure of the BOHA! ecosystem.  The final dividend payment was made in December 2019.

Stock Repurchase Program
During 2020 and 2019 we did not repurchase any shares of our common stock.

Shareholders’ Equity
Shareholders’ equity increased 4.3 million, or 17%, to $30.2 million at December 31, 2020 from $25.9 million at December 31, 2019.  The increase was
primarily  due  to  the  completion  of  the  Offering  which  raised  net  proceeds  of  $8.7  million,  after  deducting  underwriting  discounts,  commissions  and
offering  expenses,  and  sold  an  aggregate  of  1,380,000  shares  of  common  stock.    Shareholders’  equity  also  increased,  although  to  a  lesser  extent,  from
share-based compensation expense related to stock awards of $0.9 million and $0.4 million from the issuance of 62,500 shares of common stock related to
employee stock awards, net of relinquishments.  These increases were partially offset by a net loss of $5.6 million.

Off-Balance Sheet Arrangements
As of December 31, 2020, we had no off-balance sheet arrangements that have had or that we expect would be reasonably likely to have a future material
effect  on  our  financial  condition,  changes  in  financial  condition,  revenues  or  expenses,  results  of  operations,  liquidity,  capital  expenditures  or  capital
resources.

27

 
 
 
 
Item 7A. Quantitative and Qualitative Disclosures about Market Risk.
TransAct is a smaller reporting company, as defined in Item 10(f)(1) of Regulation S-K, and is not required to provide information under this item.

Item 8. Financial Statements and Supplementary Data.
The financial statements of the Company are annexed to this Annual Report as pages F-5 through F-23.  The “Report of Independent Registered Public
Accounting Firm” is annexed to this Annual Report as of page F-2.  An index to such materials appears on page F-1.

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
Not applicable.

Item 9A. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), evaluated the effectiveness of our
disclosure controls and procedures, as defined in Rule 13a-15(e) under the Exchange Act as of December 31, 2020.  In the Amendment to our Annual
Report on Form 10-K for the year ended December 31, 2018, filed with the SEC on November 21, 2019, we disclosed that management, including our
CEO  and  CFO,  concluded  that  our  disclosure  controls  and  procedures  were  not  effective  as  of  December  31,  2018,  due  to  material  weaknesses  in  our
internal control over financial reporting as described below. As of December 31, 2020, one material weakness was not fully remediated and our disclosure
controls and procedures were not effective as of December 31, 2020.  Management has begun remediation efforts, which are described below.

Notwithstanding  these  material  weaknesses,  our  management,  including  our  CEO  and  CFO,  has  concluded  that  our  consolidated  financial  statements,
included in this Form 10-K, fairly present, in all material respects, our financial condition, results of operations and cash flows for the periods presented in
conformity with generally accepted accounting principles, and that they can still be relied upon.

Management’s Annual Report on Internal Control Over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) under the
Exchange Act, to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles.  Internal control over financial reporting includes those policies and procedures that
(i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company;
(ii)  provide  reasonable  assurance  that  transactions  are  recorded  as  necessary  to  permit  preparation  of  financial  statements  in  accordance  with  generally
accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management
and  directors  of  the  Company;  and  (iii)  provide  reasonable  assurance  regarding  prevention  or  timely  detection  of  unauthorized  acquisition,  use  or
disposition of the Company’s assets that could have a material effect on the financial statements.

Our  management  assessed  our  internal  control  over  financial  reporting  as  of  December  31,  2020.  Our  management  based  its  assessment  on  criteria
established  in  Internal  Control–Integrated  Framework  issued  by  the  Committee  of  Sponsoring  Organizations  of  the  Treadway  Commission  (“2013
COSO”).    In  the  opinion  of  management,  TransAct  did  not  maintain  effective  internal  control  over  financial  reporting  as  of  December  31,  2020  solely
because  of  the  material  weakness  in  internal  control  over  financial  reporting  described  below  that  existed  as  of  December  31,  2018  and  has  not  been
remediated as of December 31, 2020.

A material weakness is defined in Rule 12b-2 under the Exchange Act as a deficiency, or a combination of deficiencies, in internal control over financial
reporting,  such  that  there  is  a  reasonable  possibility  that  a  material  misstatement  of  the  Company’s  annual  or  interim  financial  statements  will  not  be
prevented or detected on a timely basis.

Material Weaknesses in Internal Control Over Financial Reporting

We identified the following control deficiency that constituted a material weakness in our internal control over financial reporting as of December 31, 2019
and 2018 which has been fully remediated as of December 31, 2020.

● We did not design and maintain effective controls over user access within the Company’s ERP system, Oracle, to ensure appropriate segregation
of duties and to adequately restrict user access to appropriate personnel.  Specifically, the provisioning and user recertification controls were not
designed to ensure that users maintain proper segregation of duties and, as a result, users could have had inappropriate access rights (the “Access
Control Weakness”).

28

We identified the following control deficiency that constituted a material weakness in our internal control over financial reporting as of December 31, 2020
and 2019.

● We did not design and maintain effective controls over the completeness and accuracy of information included in key spreadsheets supporting our

accounting records (the “Spreadsheet Control Weakness”).

These control deficiencies constituted material weaknesses, but did not result in a material misstatement to our annual or interim consolidated financial
statements.  However,  if  the  remaining  material  weakness  is  not  remediated,  a  material  misstatement  of  account  balances  or  disclosures  may  not  be
prevented, and may go undetected, which could result in a material misstatement of future annual or interim consolidated financial statements.

Remediation Efforts to Address Material Weaknesses
Beginning  December  31,  2019,  we  commenced  developing  and  implementing  a  plan  to  enhance  the  design  and  operating  effectiveness  of  our  internal
control over financial reporting, which includes taking the following steps to remediate the identified control deficiencies and material weaknesses:

● To  address  the  Access  Control  Weakness,  we  utilized  the  services  of  an  Oracle  consulting  firm  and  an  accounting  firm  unrelated  to  our
Independent Registered Accounting Firm, to assist us in analyzing and reviewing Oracle access for all users.  During the first quarter of 2020, we
completed the analysis and deployed an action plan.  Based on this analysis and action plan, during the second quarter of 2020, we created new
Oracle responsibilities for each employee for which a conflict was identified to remove Oracle transactional responsibilities that we believed to be
conflicting and reassigned those responsibilities to a different employee to ensure proper segregation of duties.  We completed the implementation
of the new Oracle responsibilities for all users in July 2020.  During the third quarter of 2020, we completed the enhancement and implementation
provisioning  and  user  certification  controls  to  ensure  we  maintain  the  appropriate  segregation  of  duties  within  Oracle.    The  Access  Control
Weakness was deemed to be remediated as of September 30, 2020.

● To address the Spreadsheet Control Weakness, for each key spreadsheet we plan to evaluate and determine (1) if a standard Oracle report exists
containing the same information as the spreadsheet, and if so, we would utilize the standard Oracle report (without modification) instead of the
spreadsheet to support our accounting records and (2) if a standard Oracle report cannot be used, we will implement a new key control whereby an
employee performs a formal validation that the information from Oracle is completely and accurately transferred (automatically or manually) to a
spreadsheet by verifying totals and other information on a test basis.  For all key spreadsheets, we plan to design and implement a new key control
to validate the completeness and accuracy of information supporting our accounting records.  During 2020, we began the process of evaluating
each  key  spreadsheet  based  on  the  above  criteria,  and  for  several  key  spreadsheets,  we  implemented  a  new  key  control  to  validate  the
completeness and accuracy of the information contained within and supporting each such spreadsheet.

We believe these steps will address the remaining material weakness described above.

Changes in Internal Control over Financial Reporting
Other than the changes intended to remediate the material weakness noted above, no change in our internal control over financial reporting (as defined in
Rules  13a-15(f)  and  15d-15(f)  under  the  Exchange  Act)  occurred  during  the  three  months  ended  December  31,  2020  that  has  materially  affected,  or  is
reasonably likely to materially affect, our internal control over financial reporting.

Item 9B. Other Information.
Not applicable.

29

PART III

Item 10. Directors, Executive Officers and Corporate Governance.
Set forth in Item 1 of this Form 10-K is certain information regarding our executive officers.  The remaining information in response to this item will be
contained in our Proxy Statement  for our 2021 Annual Meeting of Stockholders (the “Proxy Statement”) under the headings, “Delinquent Section 16(a)
Reports,” “Corporate Governance,” “Proposal 1: Election of Directors,” “Audit Committee Report,” “Executive Compensation – Compensation Committee
Report,”  “Stockholder  Proposals  for  2022  Annual  Meeting,”  “Procedures  for  Submitted  Director  Nominations  and  Recommendations”  and  “Policy
Regarding Stockholder Communications with the Board of Directors,” which will be filed within 120 days after the end of the year covered by this Form
10-K and is incorporated herein by reference.

Code of Ethics
We maintain a Standards of Business Conduct and Code of Ethics that includes our code of ethics that is applicable to all employees, including our Chief
Executive  Officer,  Chief  Financial  Officer  and  Controller.    Our  Standards  of  Business  Conduct,  which  requires  continued  observance  of  high  ethical
standards, such as honesty, integrity and compliance with the law in the conduct of our business, is available for public access on our Internet website at
https://transacttech.gcs-web.com/corporate-governance.  Any person may request a copy of our Standards of Business Conduct free of charge by calling
(203) 859-6800.

Item 11. Executive Compensation.
The information in response to this item will be contained in the Proxy Statement under the heading “Executive Compensation,” and is incorporated herein
by reference.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
Set forth below is certain information regarding our equity compensation plans.  The remaining information in response to this item will be contained in the
Proxy Statement under the heading, “Security Ownership of Certain Beneficial Owners and Management,” and is incorporated herein by reference.

Equity Compensation Plan Information
Information regarding our equity compensation plans as of December 31, 2020 is as follows:

Plan category
Equity compensation plans approved by security holders:

2005 Equity Incentive Plan
2014 Equity Incentive Plan

Total

(a)
Number of
securities to be
issued upon
exercise
of outstanding
options,
warrants
and rights

(b)
Weighted-
average
exercise price
of outstanding
options,
warrants
and rights

(c)
Number of
securities
remaining
available for
future issuance
under
equity
compensation
plans
(excluding
securities
reflected in
column (a)

291,000 
1,107,155 
1,398,155 

  $

  $

9.47     
7.95     
8.27     

– 
837,204 
837,204 

In May 2014, our stockholders approved the adoption of the 2014 Equity Incentive Plan.  In May 2020, our stockholders approved an amendment to the
2014 Equity Incentive Plan to increase the number of common stock which may be subject to awards granted under the plan from 1,400,000 to its current
level of 2,200,000.  The Company also maintains the 2005 Equity Incentive Plan; however no new awards will be available for future issuance under this
plan.  Both plans generally provide for award in the form of: (i) incentive stock options, (ii) non-qualified stock options, (iii) restricted stock, (iv) restricted
stock units (which may include performance-based vesting), (v) stock appreciation rights or (vi) limited stock appreciation rights.  The Company does not
have any equity plans that have not been approved by its stockholders.

Item 13. Certain Relationships and Related Transactions, and Director Independence.
The information in response to this item will be contained in the Proxy Statement under the headings “Certain Relationships and Related Transactions” and
is incorporated herein by reference.

Item 14. Principal Accountant Fees and Services.
The  information  in  response  to  this  item  will  be  contained  in  the  Proxy  Statement  under  the  headings,  “Policy  Regarding  Pre-Approval  of  Services
Provided  by  the  Independent  Registered  Public  Accounting  Firm”  and  “Independent  Registered  Public  Accounting  Firm’s  Services  and  Fees”  and  is
incorporated herein by reference.

30

 
 
 
   
 
 
 
 
 
 
     
 
 
 
 
 
 
 
 
 
Item 15. Exhibits and Financial Statement Schedules.

(a) The following documents are filed as part of this Form 10-K:

1. Financial Statements.

PART IV

Report of Independent Registered Public Accounting Firm
Consolidated Balance Sheets as of December 31, 2020 and 2019
Consolidated Statements of Operations for the years ended December 31, 2020 and 2019
Consolidated Statements of Comprehensive (Loss) Income for the years ended December 31, 2020 and 2019
Consolidated Statements of Changes in Shareholders’ Equity for the years ended December 31, 2020 and 2019
Consolidated Statements of Cash Flows for the years ended December 31, 2020 and 2019
Notes to Consolidated Financial Statements

2. Schedules.

All schedules are omitted because they are either inapplicable or not required, or because the information required therein is included in the Consolidated
Financial Statements and Notes thereto.

3. Exhibits.

Exhibits Index

3.1(a)

3.1(b)

3.1(c)

3.2

4.1

4.2

10.1(x)

10.2(x)

10.3(x)

10.4(x)

10.5(x)

10.6(x)

10.7(x)

10.8(x)

10.9(x)

10.10(x)

10.11

10.12

Certificate  of  Incorporation  of  TransAct  Technologies  Incorporated  (conformed  copy)  (incorporated  by  reference  to  Exhibit  3(i)  of  the
Company’s Quarterly Report on Form 10-Q (SEC File No. 000-21121) filed with the SEC on August 9, 2019).
Certificate  of  Designation,  Series  A  Preferred  Stock,  filed  with  the  Secretary  of  State  of  Delaware  on  December  2,  1997  (incorporated  by
reference to Exhibit C of the Company’s Current Report on Form 8-K (SEC File No. 000-21121) filed with the SEC on February 18, 1999).
Certificate of Designation, Series B Preferred Stock, filed with the Secretary of State of Delaware on April 6, 2000 (incorporated by reference
to Exhibit 3.1(c) of the Company’s Quarterly Report on Form 10-Q (SEC File No. 000-21121) filed with the SEC on May 8, 2000).
Amended and Restated By-laws of the Company (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K
(SEC File No. 000-21121) filed with the SEC on August 2, 2019).
Specimen Common Stock Certificate (incorporated by reference to Exhibit 4.1 of the Company’s Registration Statement on Form S-1/A (No.
333-06895) filed with the SEC on August 1, 1996).
Description of Securities (incorporated by reference to Exhibit 4.2 of the Company’s Annual Report on Form 10-K (SEC File No.
000-21121) filed with the SEC on March 16, 2020).
2005 Equity Incentive Plan (incorporated by reference to Exhibit 99.1 of the Company’s Current Report on Form 8-K (SEC File No. 000-
21121) filed with the SEC on June 1, 2005).
TransAct  Technologies  Incorporated  2014  Equity  Incentive  Plan,  as  Amended  and  Restated  (incorporated  by  reference  to  Exhibit  A  to  the
Definitive Proxy Statement on Schedule 14A filed with the Commission on April 23, 2020, File No. 000-21121).
2014  Equity  Incentive  Plan  Time-based  Restricted  Stock  Unit  Agreement  (incorporated  by  reference  to  Exhibit  10.2  of  the  Company’s
Quarterly Report on Form 10-Q (SEC File No. 000-21121) filed with the SEC on May 6, 2016).
2014 Equity Incentive Plan Performance-based Restricted Stock Unit Agreement (incorporated by reference to Exhibit 10.1 of the Company’s
Quarterly Report on Form 10-Q (SEC File No. 000-211121) filed with the SEC on August 8, 2016).
Employment Agreement, dated July 31, 1996, by and between TransAct and Bart C. Shuldman (incorporated by reference to Exhibit 10.20 of
the Company’s Registration Statement on Form S-1/A (No. 333-06895) filed with the SEC on August 1, 1996).
Severance Agreement by and between TransAct and Steven A. DeMartino, dated June 1, 2004 (incorporated by reference to Exhibit 10.8 of
the Company’s Annual Report on Form 10-K (SEC File No. 000-21121) filed with the SEC on March 16, 2005).
Severance Agreement by and between TransAct and Tracey S. Chernay, dated July 29, 2005 (incorporated by reference to Exhibit 10.9 of the
Company’s Annual Report on Form 10-K (SEC File No. 000-21121) filed with the SEC on March 14, 2008).
Amendment  to  Employment  Agreement,  effective  January  1,  2008,  by  and  between  TransAct  and  Bart  C.  Shuldman  (incorporated  by
reference to Exhibit 10.10 of the Company’s Annual Report on Form 10-K (SEC File No. 000-21121) filed with the SEC on March 16, 2009).
Amendment  to  Severance  Agreement  by  and  between  TransAct  and  Steven  A.  DeMartino,  effective  January  1,  2008  (incorporated  by
reference to Exhibit 10.12 of the Company’s Annual Report on Form 10-K (SEC File No. 000-21121) filed with the SEC on March 16, 2009).
Amendment to Severance Agreement by and between TransAct and Tracey S. Chernay, effective January 1, 2008 (incorporated by reference
to Exhibit 10.14 of the Company’s Annual Report on Form 10-K (SEC File No. 000-21121) filed with the SEC on March 16, 2009).
Lease Agreement by and between Bomax Properties and Ithaca, dated as of March 23, 1992 (incorporated by reference to Exhibit 10.14 of the
Company’s Registration Statement on Form S-1 (No. 333-06895) filed with the SEC on June 26, 1996).
Second Amendment to Lease Agreement by and between Bomax Properties and Ithaca, dated December 2, 1996 (incorporated by reference to
Exhibit 10.27 of the Company’s Annual Report on Form 10-K (SEC File No. 000-21121) filed with the SEC on March 31, 1998).

31

10.13

10.14

10.15

10.16

10.17

10.18

10.19

10.20

10.21

10.22

10.23

10.24†
10.25†
21*
23.1*
23.2*
31.1*
31.2*
32‡

101.INS

101.SCH
101.CAL
101.DEF
101.LAB
101.PRE
104

Agreement  regarding  the  Continuation  and  Renewal  of  Lease  by  and  between  Bomax  Properties,  LLC  and  TransAct,  dated  July  18,
2001 (incorporated by reference to Exhibit 10.8 of the Company’s Annual Report on Form 10-K (SEC File No. 000-21121) filed with the SEC
on March 29, 2002).
Amendment  No.  1  to  Lease  Agreement  between  Bomax  Properties,  LLC  and  TransAct  (incorporated  by  reference  to  Exhibit  10.16  of  the
Company’s Quarterly Report on Form 10-Q (SEC File No. 000-21121) filed with the SEC on May 10, 2012).
Amendment No. 2 to Lease Agreement between Bomax Properties, LLC and TransAct, dated January 14, 2016 (incorporated by reference to
Exhibit 10.13 of the Company’s Annual Report on Form 10-K (SEC File No. 000-21121) filed with the SEC on March 11, 2016).
Amendment No. 3 to Lease Agreement between Bomax Properties, LLC and TransAct, dated February 28, 2020 (incorporated by reference to
Exhibit 10.1 to the Company’s Current Report on Form 8-K (SEC File No. 000-21121) filed with the SEC on March 4, 2020).
Lease  Agreement  by  and  between  Las  Vegas  Airport  Properties  LLC  and  TransAct  dated  December  2,  2004  (incorporated  by  reference  to
Exhibit 10.13 of the Company’s Annual Report on Form 10-K (SEC File No. 000-21121) filed with the SEC on March 16, 2005).
First Amendment to Lease Agreement by and between Las Vegas Airport Properties LLC and TransAct dated August 31, 2009 (incorporated
by reference to Exhibit 10.19 of the Company’s Annual Report on Form 10-K (SEC File No. 000-21121) filed with the SEC on March 16,
2010).
Second Amendment to Lease Agreement by and between The Realty Associates Fund IX LP and TransAct dated June 30, 2015 (incorporated
by reference to Exhibit 10.2 of the Company’s Quarterly Report on Form 10-Q (SEC File No. 000-21121) filed with the SEC on August 7,
2015).
Lease  Agreement  by  and  between  2319  Hamden  Center  I,  L.L.C.  and  TransAct  dated  November  27,  2006  (incorporated  by  reference  to
Exhibit 10.14 of the Company’s Annual Report on Form 10-K (SEC File No. 000-21121) filed with the SEC on March 15, 2007).
First Amendment to Lease by and between 2319 Hamden Center I, L.L.C. and TransAct dated January 3, 2017 (incorporated by reference to
Exhibit 10.20 of the Company’s Annual Report on Form 10-K (SEC File No. 000-21121) filed with the SEC on March 16, 2017).
Loan and Security Agreement, dated as of March 13, 2020, among Siena Lending Group LLC, TransAct Technologies Incorporated and the
other Loan Parties from time to time party thereto (incorporated by reference to Exhibit 10.2 of the Company’s Quarterly Report on Form 10-
Q (SEC File No. 000-21121) filed with the SEC on May 22, 2020).
Note, dated May 1, 2020, by TransAct Technologies Incorporated in favor of Berkshire Bank (incorporated by reference to Exhibit 10.1 of the
Company’s Current Report on Form 8-K (SEC File No. 000-21121) filed with the SEC on May 5, 2020).
Master License Agreement dated February 22, 2019 and amendments thereto.
Master Development and License Agreement dated July 20, 2018.
Subsidiaries of the Company
Consent of Marcum LLP
Consent of PricewaterhouseCoopers LLP (predecessor auditor).
Rule 13a-14(a) Certification of Chief Executive Officer in accordance with Section 302 of the Sarbanes-Oxley Act of 2002.
Rule 13a-14(a) Certification of Chief Financial Officer in accordance with Section 302 of the Sarbanes-Oxley Act of 2002.
Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002.
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded
within the Inline XBRL document).
Inline XBRL Taxonomy Extension Schema Document.
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
Inline XBRL Taxonomy Extension Definition Linkbase Document.
Inline XBRL Taxonomy Extension Label Linkbase Document.
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

These exhibits are filed herewith.

(x) Management contract or compensatory plan or arrangement.
*
† Certain portions of this exhibit (indicated by “[***]”) have been omitted pursuant to Item (601)(b)(10) of Regulation S-K.
‡

Furnished herewith.

(b) Exhibits.

The Exhibits required by Item 601 of Regulation S-K under the Exchange Act are included in the Exhibit Index above under a(3) of this Item 15.

(c) Financial Statement Schedules.

See the Notes to the Consolidated Financial Statements included in this Form 10-K.

Item 16. Form 10-K Summary.
Not applicable.

32

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.

SIGNATURES

TRANSACT TECHNOLOGIES INCORPORATED

By:
Name:
Title:

/s/ Bart C. Shuldman
Bart C. Shuldman
Chairman of the Board and Chief Executive Officer

Date: March 12, 2021

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant
and in the capacities and on the dates indicated.

Signature

/s/ Bart C. Shuldman
Bart C. Shuldman

/s/ Steven A. DeMartino
Steven A. DeMartino

/s/ David B. Peters
David B. Peters

/s/ John M. Dillon
John M. Dillon

/s/ Randall S. Friedman
Randall S. Friedman

/s/ Emanuel P. N. Hilario
Emanuel P. N. Hilario

/s/ Haydee Olinger
Haydee Olinger

/s/ Thomas R. Schwarz
Thomas R. Schwarz

Title

Chairman of the Board and Chief Executive Officer
(Principal Executive Officer)

Date

March 12, 2021  

President, Chief Financial Officer, Treasurer and Secretary
(Principal Financial Officer)

March 12, 2021  

Vice President and Chief Accounting Officer
(Principal Accounting Officer)

Director

Director

Director

Director

Director

33

March 12, 2021  

March 12, 2021  

March 12, 2021  

March 12, 2021  

March 12, 2021  

March 12, 2021  

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TRANSACT TECHNOLOGIES INCORPORATED
INDEX TO FINANCIAL STATEMENTS

Financial Statements

Report of Independent Registered Public Accounting Firm
Consolidated Balance Sheets as of December 31, 2020 and 2019
Consolidated Statements of Operations for the years ended December 31, 2020 and 2019
Consolidated Statements of Comprehensive (Loss) Income for the years ended December 31, 2020 and 2019
Consolidated Statements of Changes in Shareholders’ Equity for the years ended December 31, 2020 and 2019
Consolidated Statements of Cash Flows for the years ended December 31, 2020 and 2019
Notes to Consolidated Financial Statements

F-2
F-5
F-6
F-7
F-8
F-9
F-10

F-1

 
 
 
 
 
 
 
 
 
To the Shareholders and Board of Directors of Transact Technologies Incorporated

Opinion on the Financial Statements

Report of Independent Registered Public Accounting Firm

We  have  audited  the  accompanying  consolidated  balance  sheet  of  TransAct  Technologies  Incorporated  and  its  subsidiaries  (the  “Company”)  as  of
December 31, 2020, the related consolidated statements of operations, comprehensive loss, changes in shareholders’ equity and cash flows for the year in
the  period  ended  December  31,  2020,  and  the  related  notes  (collectively  referred  to  as  the  “consolidated  financial  statements”).    In  our  opinion,  the
consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020, and the results of
its operations and its cash flows for the year in the period ended December 31, 2020, in conformity with accounting principles generally accepted in the
United States of America.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's
consolidated financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the
applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable
assurance  about  whether  the  consolidated  financial  statements  are  free  of  material  misstatement,  whether  due  to  error  or  fraud.  The  Company  is  not
required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an
understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal
control over financial reporting. Accordingly, we express no such opinion.

Our  audit  included  performing  procedures  to  assess  the  risks  of  material  misstatement  of  the  consolidated  financial  statements,  whether  due  to  error  or
fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and
disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by
management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit provides a reasonable basis
for our opinion.

Critical Audit Matters

The  critical  audit  matter  communicated  below  is  a  matter  arising  from  the  current  period  audit  of  the  consolidated  financial  statements  that  was
communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated
financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not
alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below,
providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Revenue recognition – Identification of Distinct Performance Obligations and Estimate of Standalone Selling Price

As described in Note 2 to the consolidated financial statements, some of the Company’s contracts with customers contain multiple performance obligations
(most commonly when contracts include a hardware product, software and extended warranties). A contract's transaction price is allocated to each distinct
performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. The transaction price is determined based on the
consideration to which the Company will be entitled in exchange for transferring services to the customer. For a majority of the Company’s revenue, which
consists of printers, terminals, consumables, and replacement parts, the Company recognizes revenue as of a point of time; the revenue is recognized upon
shipment of the order when control of the goods is transferred to the customer and at the time the performance obligation is fulfilled. Performance
obligations are satisfied over time if the customer receives the benefits as the Company performs work. The Company’s cloud-based BOHA! software,
provided on a subscription basis, allows customers to use hosted software over the contract period without taking possession of the software and is
recognized ratably over the contract period. For extended warranties, the transaction price is recognized ratably over the warranty period, using output
methods, as control of the services is transferred to the customer. When there is more than one performance obligation in a customer arrangement, the
Company typically uses the “standalone selling price” method to determine the transaction price to allocate to each performance obligation.

F-2

In  2020,  the  Company  launched  a  new  service  offering  related  to  BOHA!  that  bundled  the  BOHA!  products  (cloud-based  SaaS  software  applications,
hardware  and  after-market  service)  in  one  price  payable  monthly  over  a  three  year  period.  During  the  year  ended  December  31,  2020,  the  Company
recognized  revenue  from  contracts  with  customers  related  to  this  new  service  offering  in  the  amount  of  approximately  $928  thousand.  Judgement  was
required by management to identify the performance obligations in the contract and allocate the transaction price to each performance obligation.

The  principal  considerations  for  our  determination  that  revenue  recognition,  specifically  related  to  management’s  identification  of  distinct  performance
obligations  and  the  estimation  of  standalone  selling  prices  related  to  this  new  service  offering,  is  a  critical  audit  matter  are  that  there  was  significant
judgment by management in (1) the identification of distinct performance obligations related to this new service offering, specifically the determination
that  one  distinct  performance  obligation  existed  for  point  in  time  revenue  recognition  and  three  distinct  performance  obligations  existed  for  over-time
revenue  recognition,  (2)  the  estimation  of  the  standalone  selling  price  using  market  pricing  conditions  and  other  observable  inputs,  such  as  historical
pricing practices, for each distinct performance obligation; (3) the determination that a significant financing component existed in the arrangement with the
customer,  therefore,  requiring  deferral  of  a  portion  of  the  point  in  time  revenue  to  be  recognized  as  interest  income  over  the  contract  period;  (4)
management’s election of the accounting policy expedient to exclude sales taxes collected from customers from the transaction price in accordance with
ASU 2016-12; and (5) the identification of costs incurred to obtain the contract and management’s decision to defer such costs and recognize the expense
on  a  straight-line  basis  over  the  life  of  the  contract.  This  in  turn  led  to  a  high  degree  of  auditor  judgment  and  subjectivity  in  performing  our  audit
procedures, which were designed to evaluate audit evidence related to management’s identification of distinct performance obligations within the contract
with the customer related to this new service offering and the judgments made by management to estimate the standalone selling prices used to allocate the
transaction price to those distinct performance obligations identified. Due to this complexity, there was significant effort in performing our audit procedures
to evaluate the reasonableness of management’s estimates used in the Company’s adoption of the accounting standard related to revenue recognition for
this new service offering.

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated
financial  statements.  These  procedures  included,  among  others,  (i)  evaluating  the  Company’s  revenue  recognition  accounting  policy  resulting  from  its
adoption of the accounting standard related to revenue recognition; (ii) evaluating management’s identification of distinct performance obligations in its
contract with the customer; (iii) evaluating management’s process for estimating the standalone selling price which included testing the completeness and
accuracy  of  input  data  used  and  evaluating  the  reasonableness  of  significant  assumptions  used  by  management,  principally  observable  inputs  such  as
historical pricing practices; and (iv) evaluation of the accuracy of management’s allocation of the transaction price to the performance obligations contained
within the related contract with the customer.

/s/ Marcum LLP

Marcum LLP

We have served as the Company’s auditor since 2020.

Hartford, Connecticut
March 12, 2021

F-3

To the Board of Directors and Shareholders of Transact Technologies Incorporated

Opinion on the Financial Statements

Report of Independent Registered Public Accounting Firm

We have audited the consolidated balance sheet of TransAct Technologies Incorporated and its subsidiaries (the “Company”) as of December 31, 2019, and
the related consolidated statements of operations, comprehensive (loss) income, changes in shareholders’ equity and cash flows for the year then ended,
including the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present
fairly, in all material respects, the financial position of the Company as of December 31, 2019, and the results of its operations and its cash flows for the
year then ended in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s
consolidated financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United  States)  (PCAOB)  and  are  required  to  be  independent  with  respect  to  the  Company  in  accordance  with  the  U.S.  federal  securities  laws  and  the
applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit of these consolidated financial statements in accordance with the standards of the PCAOB. Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to
error or fraud.

Our  audit  included  performing  procedures  to  assess  the  risks  of  material  misstatement  of  the  consolidated  financial  statements,  whether  due  to  error  or
fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and
disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by
management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit provides a reasonable basis
for our opinion.

/s/ PricewaterhouseCoopers LLP
Hartford, Connecticut
March 16, 2020

We served as the Company’s auditor from 1996 to 2020.

F-4

TRANSACT TECHNOLOGIES INCORPORATED

CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)

Assets:
Current assets:

Cash and cash equivalents
Accounts receivable, net
Note receivable
Inventories
Prepaid income taxes
Other current assets

Total current assets

Fixed assets, net
Notes receivable, net of current portion
Right-of-use asset
Goodwill
Deferred tax assets
Intangible assets, net
Other assets

Total assets

Liabilities and Shareholders’ Equity:
Current liabilities:

Accounts payable
Accrued liabilities
Lease liability
Deferred revenue

Total current liabilities

Long-term debt
Deferred revenue, net of current portion
Lease liability, net of current portion
Other liabilities

Total liabilities

Commitments and contingencies (Note 15)
Shareholders’ equity:

Preferred stock, $0.01 value, 4,800,000 authorized, none issued and outstanding
Preferred stock, Series A, $0.01 par value, 200,000 authorized, none issued and outstanding
Common stock, $0.01 par value, 20,000,000 authorized at December 31, 2020 and 2019; 12,976,227 and

11,515,090 shares issued; 8,931,385 and 7,470,248 shares outstanding, at December 31, 2020 and 2019,
respectively

Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss, net of tax
Treasury stock, 4,044,842 shares, at cost

Total shareholders’ equity

Total liabilities and shareholders’ equity

See accompanying notes to Consolidated Financial Statements.

F-5

December 31,
2020

December 31,
2019

  $

  $

  $

  $

10,359    $
3,377     
100     
11,286     
2,409     
644     
28,175     

1,950     
1,584     
3,618     
2,621     
2,939     
583     
777     
14,072     
42,247    $

1,691    $
3,665     
837     
504     
6,697     

2,173     
111     
2,864     
166     
5,314     
12,011     

4,203 
6,418 
1,017 
12,099 
180 
998 
24,915 

2,244 
– 
2,855 
2,621 
2,565 
817 
44 
11,146 
36,061 

2,960 
3,041 
945 
700 
7,646 

– 
219 
2,104 
166 
2,489 
10,135 

–     
–     

– 
– 

130     
42,536     
19,718     
(38)    
(32,110)    
30,236     
42,247    $

115 
32,604 
25,348 
(31)
(32,110)
25,926 
36,061 

 
   
 
 
 
     
 
 
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
  
 
 
      
  
 
 
      
  
 
 
 
 
 
 
 
 
 
 
 
      
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
  
 
 
     
 
 
 
      
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net sales
Cost of sales

Gross profit

Operating expenses:

Engineering, design and product development
Selling and marketing
General and administrative

Operating (loss) income
Interest and other income (expense):

Interest expense
Interest income
Other, net

(Loss) income before income taxes
Income tax benefit
Net (loss) income

Net (loss) income per common share:

Basic
Diluted

Shares used in per-share calculation:

Basic
Diluted

TRANSACT TECHNOLOGIES INCORPORATED
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)

Year Ended December 31,

2020

2019

  $

30,595    $
17,666     

45,748 
23,813 

12,929     

21,935 

5,703     
6,144     
9,255     
21,102     

(8,173)    

(130)    
78     
56     
4     

(8,169)    
2,539     
(5,630)   $

(0.72)   $
(0.72)   $

7,827     
7,827     

  $

  $
  $

4,393 
8,033 
9,166 
21,592 

343 

(28)
17 
35 
24 

367 
149 
516 

0.07 
0.07 

7,466 
7,677 

0.36 

Dividends declared and paid per common share:

  $

-    $

See accompanying notes to Consolidated Financial Statements.

F-6

 
 
 
 
   
 
 
 
 
     
 
 
 
 
 
 
      
  
 
 
 
 
 
      
  
 
 
      
  
 
 
 
 
 
 
 
 
 
 
 
 
      
  
 
 
 
 
      
  
 
 
 
 
 
 
 
 
 
 
 
 
      
  
 
 
 
 
 
 
 
      
  
 
 
      
  
 
 
 
      
  
 
 
      
  
 
 
 
 
 
 
 
      
  
TRANSACT TECHNOLOGIES INCORPORATED
CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME
(In thousands)

Net (loss) income
Foreign currency translation adjustment, net of tax

Comprehensive (loss) income

See accompanying notes to Consolidated Financial Statements.

F-7

Year Ended December 31,

2020

2019

  $

  $

(5,630)   $
(7)    

(5,637)   $

516 
51 

567 

 
 
 
 
   
 
 
 
 
     
 
 
 
 
 
 
      
  
TRANSACT TECHNOLOGIES INCORPORATED
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
(In thousands, except share data)

Common Stock

Shares

Amount

Additional
Paid-in
Capital

Retained
Earnings

Treasury
Stock

Accumulated
Other
Comprehensive   
    Income (Loss)    

Total
Equity

7,418,299 

  $

115 

  $

32,129    $

27,515    $

(32,110)   $

(82)   $

27,567 

45,167 

28,231 

(21,449)  

– 

– 

– 
– 

– 

– 

– 

– 

– 

– 
– 

–     

–     

–     

–     

(217)    

–     

–     

(2,683)    

692     

–     

–     
–     

–     
516     

–     

–     

–     

–     

–     

–     
–     

–     

–     

–     

–     

–     

51     
–     

– 

– 

(217)

(2,683)

692 

51 
516 

7,470,248 

  $

115 

  $

32,604    $

25,348    $

(32,110)   $

(31)   $

25,926 

62,500 

32,725 

1,380,000 

(14,088)  

– 

– 
– 

1 

– 

14 

– 

– 

– 
– 

374     

–     

8,723     

(41)    

876     

–     

–     

–     

–     

–     

–     
–     

–     
(5,630)    

–     

–     

–     

–     

–     

–     
–     

–     

–     

–     

–     

–     

375 

– 

8,737 

(41)

876 

(7)    
–     

(7)
(5,630)

Balance, January 1,

2019
Issuance of common 
stock on restricted
stock units

Issuance of common
stock on deferred
stock units

Relinquishment of
stock awards and
deferred stock units
to pay withholding
taxes

Dividends declared

and paid on
common stock

Share-based

compensation
expense

Foreign currency
translation
adjustment, net of
tax

Net income

Balance, December 31,

2019
Issuance of shares
from exercise of
stock options

Issuance of common 
stock on restricted
stock units

Issuance of common

stock, net of
issuance cost
Relinquishment of
stock awards and
deferred stock units
to pay withholding
taxes

Share-based

compensation
expense

Foreign currency
translation
adjustment, net of
tax
Net loss

Balance, December 31,

2020

8,931,385 

  $

130 

  $

42,536    $

19,718    $

(32,110)   $

(38)   $

30,236 

See accompanying notes to Consolidated Financial Statements.

F-8

 
 
 
   
   
   
 
 
 
 
 
 
 
   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TRANSACT TECHNOLOGIES INCORPORATED
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)

Year Ended December 31,

2020

2019

Cash flows from operating activities:

Net (loss) income
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:

  $

(5,630)   $

Share-based compensation expense
Depreciation and amortization
Deferred income tax benefit
(Recovery of) provision for doubtful accounts
Foreign currency transaction (gains) losses
Changes in operating assets and liabilities:

Accounts receivable
Inventories
Prepaid income taxes
Other current and long term assets
Accounts payable
Accrued liabilities and other liabilities

Net cash (used in) provided by operating activities

Cash flows from investing activities:

Capital expenditures
Additions to capitalized software

    Issuance of note receivable

Net cash used in investing activities

Cash flows from financing activities:
Revolving credit line borrowings
Revolving credit line payments
Long-term debt borrowings
Proceeds from stock option exercises
Payment of dividends on common stock
Proceeds from the issuance of common stock
Payment of common stock issuance costs
Withholding taxes paid on stock issuance
Payment of bank financing costs

Net cash provided by (used in) financing activities

Effect of exchange rate changes on cash and cash equivalents

Increase (decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period

Supplemental cash flow information:

Interest paid
Income taxes paid
Non-cash capital expenditure items

See accompanying notes to Consolidated Financial Statements.

F-9

876     
1,342     
(367)    
(1)    
(58)    

2,976     
876     
(2,226)    
(198)    
(1,276)    
176     
(3,510)    

(744)    
–     
(600)    
(1,344)    

2,756     
(2,756)    
2,173     
375     
–     
9,798     
(1,061)    
(41)    
(213)    
11,031     

(21)    

6,156     
4,203     
10,359    $

64    $
46     
25     

  $

  $

516 

692 
1,371 
(294)
16 
18 

1,589 
796 
577 
(333)
(517)
415 
4,846 

(1,062)
(304)
(1,000)
(2,366)

– 
– 
– 
– 
(2,683)
– 
– 
(214)
– 
(2,897)

(71)

(488)
4,691 
4,203 

30 
65 
17 

 
 
 
 
   
 
 
 
     
 
 
 
      
  
 
 
 
 
 
 
 
 
 
 
 
 
      
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
  
 
 
      
  
 
 
 
 
 
 
 
 
 
 
 
      
  
 
 
      
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
  
 
 
 
 
 
      
  
 
 
 
 
 
 
 
      
  
 
 
      
  
 
 
 
 
TRANSACT TECHNOLOGIES INCORPORATED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1. Description of business

TransAct  Technologies  Incorporated  (together  with  its  subsidiaries,  “TransAct,”  the  “Company,”  “we,”  “us,”  or  “our”),  which  has  its  headquarters  in
Hamden, Connecticut and its primary operating facility in Ithaca, New York, operates in one operating segment: software-driven technology and printing
solutions  for  high  growth  markets  including  food  service  technology,  casino  and  gaming,  POS  automation,  and  oil  and  gas  markets.    Our  solutions  are
designed  from  the  ground  up  based  on  market  and  customer  requirements  and  are  sold  under  the  BOHA!TM,  AccuDate™,  Epic®,  Ithaca®,
EPICENTRALTM and Printrex® product brands.  We sell our products to original equipment manufacturers, value-added resellers, select distributors, and
directly to end-users.  Our product distribution spans across the Americas, Europe, the Middle East, Africa, Asia, Australia, New Zealand, the Caribbean
Islands and the South Pacific. TransAct also provides world-class service, spare parts, accessories and printing supplies to its growing worldwide installed
base of products.  We also generate revenue from the after-market side of the business, providing printer and terminal service, consumables and spare parts
in  addition  to  revenue  from  our  two  software  solutions;  (i)  our  line  of  BOHA!  software  applications  used  to  automate  the  back-of-house  operations  of
restaurants, convenience stores and food service operators and (ii) the EPICENTRALTM Print System (“EPICENTRALTM”), that enables casino operators
to create promotional coupons and marketing messages and print them in real time at the slot machine.

Impact of the COVID-19 Pandemic
The unprecedented and rapid spread of COVID-19 and the resulting social distancing measures, including closures and restricted openings of restaurants
and casinos implemented by federal, state and local authorities, have significantly reduced recent customer demand and disrupted portions of our supply
chain, including delayed product shipments from our two manufacturers located in China and Thailand.  We are monitoring indicators of demand recovery,
including our sales pipeline, customer orders and product shipments to ascertain an estimate of the ultimate impact of the COVID-19 pandemic on our
business; however, the length and ultimate severity of the reduction in demand due to the pandemic remains uncertain.

While we began to experience a modest recovery during the second half of 2020 and expect this recovery to continue in 2021, the exact timing and pace of
recovery is unknown given uncertainty surrounding responsive measures to potential future resurgences of the virus and the significant disruption that our
customers have already experienced and may continue to experience.  In light of this uncertainty, we implemented measures to help mitigate the impact on
our financial position and operations. These measures include, but are not limited to, the following:

Expense Management. With the reduction in net sales, we implemented the following cost saving initiatives during 2020:

● a  reduction  of  our  workforce  starting  in  July  2020  by  approximately  20%  through  a  combination  of  employee  terminations  and  temporary
furloughs.  During the fourth quarter, we brought back all furloughed employees.  As of December 31, 2020 our overall headcount was reduced by
approximately 16% when compared to December 31, 2019;

● a 10% reduction in the salaries of all salaried, non-commissioned employees, including executive officers, starting in March 2020.  From May 1,
2020 until early July 2020, employees below the vice president level were paid their full salary as a result of the receipt of the PPP Loan proceeds
(defined below).  All employees’ full salaries were reinstated on January 1, 2021;

● a reduction in sales commissions for all commissioned employees starting in March 2020 through the end of 2020;

● a 10% reduction of cash retainer fees for all non-employee directors starting in March 2020 through the end of 2020; and

● the elimination of discretionary spending wherever possible starting in March 2020 and continuing into the first quarter of 2021.

Balance Sheet, Cash Flow and Liquidity. In addition to the expense management actions noted above, we took the following actions to increase liquidity
and strengthen our financial position.

● Public Offering – On October 16, 2020, the Company raised net proceeds of $8.7 million, after deducting underwriting discounts, commissions
and offering expenses, through an underwritten public offering (the “Offering”) and sold an aggregate of 1,380,000 shares of common stock.

● PPP Loan – On May 1, 2020, the Company was granted a $2.2 million loan (the “PPP Loan”) under the Paycheck Protection Program (the “PPP”)
administered by the Small Business Administration (“SBA”) established under Division A, Title I of the Coronavirus Aid, Relief, and Economic
Security (“CARES”) Act, which enabled us to return our furloughed employees to full time employment and to restore certain pay cuts until the
PPP Loan proceeds were exhausted.

● New Credit Facility – On March 13, 2020, we entered into a new credit facility with Siena Lending Group LLC that provides a revolving credit

line of up to $10.0 million, subject to a borrowing base.

● Reduced Capital Expenditures – We limited capital expenditures during 2020.

F-10

We may further modify or supplement the expense management measures we have implemented and the actions we have taken to increase liquidity as the
timing and extent of customer demand recovery develops.

After reviewing whether conditions and/or events raise substantial doubt about our ability to meet future financial obligations over the 12 months following
the date on which the Consolidated Financial Statements included in this Form 10-K (this “Report”) were issued, including consideration of the actions
taken to manage expenses and liquidity, we believe that our net cash to be provided by operations combined with our cash and cash equivalents, borrowing
availability  under  our  revolving  credit  facility  and  the  net  proceeds  from  the  Offering  will  provide  sufficient  liquidity  to  fund  our  current  obligations,
capital spending, and working capital requirements and to comply with the financial covenants of our credit facility over at least 12 months following the
date that the Consolidated Financial Statements were issued.

Use of Assumptions and Estimates

Management’s  belief  that  the  Company  will  be  able  to  fund  its  planned  operations  over  the  12  months  following  the  date  on  which  the  Consolidated
Financial Statements were issued is based on assumptions which involve significant judgment and estimates of future revenues, capital expenditures and
other operating costs. Our current assumptions are that casinos and restaurants remain open and continue to gradually increase capacity limitations during
2021, but that many casinos and restaurants may delay purchases of new slot machines and our BOHA! products, respectively, due to the extended business
closures and continuing capacity limitations.  Based on these assumptions, we anticipate that sales in casino and gaming and food service technology will
continue  to  be  negatively  impacted  for  the  foreseeable  future.    We  have  performed  a  sensitivity  analysis  on  these  assumptions  to  forecast  the  potential
impact of a slower-than-anticipated recovery and believe that we are positioned to withstand the impact of lower-than-anticipated sales and that we will be
able to take additional financial and operational actions to cut costs and/or increase liquidity if necessary. These actions may include additional expense
reductions and capital raising activities.

In addition, the presentation of the accompanying audited Consolidated Financial Statements requires us to make estimates and judgments that affect the
reported amounts of assets, liabilities, revenue and expenses, and the disclosure of contingent assets and liabilities.  Our estimates include those related to
revenue recognition, inventory obsolescence, the valuation of deferred tax assets and liabilities, depreciable lives of equipment, warranty obligations, and
contingent  liabilities.    We  base  our  estimates  on  historical  experience  and  on  various  other  assumptions  that  we  believe  to  be  reasonable  under  the
circumstances.  Actual results could differ from those estimates used.

Smaller Reporting Company

As  a  smaller  reporting  company,  as  defined  in  Item  10(f)(1)  of  Regulation  S-K,  we  may  choose  to  prepare  our  disclosures  relying  on  certain  scaled
disclosure requirements for smaller reporting companies in Regulation S-K and in Article 8 of Regulation S-X.

The  scaled  disclosure  requirements  for  smaller  reporting  companies  permit  us  (i)  to  include  less  extensive  narrative  disclosure  than  required  of  other
reporting  companies,  particularly  in  the  description  of  executive  compensation  and  (ii)  to  provide  audited  financial  statements  for  two  fiscal  years,  in
contrast to other reporting companies, which must provide audited financial statements for three years.

We may lose our status as a smaller reporting company on the last day of the fiscal year in which (i) our public float exceeds $250 million or (ii) if we have
more than $100 million in annual revenues and (a) have no public float or (b) have a public float more than $700 million.

2. Summary of significant accounting policies

Principles of consolidation: The accompanying Consolidated Financial Statements include the accounts of TransAct and its wholly-owned subsidiaries,
which require consolidation, after the elimination of intercompany accounts, transactions and unrealized profit.

Use of estimates: The preparation of Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of
America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses,
and disclosure of contingent assets and liabilities as of the date of the Consolidated Financial Statements and the reported amounts of sales and expenses
during the reporting period. Actual results could differ from those estimates.

Segment reporting: We  apply  the  provisions  of  the  Financial  Accounting  Standards  Board  (“FASB”)  Accounting  Standards  Codification  (“ASC”)  280,
“Segment  Reporting.”    We  view  our  operations  and  manage  our  business  as  one  segment:  the  design,  development  and  marketing  of  software-driven
technology  and  printing  solutions  and  providing  printer  and  terminal  related  software,  services,  supplies  and  spare  parts.    Factors  used  to  identify
TransAct’s single operating segment include the organizational structure of the Company and the financial information available for evaluation by the chief
operating decision-maker in making decisions about how to allocate resources and assess performance.

Cash  and  cash  equivalents:  We  consider  all  highly  liquid  investments  with  a  maturity  date  of  three  months  or  less  at  date  of  purchase  to  be  cash
equivalents.

Allowance for doubtful accounts: We establish an allowance for doubtful accounts to ensure trade receivables are valued appropriately. We maintain an
allowance  for  doubtful  accounts  based  on  a  variety  of  factors,  including  the  length  of  time  receivables  are  past  due,  significant  one-time  events  and
historical  experience.    We  record  a  specific  allowance  for  individual  accounts  when  we  become  aware  of  a  customer’s  inability  to  meet  its  financial
obligations, such as in the case of bankruptcy filings or deterioration in the customer’s operating results or financial position.  If circumstances related to
customers change, we further adjust estimates of the recoverability of receivables.

F-11

The following table summarizes the activity recorded in the valuation account for accounts receivable:

(In thousands)
Balance, beginning of period
Additions charged to costs and expenses
Deductions
Balance, end of period

Year Ended December 31,

2020

2019

  $

  $

221    $
1     
(2)    
220    $

205 
39 
(23)
221 

Inventories:  Inventories  are  stated  at  the  lower  of  cost  (principally  standard  cost,  which  approximates  actual  cost  on  a  first-in,  first-out  basis)  or  net
realizable value.  We review net realizable value based on estimated selling prices in the ordinary course of business less estimated costs of completions,
disposal and transportation, historical usage and estimates of future demand.  Based on these reviews, inventory write-downs are recorded, as necessary, to
reflect estimated obsolescence, excess quantities and net realizable value.

Fixed assets: Fixed assets are stated at cost.  Depreciation is recorded using the straight-line method over the estimated useful lives.  The estimated useful
life of tooling is five years; machinery and equipment is ten years; furniture and office equipment is five years to ten years; and computer software and
equipment is three years to seven years.  Leasehold improvements are amortized over the shorter of the term of the lease or the useful life of the asset. 
Costs related to repairs and maintenance are expensed as incurred.  The costs of sold or retired assets are removed from the related asset and accumulated
depreciation accounts and any gain or loss is recognized.  Depreciation expense was $1.0 million and $1.1 million in 2020 and 2019, respectively.

Leases: We account for leases in accordance with ASC 842, “Leases” (“ASC 842”) which we adopted effective January 1, 2019.  The adoption required a
modified  retrospective  transition  approach,  applying  the  new  standard  to  all  leases  existing  at  the  date  of  initial  application.    An  entity  was  allowed  to
choose to use either (1) its effective date or (2) the beginning of the earliest comparative period presented in the financial statements as its date of initial
application. The Company elected to adopt the standard using the effective date, January 1, 2019, as its date of initial application.

The standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the
lease  is  effectively  a  financed  purchase  by  the  lessee.  This  classification  determines  whether  lease  expense  is  recognized  based  on  an  effective  interest
method for finance leases or on a straight-line basis over the term of the lease for operating leases. A lessee is also required to record a right-of-use asset
and  a  lease  liability  for  all  leases  with  a  term  of  greater  than  12  months  regardless  of  their  classification.  Leases  with  a  term  of  12  months  or  less  are
accounted  for  based  on  existing  guidance  for  operating  leases.  If  risks  and  rewards  are  conveyed  without  the  transfer  of  control,  the  lease  is  treated  as
financing. If the lessor does not convey risks and rewards or control, the lease is treated as operating.

We have elected certain practical expedients available under ASC 842 upon adoption. We have applied the practical expedient which allows prospective
transition  to  ASC  842  on  January  1,  2019.  Under  this  transition  practical  expedient,  we  did  not  reassess  lease  classification,  embedded  leases  or  initial
direct costs. We have applied the practical expedient for short-term leases. We have lease agreements that include lease and non-lease components, and we
have not elected the practical expedients to combine these components for any of our leases.  The adoption of ASC 842 had no effect on our Consolidated
Statements of Operations. Upon adoption of ASC 842 on January 1, 2019, we recorded a $3.7 million right-of-use asset and a $3.9 million lease liability.
The adoption of the new standard had no impact on retained earnings.

We enter into lease agreements for the use of real estate space and certain other equipment under operating leases and we have no financing leases. We
determine  if  an  arrangement  contains  a  lease  at  inception.  Our  leases  are  included  in  Right  of  use  assets  and  Lease  liabilities  in  our  Condensed
Consolidated Balance Sheet.

Right of use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments
arising from the lease. Lease right of use assets and liabilities are recognized at the commencement date of the lease based on the present value of lease
payments  over  the  lease  term.  Our  right-of-use-asset  and  lease  liability  was  higher  at  December  31,  2020  compared  to  December  31,  2019  due  to  the
extension  of  one  of  our  leases.    On  February  28,  2020,  we  entered  into  an  amendment  to  extend  the  lease  on  our  facility  in  Ithaca,  New  York,  which
resulted  in  recording  an  additional  right-of-use-asset  and  lease  liability  of  $1.5  million.    The  lease,  which  was  last  amended  on  January  14,  2016,  was
scheduled to expire on May 31, 2021.  The lease amendment provides for an extension of the lease for four additional years from June 1, 2021 to May 31,
2025.    Lease  expense  is  recognized  on  a  straight-line  basis  over  the  lease  term.    As  most  of  our  leases  do  not  provide  an  implicit  rate,  the  Company
determines  its  incremental  borrowing  rate  by  using  the  rate  of  interest  that  the  Company  would  have  to  pay  to  borrow  on  a  collateralized  basis  over  a
similar term, an amount equal to the lease payments in a similar economic environment.  Our lease right of use assets exclude lease incentives. Our leases
have remaining lease terms of one year to seven years, some of which include options to extend. The majority of our leases with options to extend provide
for extensions of up to five years. The exercise of lease renewal options is at our sole discretion and our lease right of use assets and liabilities reflect only
the options we are reasonably certain that we will exercise. Lease expense is recognized on a straight-line basis over the lease term.

F-12

 
 
 
 
   
 
 
 
 
 
Goodwill  and  Intangible  assets:  We  acquire  businesses  in  purchase  transactions  that  result  in  the  recognition  of  goodwill  and  intangible  assets.  The
determination  of  the  value  of  intangible  assets  requires  management  to  make  estimates  and  assumptions.  In  accordance  with  ASC  350-20  “Goodwill,”
acquired goodwill is not amortized but is subject to impairment testing at least annually and when an event occurs or circumstances change that indicate it
is  more  likely  than  not  an  impairment  exists.    We  perform  a  fair  value-based  impairment  test  to  the  carrying  value  of  goodwill  and  indefinite-lived
intangible assets on an annual basis (as of December 31) and, if certain events or circumstances indicate that an impairment loss may have been incurred,
on  an  interim  basis.    The  Company  utilizes  the  option  to  first  assess  qualitative  factors  to  determine  whether  it  is  necessary  to  perform  the  Step  1
quantitative  goodwill  impairment  test  in  accordance  with  the  applicable  accounting  standards.  Under  the  qualitative  assessment,  management  considers
relevant events and circumstances including but not limited to macroeconomic conditions, industry and market considerations, Company performance and
events directly affecting the Company. If the Company determines that the Step 1 quantitative impairment test is required, management estimates the fair
value of the reporting unit primarily using the income approach, which reflects management’s cash flow projections, and also evaluates the fair value using
the  market  approach.  Factors  considered  that  may  trigger  an  interim  period  impairment  review  of  either  acquired  goodwill  or  intangible  assets  are:
significant underperformance relative to expected historical or projected future operating results; significant changes in the manner of use of acquired assets
or the strategy for the overall business; significant negative industry or economic trends; and significant decline in market capitalization relative to net book
value. Finite lived intangible assets are amortized and are tested for impairment when appropriate.

During the three months ended March 31, 2020, our stock price declined to the lowest price since 2009. We determined that the significant decline in our
market capitalization and broader economic downturn arising from the COVID-19 pandemic was a triggering event and an indicator that it was more likely
than not that the carrying value of goodwill exceeded fair value. Therefore, we concluded that quantitative analyses were required to be performed due to
the triggering event occurring during the first quarter of 2020.  We utilized an implied market value method under the market approach to calculate the fair
value  of  the  Company  as  of  March  31,  2020,  which  we  determined  was  the  best  approximation  of  fair  value  in  the  current  social  and  economic
environment.  Based on our interim impairment assessment as of March 31, 2020, we determined that no goodwill or intangible asset impairment occurred
and the fair value of goodwill was substantially higher than our carrying value.

As  of  December  31,  2020,  we  have  determined  that  no  goodwill  or  intangible  asset  impairment  has  occurred  and  the  fair  value  of  goodwill  was
substantially higher than our carrying value based on our assessment as of December 31, 2020 when our annual review for impairment was performed.

Revenue recognition: We account for revenue in accordance with ASC Topic 606: Revenue from Contracts with Customers.  In accordance with ASC 606,
a  performance  obligation  is  a  promise  in  a  contract  with  a  customer  to  transfer  a  distinct  good  or  service  to  the  customer.  Some  of  our  contracts  with
customers contain a single performance obligation, while other contracts contain multiple performance obligations (most commonly when contracts include
a hardware product, software and extended warranties).  A contract’s transaction price is allocated to each distinct performance obligation and recognized
as revenue when, or as, the performance obligation is satisfied.

The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring services to the customer. 
To  the  extent  the  transaction  price  includes  variable  consideration,  such  as  price  protection,  reserves  for  returns  and  other  allowances,  the  Company
estimates the amount of variable consideration that should be included in the transaction price utilizing either the “expected value” method or the “most
likely  amount”  method  depending  on  the  nature  of  the  variable  consideration.    Variable  consideration  is  included  in  the  transaction  price  if,  in  the
Company’s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur.

For a majority of our revenue, which consists of printers, terminals, consumables, and replacement parts, the Company recognizes revenue as of a point of
time.    The  transaction  price  is  recognized  upon  shipment  of  the  order  when  control  of  the  goods  is  transferred  to  the  customer  and  at  the  time  the
performance obligation is fulfilled.  We also sell a software solution in our casino and gaming market, EPICENTRAL™, that enables casino operators to
create promotional coupons and marketing messages and to print them in real time at the slot machine.  EPICENTRALTM is primarily comprised of both a
software component, which is licensed to the customer, and a hardware component.  EPICENTRAL™ software and hardware are integrated to deliver the
system’s  full  functionality.    The  transaction  prices  from  EPICENTRAL™  software  license  and  hardware  are  recognized  upon  installation  and  formal
acceptance by the customer when control of the license is transferred to the customer.  For out-of-warranty repairs, the transaction price is recognized after
the  repair  work  is  completed  and  the  printer  or  terminal  is  returned  to  the  customer,  as  control  of  the  product  is  transferred  to  the  customer  and  our
performance obligation is completed.

Performance obligations are satisfied over time if the customer receives the benefits as we perform work, if the customer controls the asset as it is being
produced, or if the product being produced for the customer has no alternative use and we have a contractual right to payment.  For our separately priced
extended warranty, BOHA! cloud-based software applications, technical support for our food service technology terminals and maintenance agreements
(including  free  one-year  maintenance  received  by  customers  upon  completion  of  EPICENTRAL™  installation)  revenue  is  recognized  over  time  as  the
customer receives the benefit.  The transaction price from the maintenance services is recognized ratably over time, using output methods, as control of the
services  is  transferred  to  the  customer.    Our  cloud-based  BOHA!  software  allows  customers  to  use  hosted  software  over  the  contract  period  on  a
subscription  basis  without  taking  possession  of  the  software  and  the  subscription  price  is  recognized  ratably  over  the  contract  period.    For  extended
warranties,  the  transaction  price  is  recognized  ratably  over  the  warranty  period,  using  output  methods,  as  control  of  the  services  is  transferred  to  the
customer.

When  there  is  more  than  one  performance  obligation  in  a  customer  arrangement,  the  Company  typically  uses  the  “standalone  selling  price”  method  to
determine the transaction price to allocate to each performance obligation. The Company sells the performance obligations separately and has established
standalone  selling  prices  for  its  products  and  services.  In  the  case  of  an  overall  price  discount,  the  discount  is  applied  to  each  performance  obligation
proportionately based on standalone selling price. To determine the standalone selling price for initial EPICENTRAL™ installations, the Company uses the
adjusted market assessment approach.

For contracts with terms of less than 12 months, the Company expenses sales commissions as they are incurred, since the expected amortization period of
the cost to obtain a contract is less than 12 months.

F-13

Disaggregation of revenue
The following table disaggregates our revenue by market type, as we believe it best depicts how the nature, amount, timing and uncertainty of our revenue
and cash flows are affected by economic factors.  Sales and usage-based taxes are excluded from revenues.

 (In thousands)

Food service technology
POS automation and banking
Casino and gaming
Lottery
Printrex
TransAct Services Group

Total net sales

 (In thousands)

Food service technology
POS automation and banking
Casino and gaming
Lottery
Printrex
TransAct Services Group

Total net sales

Year Ended December 31, 2020

  United States  
6,956 
  $
3,763 
6,852 
817 
83 
6,262 
24,733 

  $

  $

  $

International    

Total

778    $
7     
4,127     
–     
217     
733     
5,862    $

7,734 
3,770 
10,979 
817 
300 
6,995 
30,595 

Year Ended December 31, 2019

  United States  
5,522 
  $
5,714 
13,076 
1,290 
961 
8,769 
35,332 

  $

  $

  $

International    

Total

582    $
44     
8,453     
1     
205     
1,131     
10,416    $

6,104 
5,758 
21,529 
1,291 
1,166 
9,900 
45,748 

Contract balances
Contract assets consist of unbilled receivables.  Pursuant to the over-time revenue recognition model, revenue may be recognized prior to the customer
being invoiced. An unbilled receivable is recorded to reflect revenue that is recognized when such revenue exceeds the amount invoiced to the customer.
Unbilled receivables are separated into current and non-current assets and included within “Accounts Receivable” and “Other Non-Current Assets” on the
Consolidated Balance Sheets as of December 31, 2020.  We first recorded contract assets during 2020 upon the start of a long-term BOHA! contract.

Contract  liabilities  consist  of  customer  prepayments  and  deferred  revenue.    Customer  prepayments  are  reported  as  “Accrued  Liabilities”  in  current
liabilities in the Condensed Consolidated Balance Sheets and represent customer payments made in advance of performance obligations in instances where
credit has not been extended and is recognized as revenue when the performance obligation is complete.  Deferred revenue is reported separately in current
liabilities  and  non-current  liabilities  and  consists  of  our  extended  warranty  contracts,  technical  support  for  our  food  service  technology  terminals,
EPICENTRAL™  maintenance  contracts  and  prepaid  software  subscriptions  for  our  BOHA!  software  applications,  and  is  recognized  as  revenue  as  (or
when) we perform under the contract.  The decrease in current deferred revenue in 2020 compared to 2019 is primarily due to delayed renewals of our
EPICENTRAL™ maintenance contracts from COVID-19 related closures of casinos during 2020.  Non-current deferred revenue decreased primarily due
to decreased sales of long-term extended warranties for a legacy POS printer.  During the year ended December 31, 2020, we recognized revenue of $1.3
million related to our contract liabilities as of December 31, 2019.

Net contract assets (liabilities) consist of the following:

 (In thousands)
Unbilled receivables, current
Unbilled receivables, non-current
Customer pre-payments
Deferred revenue, current
Deferred revenue, non-current
Net contract assets (liabilities)

December 31,

2020

2019

290    $
591     
(216)    
(504)    
(111)    
50    $

– 
– 
(232)
(700)
(219)
(1,151)

  $

  $

Remaining performance obligations
Remaining performance obligations represent the transaction price of firm orders for which a good or service has not been delivered to our customer.  As of
December 31, 2020, the aggregate amount of the transaction price allocated to remaining performance obligations was $4.4 million.  The Company expects
to recognize revenue on $3.8 million of our remaining performance obligations within the next 12 months, $0.4 million within the next 24 months and the
balance of these remaining performance obligations recognized within the next 36 months.

F-14

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
Concentration of credit risk:  Financial instruments that potentially expose us to concentrations of credit risk are limited to cash and cash equivalents held
by our banks in excess of insured limits and accounts receivable.

Accounts receivable from customers representing 10% or more of total accounts receivable were as follows:

International Gaming Technology (“IGT”)
Scientific Games

Sales to customers representing 10% or more of total net sales were as follows:

IGT

December 31,

2020

2019

11%   
– 

15%
10%

December 31,

2020

2019

15%   

14%

Warranty: We generally warrant our products for up to 24 months and record the estimated cost of such product warranties at the time the sale is recorded. 
Estimated  warranty  costs  are  based  upon  actual  past  experience  of  product  repairs  and  the  related  estimated  cost  of  labor  and  material  to  make  the
necessary repairs.

The following table summarizes the activity recorded in the accrued product warranty liability:

(In thousands)
Balance, beginning of period
Warranties issued
Warranty settlements
Balance, end of period

December 31,

2020

2019

  $

  $

215    $
56     
(131)    
140    $

273 
181 
(239)
215 

$112 thousand and $174 thousand of the accrued product warranty liability were classified as current in Accrued liabilities at December 31, 2020 and 2019,
respectively.  The remaining $28 thousand and $41 thousand of the accrued product warranty liability as of December 31, 2020 and 2019, respectively, is
classified as long-term in Other liabilities.

Engineering,  design  and  product  development:  Engineering,  design  and  product  development  expenses  include  expenses  incurred  in  connection  with
specialized engineering and design to introduce new products and to customize existing products, and are expensed as a component of operating expenses
as incurred.  We recorded $5.7 million and $4.4 million of research and development expenses in 2020 and 2019, respectively.

Costs incurred in the engineering, design and product development of a computer software product are charged to expense until technological feasibility
has been established, at which point all material software costs are capitalized within Intangible assets in our Consolidated Balance Sheet until the product
is available for general release to customers.  While judgment is required in determining when technological feasibility of a product is established, we have
determined that it is reached after all high-risk development issues have been documented in a formal detailed plan design.  The amortization of these costs
have been included in cost of sales over the estimated life of the product.  During 2019, we contracted several third-parties to develop software for our food
service technology products, the cost for which we capitalized.  Unamortized development costs for such software were $551 thousand as of December 31,
2020.    The  total  amount  charged  to  cost  of  sales  for  capitalized  software  development  costs  was  $153  thousand  and  $186  thousand  in  2020  and  2019,
respectively.

Advertising: Advertising costs are expensed as incurred.  Advertising expenses, which are included in selling and marketing expense on the accompanying
Consolidated  Statements  of  Operations,  for  2020  and  2019  totaled  $0.7  million  and  $1.4  million,  respectively.  These  expenses  include  items  such  as
consulting and professional services, tradeshows, and print advertising.

Income taxes: The income tax amounts reflected in the accompanying Consolidated Financial Statements are accounted for under the liability method in
accordance  with  ASC  740,  “Income  Taxes”  (“ASC  740”).    Deferred  tax  assets  and  liabilities  are  recognized  for  the  estimated  future  tax  consequences
attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating
loss and tax credit carryforwards.  Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary
differences are expected to be recovered or settled.  We assess the likelihood that net deferred tax assets will be realized from future taxable income, and to
the  extent  that  we  believe  that  realization  is  not  likely,  we  establish  a  valuation  allowance.    In  accordance  with  ASC  740,  we  identified,  evaluated  and
measured the amount of benefits to be recognized for our tax return positions.

Foreign currency translation: The financial position and results of operations of our foreign subsidiary in the UK are measured using local currency as the
functional currency.  Assets and liabilities of such subsidiary have been translated into U.S. dollars at the year-end exchange rate, related sales and expenses
have been translated at the exchange rate as of the date the transaction was recognized, and shareholders’ equity has been translated at historical exchange
rates.    The  resulting  translation  gains  or  losses,  net  of  tax,  are  recorded  in  shareholders’  equity  as  a  cumulative  translation  adjustment,  which  is  a
component of accumulated other comprehensive income.  Foreign currency transaction gains and losses, including those related to intercompany balances,
are recognized in Other, net on the Consolidated Statements of Operations.

F-15

 
 
 
 
 
 
 
   
   
   
 
 
 
 
 
 
 
   
 
 
 
 
   
 
 
 
 
 
Share-based payments: At December 31, 2020, we have share-based employee compensation plans, which are described more fully in Note 10 - Stock
incentive  plans.    We  account  for  those  plans  under  the  recognition  and  measurement  principles  of  ASC  718,  “Compensation  –  Stock  Compensation”. 
Share-based compensation expense is measured at the grant date, based on the estimated fair value of the award, and is recognized as expense over the
employee’s requisite service period.

We use the Black-Scholes option-pricing model to calculate the fair value of share-based awards.  The key assumptions for this valuation method include
the expected term of the option, stock price volatility, risk-free interest rate, dividend yield, market price of our underlying stock and exercise price.  Many
of these assumptions are require judgment and are highly sensitive in the determination of compensation expense.  Forfeitures are recognized as they occur.

Net income and loss per share: We report net income or loss per share in accordance with ASC 260, “Earnings per Share (EPS).” Under this guidance,
basic  EPS,  which  excludes  dilution,  is  computed  by  dividing  income  or  loss  available  to  common  shareholders  by  the  weighted  average  number  of
common shares outstanding for the period.  Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common
stock were exercised or converted into common stock.  Diluted EPS includes in-the-money stock options using the treasury stock method.  During a loss
period, the assumed exercise of in-the-money stock options has an anti-dilutive effect, and therefore, these instruments are excluded from the computation
of diluted EPS.  See Note 12 - Earnings per share.

3. Note receivable

The note receivable balance relates to loans given to a third party software developer for whom we license our food service technology software with an
interest rate of 4.5%,  which  were  due  in  April  2020.    We  intend  to  collect  the  remaining  principal  and  interest  due  under  the  note  pursuant  to  a  lender
recourse provision that enables us to apply payments that would have been due to the third party under revenue sharing provisions of a previously signed
license agreement towards the loan balance.  A $100 thousand royalty fee was scheduled to be paid to the third party in January 2021 that was instead
applied towards the note receivable balance as it became due.  As a result $100 thousand of the balance was classified as current and the remaining $1.6
million  is  expected  to  be  reduced  thereafter  using  the  lender  recourse  provision.    Notes  receivable  are  stated  at  unpaid  balances  and  interest  income  is
recognized  on  the  accrual  method.    As  of  December  31,  2020,  we  have  no  allowances  for  loan  losses,  unamortized  deferred  loan  fees  or  unearned
discounts.

4. Inventories

The components of inventories are:

(In thousands)
Raw materials and purchased component parts
Finished goods

5. Fixed assets, net

The components of fixed assets, net are:

(In thousands)
Tooling, machinery and equipment
Furniture and office equipment
Computer software and equipment
Leasehold improvements

Less: Accumulated depreciation and amortization

Construction in-process

F-16

December 31,

2020

2019

5,467    $
5,819     
11,286    $

7,724 
4,375 
12,099 

December 31,

2020

2019

9,508    $
1,706     
7,364     
2,873     
21,451     
(19,979)    
1,472     
478     
1,950    $

9,175 
1,694 
7,062 
2,696 
20,627 
(19,010)
1,617 
627 
2,244 

  $

  $

  $

  $

 
 
 
   
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6. Intangible assets, net

Identifiable intangible assets are recorded in Intangible assets in the accompanying Consolidated Balance Sheets and are comprised of the following:

December 31,

2020

2019

(In thousands)
Purchased technology
Customer relationships
Trademark
Covenant not to compete
Patents
Other

Total

  Gross Amount  
2,526 
  $
1,300 
480 
146 
56 
80 
4,588 

  $

  $

  $

(1,975)   $
(1,300)    
(450)    
(146)    
(54)    
(80)    
(4,005)   $

Accumulated
Amortization  
(1,792)
(1,300)
(402)
(146)
(51)
(80)
(3,771)

2,526    $
1,300     
480     
146     
56     
80     
4,588    $

Accumulated
Amortization     Gross Amount    

Amortization expense was $234 thousand and $284 thousand in 2020 and 2019 , respectively.  Amortization expense for each of the next five years ending
December  31  is  expected  to  be  as  follows:  $188  thousand  in  2021;  $154  thousand  in  2022;  $154  thousand  in  2023;  $87  thousand  in  2024;  and  none
thereafter.

7. Accrued liabilities

The components of accrued liabilities are:

(In thousands)
Salaries and compensation related
Warranty
Professional and consulting
Other

8. Retirement savings plan

December 31,

2020

2019

2,328    $
112     
257     
968     
3,665    $

1,541 
174 
465 
861 
3,041 

  $

  $

We maintain a 401(k) plan under which all full-time employees are eligible to participate at the beginning of the month immediately following their date of
hire.  We match employees’ contributions at a rate of 50% of employees’ contributions up to the first 6% of the employees’ compensation contributed to
the 401(k) plan.  Our matching contributions were $270 thousand and $305 thousand in 2020 and 2019, respectively.

9. Borrowings

On March 13, 2020, we entered into a new credit facility (the “Siena Credit Facility”) with Siena Lending Group LLC.  The Siena Credit Facility provides
for a revolving credit line of up to $10.0 million expiring on March 13, 2023.  Borrowings under the Siena Credit Facility bear a floating rate of interest
equal to the greatest of (i) the prime rate plus 1.75%, (ii) the federal funds rate plus 2.25%, and (iii) 6.50%. The total deferred financing costs related to
expenses  incurred  to  complete  the  Siena  Credit  Facility  was  $245  thousand,  which  were  reported  as  “other  current  assets”  in  current  assets  and  “other
assets”  in  non-current  assets  in  the  Condensed  Consolidated  Balance  Sheets.    We  also  pay  a  fee  of  0.50%  on  unused  borrowings  under  the  facility. 
Borrowings under the facility are secured by a lien on substantially all the assets of the Company.  The Siena Credit Facility imposes a minimum EBITDA
financial covenant on the Company and borrowings are subject to a borrowing base based on (i) 85% of eligible accounts receivable plus the lesser of (a)
$5.0 million and (b) 50% of eligible raw material and 60% of finished goods inventory.  As of  December 31, 2020, we had $4.5 million of borrowing
capacity available under the Siena Credit Facility and had no outstanding borrowings.  We were in compliance with all financial covenants of the Siena
Credit Facility at December 31, 2020.

Prior  to  entering  the  Siena  Credit  Facility,  we  maintained  a  credit  facility  with  TD  Bank  N.A.  (“TD  Bank)  which  provided  for  a  $20  million  revolving
credit line.  Borrowings under the revolving credit line bore a floating rate of interest at the prime rate minus one percent and were secured by a lien on all
our assets.  We also paid a fee of 0.125% on unused borrowings under the revolving credit line.

On May 1, 2020 (the “Loan Date”), the Company was granted the PPP Loan from Berkshire Bank in the aggregate amount of $2.2 million, pursuant to the
PPP.

F-17

 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
The PPP Loan, which is evidenced by a Note dated the Loan Date issued by the Company (the “Note”) in favor of Berkshire Bank, as lender (the “PPP
Lender”), matures on May 1, 2022 and bears interest at a fixed rate of 1.0% per annum, accruing from the Loan Date and payable monthly. No payments
were  due  on  the  PPP  Loan  for  six  months  from  the  date  of  first  disbursement,  and if a loan forgiveness application is submitted to the SBA within 10
months after the end of the covered period, no payments are due until the date on which the SBA remits the loan forgiveness amount to the PPP Lender (or
notifies the PPP Lender that no loan forgiveness is allowed), but interest continues to accrue during the deferment period.  If no loan forgiveness is allowed,
the Company will be required to pay the PPP Lender equal monthly payments of principal and interest based on the principal amount outstanding on the
PPP Loan, plus interest outstanding at the end of the deferment period, and taking into account any reductions in the principal amount due to forgiveness, if
any.   The Note is unsecured and guaranteed by the SBA.  The Note may be prepaid by the Company at any time prior to maturity with no prepayment
penalties.  The Note provides for customary defaults, including failure to make payment when due or to fulfill the Company’s obligations under the Note or
related  documents,  reorganizations,  mergers,  consolidations  or  other  changes  to  the  Company’s  business  structure,  and  certain  defaults  on  other
indebtedness,  bankruptcy  events,  adverse  changes  in  financial  condition  or  civil  or  criminal  actions.    The  PPP  Loan  may  be  accelerated  upon  the
occurrence of a default.

Under the terms of the PPP, the PPP Loan may be forgiven to the extent that funds from the PPP Loan are used for payroll costs and costs to continue group
health  care  benefits,  as  well  as  for  interest  on  mortgage  obligations  incurred  before  February  15,  2020,  rent  under  lease  agreements  in  effect  before
February  15,  2020,  utilities  for  which  service  began  before  February  15,  2020,  and  interest  on  debt  obligations  incurred  before  February  15,  2020
(collectively, “qualifying expenses”), subject to conditions and limitations provided in the CARES Act.  At least 60% (as amended) of the proceeds from
the PPP Loan must be used for eligible payroll costs for the PPP Loan to be forgiven. The Company has maximized the use of PPP Loan proceeds for
qualifying expenses and intends to apply for forgiveness of the PPP Loan in accordance with the terms of the CARES Act, as amended by the Paycheck
Protection Flexibility Act of 2020.  Whether forgiveness will be granted and in what amount is subject to an application to, and approval by, the SBA and
may also be subject to further requirements in any regulations and guidelines the SBA may adopt.  The PPP Loan is classified as “Long-term debt” in the
Condensed Consolidated Balance Sheet until the forgiveness determination has been made by the SBA.  In the event that no portion of the PPP Loan is
forgiven by the SBA, $1.5 million in principal and interest of the $2.2 million PPP Loan would be due in 2021 with the remaining balance due in 2022.

10. Stock incentive plans

Stock incentive plans.  We currently have two primary stock incentive plans: the 2005 Equity Incentive Plan and the 2014 Equity Incentive Plan, which
provide  for  awards  to  executives,  key  employees,  directors  and  consultants.    The  plans  generally  provide  for  awards  in  the  form  of:  (i)  incentive  stock
options,  (ii)  non-qualified  stock  options,  (iii)  restricted  stock,  (iv)  restricted  stock  units  (which  may  include  performance-based  vesting),  (v)  stock
appreciation rights or (vi) limited stock appreciation rights.  Awards granted under these plans have exercise prices equal to 100% of the fair market value
of the common stock at the date of grant.  Awards granted have a ten-year term and generally vest over a two-year to five-year period, unless automatically
accelerated  for  certain  defined  events.    As  of  May  2014,  no  new  awards  may  be  made  under  the  2005  Equity  Incentive  Plan.    Under  our  2014  Equity
Incentive Plan, as amended in May 2020, we are authorized to grant awards of up to 2,200,000 shares of TransAct common stock.  At December 31, 2020,
837,204 shares of common stock remained available for issuance under the 2014 Equity Incentive Plan.

Under  the  assumptions  indicated  below,  the  weighted-average  per  share  fair  value  of  stock  option  grants  for  2020  and  2019  was  $3.19  and  $3.01,
respectively.    We  also  issued  restricted  stock  units  for  certain  executives  and  directors  that  vest  over  a  specified  period  of  time,  and  in  some  instances
require achieving certain performance metrics.  The weighted-average per share fair value of these restricted stock units was $9.77 and $10.46 in 2020 and
2019, respectively.

The  table  below  indicates  the  key  assumptions  used  in  the  option  valuation  calculations  for  options  granted  in  2020  and  2019  and  a  discussion  of  our
methodology for developing each of the assumptions used in the valuation model:

Expected option term (in years)
Expected volatility
Risk-free interest rate
Dividend yield

December 31,

2020

2019

7.0 
41.7%   
0.9%   
0.0%   

6.8 
38.8%
2.6%
3.5%

Expected  Option  Term  -  This  is  the  weighted  average  period  of  time  over  which  the  options  granted  are  expected  to  remain  outstanding  giving
consideration to our historical exercise patterns.  Options granted have a maximum term of ten years and an increase in the expected term will increase
compensation expense.

Expected Volatility – The stock volatility for each grant is measured using the weighted average of historical daily price changes of our common stock over
the  most  recent  period  approximately  equal  to  the  expected  option  term  of  the  grant.    An  increase  in  the  expected  volatility  factor  will  increase
compensation expense.

Risk-Free Interest Rate - This is the U.S. Treasury rate in effect at the time of grant having a term approximately equal to the expected term of the option. 
An increase in the risk-free interest rate will increase compensation expense.

Dividend Yield –The dividend yield is calculated by dividing the annual dividend declared per common share by the weighted average market value of our
common stock on the date of grant. An increase in the dividend yield will decrease compensation expense.

F-18

 
 
 
 
 
 
 
   
   
   
   
   
For 2020 and 2019, we recorded $876 thousand and $692 thousand of share-based compensation expense, respectively, included primarily in general and
administrative expense in our Consolidated Statements of Operations.  We also recorded income tax benefits of $193 thousand and $152 thousand in 2020
and  2019,  respectively,  related  to  such  share-based  compensation.    At  December  31,  2020,  these  benefits  are  recorded  as  a  deferred  tax  asset  in  the
Consolidated Balance Sheets.

Equity award activity in the 2005 Equity Incentive Plan and the 2014 Equity Incentive Plan is summarized below:

Outstanding at December 31, 2019

Granted
Exercised
Forfeited
Expired

Outstanding at December 31, 2020

1,287,605 

  $

* weighted average exercise price per share
** weighted average grant stock price per share

Stock Options

  Average Price*    
  $

Number of
Shares
1,142,468 
245,950 
(62,500)  
(1,563)  
(36,750)  

Restricted Stock Units

Number of
Units

Average
Price**

90,575    $
52,700     
(32,725)    
–     
–     
110,550    $

10.46 
9.76 
9.88 
– 
– 
10.30 

9.23     
7.43     
7.79     
10.32     
8.61     
8.98     

The  following  summarizes  information  about  equity  awards  outstanding  that  are  vested  and  expect  to  vest  and  equity  awards  that  are  exercisable  at
December 31, 2020:

Equity Awards Vested and Expected to Vest

Equity Awards That Are Exercisable

Stock Options
Restricted stock units

Awards
  1,287,605 
110,550 

  $

Average
Price*

Aggregate
Intrinsic
Value

  $

8.98 
– 

366     
785     

* weighted average exercise price per share
** weighted-average contractual remaining term in years

Remaining

Term**     Awards
5.8     
2.4     

809,512    $
–     

Average
Price*

Aggregate
Intrinsic
Value

8.85    $
–     

67     
–     

Remaining
Term**  
4.2 
– 

Shares that are issued upon exercise of employee stock awards are newly issued shares and not issued from treasury stock.  As of December 31, 2020,
unrecognized  compensation  cost  related  to  non-vested  equity  awards  granted  under  our  stock  incentive  plans  is  approximately  $1.9  million,  which  is
expected to be recognized over a weighted average period of 2.2 years.

The  total  fair  value  of  awards  vested  during  the  years  ended  December  31,  2020  and  2019  was  $1.7  million  and  $1.6  million,  respectively.    The  total
intrinsic value (which is the amount by which the stock price exceeded the exercise price on the date of exercise) of stock options exercised during the
years ended December 31, 2020 was $174 thousand and cash received from option exercises was $375 thousand in 2020.  No stock options were exercised
during the year ended December 31, 2019.  We recorded a realized tax provision in 2020  from equity-based awards of $14 thousand related to options
exercised.

11. Income taxes

The components of the income tax benefit are as follows:

(In thousands)
Current:

Federal
State
Foreign

Deferred:
Federal
State
Foreign

Income tax benefit

December 31,

2020

2019

  $

  $

(2,141)   $
17     
(48)    
(2,172)    

(483)    
(36)    
152     
(367)    
(2,539)   $

58 
51 
(58)
51 

(205)
5 
- 
(294)
(149)

Our effective tax rates were 31.1 % and (40.6)% for 2020 and 2019, respectively.  The effective tax rate for 2020 included the impact of the net operating
loss (“NOL”) that we expect to carry back to prior years.  The CARES Act permits NOLs incurred in 2018, 2019 and 2020 to be carried back to each of the
five preceding taxable years to generate a refund of previously paid income taxes.  We generated a NOL for 2020 which we will carry back to tax years that
had a federal statutory tax rate of 34% compared to 21% in 2020.  We recorded an unusually high tax benefit in 2019 due to the impact of R&D credits on a
near break-even level of income before income tax.

F-19

 
   
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
   
   
   
   
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
     
 
 
 
 
 
 
 
 
 
 
      
  
 
 
 
 
 
 
 
 
 
At December 31, 2020, we have no federal net operating loss carryforwards and $33 thousand of state net operating loss carryforwards, $460 thousand in
R&D  credit  carryforwards,  and  no  state  tax  credit  carryforwards.    Foreign  loss  before  taxes  was  $468  thousand  and  $515  thousand  in  2020  and  2019,
respectively.

Deferred  income  taxes  arise  from  temporary  differences  between  the  tax  basis  of  assets  and  liabilities  and  their  reported  amounts  in  the  Consolidated
Financial Statements.  Our deferred tax assets and liabilities were comprised of the following:

(In thousands)
Deferred tax assets:

Foreign net operating losses
Depreciation
Inventory reserves
Deferred revenue
Warranty reserve
Stock compensation expense
Other accrued compensation
R&D credit carryforward
Other liabilities and reserves
Gross deferred tax assets
Valuation allowance

Net deferred tax assets

Deferred tax liabilities:

Other

Net deferred tax liabilities

Total net deferred tax assets

December 31,

2020

2019

563    $
302     
719     
47     
31     
731     
388     
460     
394     
3,635     
(659)    
2,976     

37     
37     
2,939    $

538 
165 
916 
58 
47 
701 
226 
111 
276 
3,038 
(444)
2,594 

29 
29 
2,565 

  $

  $

As of December 31, 2020 a valuation allowance of $659 thousand has been established for foreign net operating loss carryforwards that are not expected to
be used. The following table summarizes the activity recorded in the valuation allowance on the deferred tax assets:

(In thousands)
Balance, beginning of period
Additions charged to income tax provision
Balance, end of period

Differences between the U.S. statutory federal income tax rate and our effective income tax rate are analyzed below:

Federal statutory tax rate
U.S. corporate tax rate change
R&D credit
State income taxes, net of federal income taxes
Business meals and entertainment
Miscellaneous permanent items
Uncertain tax positions
Foreign-derived intangible income deduction
Stock award excess tax benefit
Stock option cancellations
Valuation allowance and tax accruals
Other
Effective tax rate

F-20

Year Ended December 31,

2020

2019

  $

  $

444    $
215     
659    $

390 
54 
444 

Year Ended December 31,
2019
2020

21.0%   
9.5 
4.2 
0.2 
0.1 
– 
(0.2)    
– 
(0.3)    
(0.5)    
(2.6)    
(0.3)    
31.1%   

21.0%
– 
(83.2)
12.0 
5.4 
1.4 
1.0 
(5.4)
(8.4)
0.8 
14.8 
– 
(40.6)%

 
 
 
   
 
 
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
  
 
 
      
  
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
   
 
   
 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
We had $121 thousand and $107 thousand of total gross unrecognized tax benefits at December 31, 2020 and 2019, respectively that, if recognized, would
favorably affect the effective income tax rate in any future periods.  We are not aware of any events that could occur within the next twelve months that
could  cause  a  significant  change  in  the  total  amount  of  unrecognized  tax  benefits.    A  tabular  reconciliation  of  the  gross  amounts  of  unrecognized  tax
benefits at the beginning and end of the year is as follows:

(In thousands)
Unrecognized tax benefits as of January 1
Tax positions taken during the current period
Lapse of statute of limitations
Unrecognized tax benefits as of December 31

December 31,

2020

2019

  $

  $

107    $
41     
(27)    
121    $

104 
28 
(25)
107 

We expect $24 thousand of the $121 thousand of unrecognized tax benefits will reverse in 2021 upon the expiration of the statute of limitations.

We  recognize  interest  and  penalties  related  to  uncertain  tax  positions  in  the  income  tax  provision.    We  have  accrued  interest  and  penalties  related  to
uncertain tax positions of $19 thousand and $18 thousand as of December 31, 2020 and 2019, respectively.

We are subject to U.S. federal income tax as well as income tax of certain state and foreign jurisdictions.  We have substantially concluded all U.S. federal
income  tax,  state  and  local,  and  foreign  tax  matters  through  2016.    However,  our  federal  tax  returns  for  the  years  2017  through  2019  remain  open  to
examination.  Various  state  and  foreign  tax  jurisdiction  tax  years  remain  open  to  examination  as  well,  though  we  believe  that  any  additional  assessment
would be immaterial to the Consolidated Financial Statements.

12. Earnings per share

Earnings per share was computed as follows (in thousands, except per share amounts):

Net (loss) income

Shares:
Basic:  Weighted average common shares outstanding
Add:  Dilutive effect of outstanding equity awards as determined by the treasury stock method
Diluted:  Weighted average common and common equivalent shares outstanding

Net (loss) income per common share:

Basic
Diluted

Year Ended December 31,

2020

2019

  $

(5,630)   $

516 

7,827     
-     
7,827     

  $

(0.72)   $
(0.72)    

7,466 
211 
7,677 

0.07 
0.07 

The computation of diluted earnings per share excludes the effect of the potential exercise of stock awards, including stock options, restricted stock units
and performance stock awards, when the average market price of the common stock is lower than the exercise price of the related stock award during the
period.  These outstanding stock awards are not included in the computation of diluted earnings per share because the effect would be anti-dilutive.  Anti-
dilutive  stock  awards  excluded  from  the  computation  of  earnings  per  dilutive  share  were  1,284,000  and  447,000  ,  at  December  31,  2020  and  2019,
respectively.

13. Stock repurchase program

We  use  the  cost  method  to  account  for  treasury  stock  purchases,  under  which  the  price  paid  for  the  stock  is  charged  to  the  treasury  stock  account. 
Repurchases of our common stock are accounted for as of the settlement date.  During 2020 and 2019 we did not repurchase any shares of our common
stock.  From January 1, 2005 through December 31, 2020, we repurchased a total of 4,044,842 shares of common stock for $32.1 million, at an average
price of $7.94 per share.

F-21

 
 
 
   
 
 
 
 
 
 
 
 
 
   
 
 
 
 
      
  
 
 
      
  
 
 
 
 
 
 
 
 
 
      
  
 
 
      
  
 
 
14. Geographic area information

Information regarding our operations by geographic area is contained in the following table.  These amounts in the geographic area table are based on the
location of the customer and asset.

(In thousands)
Net sales:

United States
International

Total

Fixed assets, net:
United States
International

Total

Year Ended December 31,

2020

2019

  $

  $

  $

  $

24,733    $
5,862     
30,595    $

1,079    $
871     
1,950    $

35,332 
10,416 
45,748 

1,326 
918 
2,244 

Sales to international customers were 19% and 23% of total sales in 2020 and 2019, respectively.  Sales to Europe represented 45% and 44%, sales to the
Pacific Rim (which includes Australia and Asia) represented 45% and 46%, and sales to Canada represented 8% of total international sales in  both 2020
and 2019.  International long-lived assets consist of net fixed assets located at our foreign subsidiary in the UK as well as our contract manufacturers in
China, Thailand, Malaysia and Mexico.

15. Leases

Operating lease expense for the years ended December 31, 2020 and 2019 was $1.0 million and $1.0 million, respectively, and are reported as “Cost  of
sales,”  “Engineering,  design  and  product  development  expense,”  “Selling  and  marketing  expense,”  and  “General  and  administrative  expense”  in  the
Consolidated Statements of Operations.  Operating costs include short-term lease costs which were immaterial during the period.

The following information represents supplemental disclosure for the statement of cash flows related to operating leases (in thousands):

Operating cash outflows from leases

The following summarizes additional information related to our leases as of December 31, 2020:

Weighted average remaining lease term (in years)
Weighted average discount rate

The maturity of the Company’s operating lease liabilities as of December 31, 2020 are as follows (in thousands):

2021
2022
2023
2024
2025
Thereafter
Total undiscounted lease payments
Less imputed interest
Total lease liabilities

F-22

Year Ended December 31,

2020

2019

  $

1,040    $

1,031 

Year Ended December 31,
2019
2020

4.9 
4.1%   

5.0 
3.7%

December 31,
2020

  $

  $

971 
879 
713 
718 
464 
180 
3,925 
224 
3,701 

 
 
 
 
   
 
 
 
     
 
 
 
 
 
 
      
  
 
 
      
  
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
   
   
   
 
 
   
   
   
   
   
   
   
16. Quarterly results of operations (unaudited)

Our quarterly results of operations for 2020 and 2019 are as follows:

(In thousands, except per share amounts)
2020:

Net sales
Gross profit
Net loss
Net loss per common share:

Basic
Diluted

2019:

Net sales
Gross profit
Net income (loss)
Net income (loss) per common share:

Basic
Diluted

17. Subsequent events

  March 31

June 30

    September 30     December 31  

Quarter Ended

  $

  $

  $

10,247 
4,918 
(992)  

(0.13)  
(0.13)  

  $

11,550 
6,086 
746 

0.10 
0.10 

5,285    $
2,290     
(1,853)    

(0.25)    
(0.25)    

11,350    $
5,704     
186     

0.02     
0.02     

7,300    $
3,349     
(867)    

(0.11)    
(0.11)    

11,686    $
5,546     
384     

0.05     
0.05     

7,763 
2,372 
(1,918)

(0.22)
(0.22)

11,162 
4,599 
(800)

(0.11)
(0.11)

The Company has evaluated all events or transactions that occurred up to the date the consolidated financial statements were available to issue. Based upon
this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the consolidated financial statements.

F-23

 
 
 
 
 
 
 
 
 
     
     
 
 
 
 
 
 
 
 
 
 
  
 
 
      
      
  
 
 
 
 
 
 
 
 
 
  
 
 
      
      
  
 
 
  
 
 
      
      
  
 
 
 
 
 
 
 
 
 
 
  
 
 
      
      
  
 
 
 
 
 
 
 
 
Exhibit 10.24

[***] Certain information in this document has been excluded pursuant to Item (601)(b)(10) of Regulation S-K because it is not material and
would likely cause competitive harm to the registrant if publicly disclosed.

MASTER LICENSE AGREEMENT

This  Master  License  Agreement  (this  “Agreement”),  dated  as  of  February  22,  2019  (the  “Effective  Date”)  by  and
between  TransAct  Technologies  Incorporated,  having  an  address  at  One  Hamden  Center,  2319  Whitney  Avenue,  Suite  3B,
Hamden, Connecticut 06518, USA (“TransAct”) and [***], each a “Party” and collectively the “Parties.”

BACKGROUND

A.          [***] has developed and is in the process of developing a suite of proprietary, web-based programs for use in the
food service and food preparation industries (the “[***] Solution”), and is engaged in the business of continuing to develop such
programs  and  other  related  and  complimentary  software  applications,  services  and  products,  including  hardware  and  other
equipment; and

B.          TransAct desires to retain [***] to provide a version of the [***] Solution to be rebranded and sold to TransAct
customers as a TransAct branded platform called BOHA! (the “BOHA! Solution”) and to provide certain services and additional
products related thereto, including software development for TransAct customers who wish to augment the functionality of the
BOHA! Solution, from time to time as described herein, and [***] desires to provide the same to TransAct, each on the terms and
conditions set forth herein.

NOW THEREFORE, in consideration of the mutual covenants and promises contained herein, the Parties, intending to be

legally bound, agree as follows:

1.          Services; Additional Agreements.

1.1          Services.  TransAct hereby engages [***], and [***] accepts such engagement, to provide to TransAct certain Licensed
Products (including the BOHA! Solution, a white labeled version of the [***] Solution) (as defined below) and the services to
TransAct as set forth in Section 2 below and such other services as the Parties may agree from time to time (such services, the
“Services”).

a.          Software; Certain Definitions.  For purposes of this Agreement, “Software” shall mean the computer

programs, including programming tools, scripts, and routines that [***] has developed, develops or otherwise provides under this
Agreement including, without limitation, the [***] Applications (as defined below) in white label form with BOHA! Solution
rebranding (regardless of whether performed domestically or abroad and regardless of whether performed before or after
execution of this Agreement), and all updates, upgrades, new versions, new releases, enhancements, improvements, and other
modifications made or provided thereto and any New Products (as defined below) from time to time. Without limitation, the
Software shall have the functionality and compatibilities set forth in Exhibit A hereto. “[***] Applications” means [***]’s [***]
applications, including any new versions or updates of the same from time to time.  “New Products” means any new software or
applications developed by [***] during the Term that are used or useable in, related to, or otherwise complimentary to the [***]
Solution.

1

1.2          Documentation.  Prior to or concurrently with the delivery of any Software hereunder, [***] shall provide TransAct
complete and accurate user manuals, operating manuals, and other instructions, specifications, documents and materials, in any
form or media, that describe the components, features, requirements, and other aspects of the Software, including any
functionality, testing, operation or use thereof (the “Documentation”) for such Software.  Documentation shall include all such
information as may be reasonably necessary for the effective testing, use, support, and maintenance of the applicable Software by
TransAct and its customers, including the effective configuration, integration, and systems administration of the Software and
performance of all other functions set forth in the Software specifications for use with a TransAct branded internet portal that
hosts the BOHA! Solution or as otherwise reasonably requested by TransAct.  Unless otherwise agreed in writing, [***] shall
provide all Documentation in electronic form, in such formats and media as TransAct may reasonably request.  “Licensed
Products” (and individually, a “Licensed Product”) as used in this Agreement means the Software and the Documentation.

1.3          Open-Source Components.  [***] has identified to TransAct all Open Source Components incorporated into, combined
with or distributed with any Software and [***] represents and warrants to TransAct that [***] is in compliance with the terms
and conditions of all licenses for such Open Source Components. “Open Source Components” means any software component
that is subject to any open source copyright license agreement, including software available under the GNU Affero General
Public License (AGPL), GNU General Public License (GPL), GNU Lesser General Public License (LGPL), Mozilla Public
License (MPL), Apache License, BSD licenses, or any other license that is approved by the Open Source Initiative.

1.4          [***] Personnel.  [***] is solely responsible for all of its employees and sub-contractors (if permitted pursuant to
Section 10.8) (the “[***] Personnel”) and for the payment of their compensation, including, if applicable, withholding of income
taxes, and the payment and withholding of social security and other payroll taxes, unemployment insurance, workers
compensation insurance and disability benefits.  If TransAct assigns any of its employees to contribute to the development of any
Licensed Products, TransAct shall be responsible for the payment of such TransAct employees’ compensation, including, if
applicable, withholding of income taxes, and the payment and withholding of social security and other payroll taxes,
unemployment insurance, workers compensation insurance and disability benefits.

1.5          Change Orders.  The Parties may change the scope of the Services, Licensed Products and other matters specified in this
Agreement (including feature changes to the Licensed Products used by an individual TransAct customer) by either a written
change order signed by representatives of both Parties or an exchange of emails between representatives of both Parties
(“Change Order”) (e.g. a request email for a change by a TransAct representative and a confirmatory email of the same by a
[***] representative). In the event that [***] does not respond to a Change Order request from TransAct within fifteen (15)
business days, [***] will be deemed to have confirmed and accepted such Change Order. [***] will use its best efforts to
accommodate Change Order requests from TransAct.  Any additional functionalities that a TransAct customer may request with
respect to any Licensed Products that are the subject of a Change Order will be evaluated by [***] to determine whether such
additional functionalities can be accommodated using reasonable time and efforts (each, an “Ordinary Development Request”)
or whether such additional functionalities would require significant time and incur substantial costs to develop (each, a
“Substantial Development Request”).

2

[***] will promptly notify TransAct whether such customer request is an Ordinary Development Request or a Substantial
Development Request.  Ordinary Development Requests will be developed in a timely manner by [***] following notification
and at no additional cost to TransAct, it being agreed by the Parties that the Monthly Fees received by [***] pursuant to this
Agreement are adequate compensation for such additional development activities.  Any notification of a Substantial Development
Request will include [***]’s good faith estimate of the development time and likely costs (based on [***]’s standard rates)
involved in the development of the additional functionalities.  TransAct will confer with the customer making the Substantial
Development Request, and if the customer wishes to pursue such development, [***] and TransAct shall enter into a mutually
acceptable separate agreement regarding such development, which among other things, will address the final price of, and
ownership rights with respect to, such developed materials.

1.6          Standard of Performance.  [***] will be responsible for overall management and performance of the Services.  [***]
will design, develop, create, test, deliver, configure, integrate, customize, and otherwise provide and make fully operational
Licensed Products on a timely and professional basis in accordance with all terms, conditions, and specifications set forth in this
Agreement.  The [***] Personnel will perform the Services in a timely, professional and workmanlike manner, using the degree
of skill, care, and judgment consistent with customarily accepted good business practices.  All Services and Licensed Products
provided hereunder will be subject to TransAct’s review and approval in accordance with the terms contained herein.  In addition
to the warranty obligations contained herein, any claim made in good faith by TransAct regarding the deficiency of the Services
or Licensed Products shall be resolved by [***] repairing the deficiency of the Services or Licensed Products at no additional
cost to TransAct.

1.7          Confirmation Testing.  TransAct shall have the right to test and evaluate the Licensed Products for operational
compatibility with TransAct systems and white label branding as and when such Licensed Products are made available for use on
in BOHA! Solution.  [***] will provide to TransAct all relevant documents, deliverables and other information that is reasonably
necessary for TransAct to make its evaluation.  If TransAct determines that such Licensed Product is deficient in one or more
respects, TransAct shall notify [***] in writing outlining each deficiency, and [***] shall use its reasonable best efforts to
promptly repair the deficiency.  Promptly following any initial testing and evaluation, or testing and evaluation following
identification of any deficiencies (and after the same have been repaired) TransAct will confirm to [***] that such Licensed
Products are ready to be used in a production environment.  Notwithstanding the foregoing, TransAct’s confirmation of  Licensed
Products shall in no way limit the performance and warranty obligations of [***] as identified in Section 1.7 and Section 8.

1.8          Data Security; Disaster Recovery.

(a)          [***] will employ data security measures in accordance with applicable industry practice with respect to
the delivery of Services hereunder (including the protection of the data of any customers of TransAct and hosting of the BOHA!
Solution), but in no event less rigorous than those employed by [***] with respect to its internal systems.  [***] maintains a data
breach plan in accordance with applicable industry practice.

3

(b)          [***] shall maintain or cause to be maintained disaster avoidance and recovery procedures designed to
safeguard  the  data  of  TransAct  and  its  customers  and  TransAct's  other  Confidential  Information,  and  the  availability  of  the
Services and Licensed Product (including the operations of the BOHA! Solution), in each case throughout the Term and at all
times in connection with its actual or required performance of the Services  hereunder.    [***]  shall  conduct  or  have  conducted
daily  backups  of  TransAct’s  and  its  customer’s  data  in  the  BOHA!  Solution  and  store  such  backup  data  in  a  commercially
reasonable  location  and  manner.    The  force  majeure  provisions  of  Section  10.12  shall  not  limit  [***]’s  obligations  under  this
Section 1.8(b).

1.9          Insurance.  At all times during the Term and for a period of five (5) years thereafter, the Parties shall procure and
maintain,  at  its  sole  cost  and  expense,  from  reputable  insurance  companies,  insurance  coverage  in  the  following  types  and
amounts : (i) Commercial General Liability with limits no less than $1,000,000 per occurrence and $4,000,000 in the aggregate,
including bodily injury and property damage and products and completed operations and advertising liability, which policy will
include  contractual  liability  coverage  insuring  the  activities  of  [***]  under  this  Agreement,  (ii)  Cyber  Liability  Insurance,
including first party and third party coverage, with limits no less than $2,000,000 per occurrence and $2,000,000 in the aggregate
for  all  claims  each  policy  year,  and  (iii)  Errors  and  Omissions/Professional  Liability  with  limits  no  less  than  $2,000,000  per
occurrence and $2,000,000 in the aggregate for all claims each policy year.

1.10          [***] Hardware.  The Parties agree that promptly following the execution of this Agreement they will negotiate
in good faith one or more agreements to provide TransAct the right to sell certain equipment and hardware designed, owned or
licensed  by  [***]  for  use  with  the  Licensed  Products,  including,  without  limitation,  a  wireless  printer,  handheld  device,
temperature probe and case and wireless sensors and gateway.

2.          Services including Training, Maintenance and Support; Hosting; Web Portal; White Labeling; Customer and Sales
Support; Pricing; Non-Solicitation.  All Services described in this Section 2 shall be provided at no additional charge to Transact,
it being acknowledged and agreed that the fees to be paid to [***] pursuant to Section 4 include full consideration therefor.

2.1          Training.  [***] shall provide TransAct and its designees with such training as it provides to other users of its [***]
Solution.

2.2          Maintenance and Support.  During the Term and following the termination or expiration of the Term, [***] agrees to
provide TransAct and its customers with the product support and maintenance services, including those described in Schedule A
hereto with respect to the Software and Licensed Products for as long as [***] receives its portion of the Monthly Fees paid by
TransAct customers as described in Section 4.1.  [***] shall offer such product support 24 hours per day, seven days per week, as
described in Section 2.6.

2.3          Hosting.  During the Term and following the termination or expiration of the Term for as long as [***] receives its
portion of the Monthly Fees paid by TransAct customers as described in Section 4.1, [***] shall provide a web portal (“Web
Portal”) for and host the BOHA! Solution (the “Hosted Services”) for the benefit of TransAct and its customers, including
compliance with any service levels described on Schedule A hereto.  The Hosted Services shall include a single production
instance of the BOHA! Solution. 

4

If a TransAct customer requires a separate production instance of the BOHA! Solution, [***] agrees to create such separate
instance for a fee and within a timeframe to be reasonably and mutually agreed to by both Parties.  In the event that [***] fails to
provide the Hosted Services in accordance with Schedule A hereto, solely in order to allow TransAct to take over hosting the
BOHA! Solution and allow TransAct customers to continue using such software on their TransAct products (i) [***] shall
promptly and at no additional cost to TransAct assist TransAct to migrate all relevant data, such as our user profiles and analytics
data, to TransAct; (ii) TransAct shall immediately be entitled to a complete duplicate of all source code and documentation for
the BOHA! Solution, and (iii) [***] grants TransAct a limited, worldwide, irrevocable, fully-paid, non-exclusive, transferable,
royalty-free right and license to, and to sublicense to third parties to, host, use, modify, operate, execute, reproduce, display, and
perform the source code (and related documentation) for the BOHA! Solution until the earlier of such time as (i) TransAct has no
customers for the BOHA! Solution who first became customers during the Term, and (ii) [***] resumes providing Hosting
Services in accordance with Schedule A hereto.

2.4          Web Portal.  The Web Portal will include (i) functionality that allows TransAct administrators and TransAct
customers the ability  to  manage  accounts,  menu  information,  label  designs,  batch  lists,  documents,  media  and  more  and  (ii)  a
section in the Web Portal for analytics that aggregates data for TransAct customers in specified reports as well as ability to export
data. [***] will create the Web Portal with TransAct’s input as to look and feel, design and functionality.

2.5          White Labeling.  The white labeling of the [***] Solution for use as the BOHA! Solution will include rebranding
of all trademarks and tradenames to the coordinate TransAct names, as well as trade dress and “look and feel” (including use of
TransAct color schemes).  [***] and TransAct will consult and coordinate on all white labeling matters.

2.6          Customer Support.  TransAct will provide Low and Medium level customer support to TransAct customers, and
[***]  will  provide  High  level  customer  support  to  TransAct  customers,  each  as  described  on  Schedule  A  hereto.  [***]  will
cooperate  with  and  assist  TransAct  in  TransAct’s  provision  of  Low  and  Medium  level  customer  support  and  TransAct  will
cooperate with and assist [***]’s provision of High level customer support.

2.7          Sales Support.  TransAct is responsible for primary sales support during the Term.  At TransAct’s request, [***]
will assist TransAct with initial customer demonstrations, pilot tests and evaluations and other customer prospecting support as
TransAct may reasonably request from time to time.

2.8          Pricing.  TransAct is solely responsible for the pricing of the BOHA! Solution offered to any TransAct customer,
provided that the  pricing  for  the  applicable  components  of  the  BOHA!  Solution  meet  the  minimum  requirements  set  forth  on
Exhibit  B  hereto.    In  the  event  that  TransAct  wishes  to  offer  a  customer  pricing  for  one  or  more  components  of  the  BOHA!
Solution that is less than the minimum requirements set forth on Exhibit B hereto, TransAct will obtain [***]’s prior approval for
such pricing (not to be unreasonably conditioned, withheld or delayed).

2.9          Non-Solicitation.

(a)          As long as [***] is receiving Monthly Fees arising from a subscription for the BOHA! Solution with
respect to a TransAct customer (an “Active TransAct Customer”) [***] agrees that it shall not sell or offer to sell any product
similar to a Licensed Product, directly or indirectly, to any Active TransAct Customer.

5

(b)          [***] agrees that it shall not sell or offer to sell any product that can substitute for a Licensed Product,
directly  or  indirectly,  to  any  Active  TransAct  Prospect.  “Active  TransAct  Prospect”  as  used  herein  means  a  prospective
customer of TransAct that (i) has been identified to [***] as an Active TransAct Prospect in writing, (ii) [***] has been engaged
to assist in configuring the Licensed Products for such prospective customer’s use, and (iii) TransAct is actively engaged with
communications with such prospective customer regarding the purchase of a subscription to the BOHA! Solution.  A prospective
customer shall cease to be an Active TransAct Prospect if there has been no forward sales progress  or no bona fide negotiations
with such prospective customer within any twelve (12) month period following the initial identification to [***].

(c)          [***] will not, directly or indirectly, solicit any (i) Active TransAct Customer to terminate its relationship
with TransAct or decrease its services with respect to the BOHA! Solution, or (ii) Active TransAct Prospect not to subscribe to
the BOHA! Solution.

(d)                    For  purposes  of  this  Section  2.9,  a  “customer”  or  “prospective  customer”  of  TransAct  refers  to  an
individual operator, a franchisee or a corporate-owned entity that is subject to an agreement with TransAct or considering such an
agreement with respect to the BOHA! Solution.  An “independent operator” means an operator that does not franchise its stores.
Examples of independent operators would include [***] stores.  A “franchisee” means an operator associated with one or more
brands that is able to make a decision regarding subscribing to the BOHA! Solution separate and apart from the brands’ corporate
decision-making.  An example would be [***], which is a [***] franchisee ([***] would be prevented from soliciting [***], but
not [***]).  A “corporate-owned entity” means an organization that has both corporate owned stores and franchise-owned stores. 
An example would be [***], and if [***] was the customer, [***] would be prohibited from soliciting both corporate-owned and
franchise-owned stores.

3.          Independent Contractors; No Partnership.

3.1          Independent Contractors.  This Agreement is intended to create an independent contractor relationship between the
Parties for purposes of Federal, state and local law.  The Parties understand and agree that [***] Personnel will be: (a) the
employees or subcontractors of [***] only, and [***] alone will determine the terms and conditions of such employment or
engagement; and (b) hired, paid, supervised, directed, controlled, promoted or demoted, terminated, engaged and otherwise
managed solely by [***].

3.2          No Partnership.  Nothing in this Agreement will be construed or implied to create a relationship of agency, affiliates,
joint employers, or joint venturers.  Each Party acknowledges that no legal partnership is created under any applicable law under
this Agreement. Neither Party will have the power or authority to act for the other in any manner or to create obligations or debts
which would be binding on the other.  Neither Party will be responsible for any obligation of the other or be responsible for any
act or omission of the other.

6

4.          Fees; Expenses; Taxes.

4.1          Fees.

(a)          In exchange for the provision of the Services and Licensed Products (including, without limitation, the
software  development,  licenses,  hosting,  and  support  and  maintenance  services)  described  herein,  TransAct  shall  pay  [***]  an
aggregate fee consisting of the Base Fee, the Monthly Fees and the White Labeling Fee, each as described herein.

(b)          “Base Fee” means a one-time fee in an amount equal to $[***] payable within ten (10) business days

following the execution by both Parties of this Agreement, and subject to repayment by [***] as provided below.

(c)          “Monthly Fees” means an amount equal to [***]% of the monthly subscription fee invoiced by TransAct
to,  and  collected  from,  each  of  its  customers  for  use  of  the  BOHA!  Solution  during  the  Term,  which  Monthly  Fees  will  be
calculated at the end of each calendar month following TransAct’s acquisition of its first subscribing customer with respect to
each  active  subscribing  customer  and  payable  to  [***]  by  the  20th  day  of  the  month  following  the  month  for  which  the
subscription fee is collected; provided, that TransAct shall withhold and retain [***]% of such Monthly Fees until the earlier of
such time as TransAct has retained an amount equal to the Base Fee; provided, further, that TransAct shall not retain any amount
of such Monthly Fees payable with respect to periods after December 31, 2020 (the “Repayment Period Termination”),  and
any amount of the Base Fee not repaid following such date shall not be repaid to TransAct.  Following the earlier of repayment in
full to TransAct of the Base Fee or the Repayment Period Termination, [***] will be entitled to receive the full amount of such
Monthly Fees.  The foregoing notwithstanding, TransAct may suspend payment of Monthly Fees to [***] in the event, and for
the duration, of any material breach by [***] of its representations and warranties that affects the provision of  the  Services  or
Licensed  Products  to  TransAct  customers,  and  such  suspension  shall  not  be  deemed  a  breach  of  any  other  provisions  hereof,
including, but not limited to Sections 2.2 and 2.3 related to the continuation of certain services contingent upon the receipt of
Monthly Fees.  Upon satisfactory correction of the material breach by [***], Monthly Fees will resume and previously suspended
amounts shall be paid.

(d)          “White Labeling Fee” means a lump sum payment of $[***] from TransAct to [***] that will be due and
payable within ten (10) business days of January 1 of each year of the Term beginning on and after January 1, 2021.  In the event
that [***] provides a white label version of the [***] Solution to any other third party during the Term it will charge any such
third party a white label fee that is not less than the White Labeling Fee, or it will reduce TransAct’s White Label Fee to the
amount charged to such third party.

(e)                    The  foregoing  represents  [***]’s  sole  compensation  for  the  Services  to  be  rendered  and  Licensed

Products to be delivered under hereunder.

4.2          Expenses.  [***]’s expenses, including actual travel or other transportation-related expenses incurred by [***] in
performing the Services or providing the Licensed Products will be included in the fees paid by TransAct as set forth in Section
4.1.  TransAct shall be responsible for the costs of establishing and maintaining a source code escrow (as described in Section
10.2 hereof) for the Licensed Products.

7

4.3          Taxes.  All fees set forth herein are exclusive of taxes.  [***] shall be responsible for all sales, use, VAT, gross receipts,
real estate, personal property and any other similar taxes, duties, and charges of any kind imposed by any federal, state, or local
governmental entity on any amounts payable by TransAct to [***] hereunder, other than any taxes imposed on, or with respect to,
TransAct’s income.  [***] will indemnify and hold harmless TransAct for any loss or damage (including without limitation any
penalties and interest) sustained because of [***]’s failure to pay such taxes, if any.

4.4          Reports.  TransAct shall maintain complete, clear and accurate records of the information required or

appropriate to determine the amounts of fees payable hereunder.  TransAct will also provide [***], periodically upon reasonable
request, a summary report of licenses for the BOHA! Solution sold and related terms.

4.5          Audits.  Upon not fewer than five (5) business days’ advance written notice from [***], TransAct will permit

audits of TransAct financial records to be performed by external auditors designated by [***] (collectively, “Auditors”) at
[***]’s expense to verify TransAct’s adherence to its obligations under Section 4.1 and related provisions of this Agreement (the
“Payment Obligations”).  The Auditors shall be subject to confidentiality obligations substantially similar to Section 6, and if
not otherwise subject to such an obligation will execute and deliver to TransAct a confidentiality agreement regarding such
obligations. Unless a breach of TransAct’s Payment Obligations under this Agreement shall have occurred, [***] shall not be
entitled to exercise its audit rights hereunder more than once in any calendar year.  TransAct will, in a timely manner, fully
cooperate with the Auditors and provide the Auditors all assistance as they may reasonably request in connection with an Audit. 
Any Audit shall be conducted during TransAct’s regular business hours.  The Auditors shall use commercially reasonably efforts
to avoid disrupting TransAct’s operations during any Audit.  If the Auditors document an undercharge of more than [***] for the
audited period then TransAct will promptly (a) reimburse [***] for its reasonable cost of performing the Audit, and (b) reimburse
[***] for any underpayment as the case may be. For undercharges less than [***], the Parties agree to  reasonably reconcile the
outstanding amount.

4.6          Forecast.  On a quarterly basis, TransAct shall provide a non-binding, rolling six-month forecast of sales

opportunities of the Services and Licensed Products to [***].

5.          Payment Terms.

5.1          Payments.  Monthly Fees due [***], subject to the retention described in Section 4.1 with respect to repayment of the
Base Fee, shall be payable by TransAct to [***] within twenty days (20) days after the end of each month.

5.2          Disputed Amounts.  TransAct may withhold from payment any amount disputed by TransAct in good faith, pending
resolution of the dispute, provided that TransAct: (a) timely pays all amounts not subject to dispute; (b) notifies [***] of the
dispute prior to the due date, specifying in such notice (i) the amount in dispute, and (ii) the reason for the dispute; (c) works with
[***] in good faith to resolve the dispute promptly; and (d) promptly pays any amount determined to be due by resolution of the
dispute.  [***] shall continue performing its obligations under this Agreement notwithstanding any such dispute or actual or
alleged nonpayment that is the subject of the dispute, pending its resolution.

8

6.          Confidential Information.

6.1          Definition.  “Confidential Information” shall mean confidential or other proprietary information that is disclosed by
one Party (the “Disclosing Party”) to the other Party (the “Receiving Party”) under this Agreement or relates to the Licensed
Products or the Services, including without limitation, product specifications and documentation, financial data, business and
product plans, each Party’s software source code, and other confidential business information.  Without limitation, data and
information concerning customers of TransAct (including, without limitation, (i) data entered by TransAct customers on
TransAct terminals and software and hosted by [***], and (ii) information regarding how TransAct’s customers use TransAct-
supplied terminals) constitutes Confidential Information of TransAct.  Confidential Information shall not include information
which the Receiving Party can demonstrate: (a) is or becomes public knowledge without any action by, or involvement of the
Receiving Party; (b) is disclosed by the Receiving Party with the prior written approval of the Disclosing Party; (c) was
previously known to the Receiving Party without an obligation of confidence; (d) is independently developed by the Receiving
Party without use of the Confidential Information; or (e) was acquired by the Receiving Party from a third party which is not,
under an obligation of confidence with respect to such information.

6.2          Restrictions.  As a condition to being provided with any disclosure of or access to Confidential Information, the
Receiving Party shall (a) not access or use Confidential Information other than as necessary to exercise its rights or perform its
obligations under and in accordance with this Agreement; (b) except as may be permitted by and subject to its compliance with
Section 6.4, not disclose or permit access to Confidential Information other than to its employees, officers, directors, consultants,
legal advisors and permitted subcontractors (collectively, “Representatives”) who (i) need to know such Confidential
Information for the performance of their obligations under and in accordance with this Agreement; (ii) have been informed of the
confidential nature of the Confidential Information and their obligations under Section 6; and (iii) are bound by written
confidentiality and restricted use obligations at least as protective of the Confidential Information as the terms set forth in Section
6; (c) safeguard the Confidential Information from unauthorized use, access or disclosure using at least the degree of care it uses
to protect its own sensitive information and in no event less than a reasonable degree of care; and (d) ensure its Representatives’
compliance with, and be responsible and liable for any of its Representatives’ noncompliance with, the terms of Section 6.

6.3          Duration.  The Receiving Party shall continue such confidential treatment of Confidential Information for a period of
five (5) years from the date of termination, expiration or cancellation of  this Agreement.  Notwithstanding the foregoing, trade
secrets of the Disclosing Party will remain Confidential Information for so long as they remain trade secrets under applicable law.

9

6.4          Compelled Disclosures.  If the Receiving Party or any of its Representatives is compelled by applicable law to disclose
any Confidential Information then, to the extent legally permitted, the Receiving Party shall: (a) promptly, and prior to such
disclosure, notify the Disclosing Party in writing of such requirement so that the Disclosing Party can seek a protective order or
other remedy, or waive its rights under Section 6.2; and (b) provide reasonable assistance to the Disclosing Party in opposing
such disclosure or seeking a protective order or other limitations on disclosure.  If the Disclosing Party waives compliance or,
after providing the notice and assistance required under this Section 6.4, the Receiving Party remains required by law to disclose
any Confidential Information, the Receiving Party shall disclose only that portion of the Confidential Information that the
Disclosing Party is legally required to disclose and, upon the Receiving Party’s request, shall use commercially reasonable efforts
to obtain assurances from the applicable court or other presiding authority that such Confidential Information will be afforded
confidential treatment.

7.          Intellectual Property Rights.

7.1          Licensed Products.

(a)          The Licensed Products shall be delivered in a form and format acceptable to TransAct (which shall include making such
Licensed Products available for use by TransAct customers via the Web Portal).  The Licensed Products shall be owned solely
and exclusively by [***], including any product changes or customization requested by TransAct under Section 1.5, except that
TransAct shall retain ownership of any of TransAct’s Confidential Information or other proprietary information of TransAct (such
as trademarks), subject to the license granted by TransAct to use such proprietary information as set forth in Section 7.2(b)
below.  Ownership terms of materials developed pursuant to a Substantial Development Request will be addressed in a separate
agreement with TransAct.  Licensed Products include, without limitation, the Software and Documentation.  Notwithstanding the
foregoing, any ancillary works to the Licensed Products (such as applications that run on the BOHA! Solution) created by
TransAct shall belong exclusively to TransAct.  TransAct will require that each of its customers subscribing to the BOHA!
Solution will enter into an end user license agreement substantially in a form to be approved by [***].

(b)          [***] shall not design, develop or provide to TransAct any Licensed Products that infringe upon or violates the rights of
any person or entity, including rights relating to defamation, privacy, publicity, contract, patent, copyright, trademark, trade secret
or other intellectual property rights (collectively, “Third-Party Rights”).  If [***] becomes aware of any such possible violation
or infringement, [***] shall immediately so notify TransAct in writing and correct the issue.

(c)          TransAct shall not (i) modify, adapt, alter, translate, copy or create derivative works of the Licensed

Products; (ii) merge or bundle the Licensed Products with other software without written consent of [***]; (iii) reverse engineer,
decompile, disassemble, or otherwise attempt to derive the source code for the Licensed Products (except as otherwise permitted
pursuant to the terms of the source code escrow to be entered into pursuant to Section 10.2).

10

7.2          License Grant.

(a)          Upon the terms and conditions of this Agreement and in exchange for the payments set forth herein, [***] hereby grants
to TransAct a limited, worldwide, irrevocable, non-exclusive, transferable, royalty-free right and license to, and to sublicense
third parties to, make, have made, use, sell, offer for sale, export, import, execute, reproduce, distribute, display, perform and
exploit the Licensed Products, including any enhancements thereto (i) during the Term of this Agreement, and (ii) thereafter for
so long as TransAct customers continue to use the Licensed Products and the related Monthly Fees are paid to [***].  For
purposes of clarification, TransAct shall have the right to create its own applications, or use third party applications, on
TransAct’s devices in connection with the Software.

(b)          In connection with the Web Portal and BOHA! Solution, TransAct hereby grants to [***] a limited, revocable,
worldwide, non-exclusive, non-transferable, royalty-free right and license to use the TransAct name and trademarks solely for the
purposes of the Web Portal and BOHA! Solution during the period of time that the license granted by [***] in Section 7.2(a)
remains in effect; provided that [***] shall comply with such guidelines for the use of the TransAct name and trademarks as
TransAct may provide to [***] from time to time in writing.  Subject to this clause (b), TransAct retains all right, title and interest
in the TransAct name and trademarks.

8.          Indemnification; Limitation of Liability; Warranties.

8.1          Indemnification by [***].  [***] shall defend, indemnify, and hold harmless TransAct and its officers, directors,
employees, agents, contractors, successors, and assigns (each, a “TransAct Indemnitee”) from and against any and all losses,
damages, deficiencies, claims, actions, judgments, settlements, interest, awards, penalties, fines, costs, or expenses of whatever
kind, including reasonable attorneys’ fees (together, “Losses”) incurred by the TransAct Indemnitee resulting from any claim,
action, cause of action, demand, suit, arbitration, inquiry, audit, notice of violation, proceeding, litigation, citation, summons,
subpoena, or investigation of any nature, civil, criminal, administrative, regulatory, or other, whether at law, in equity, (each an
“Action”) by a third party that arises out of or results from, or is alleged to arise out of or result from (a) [***]’s breach of any
representation, warranty, covenant, or obligation of [***] (including any action or failure to act by any permitted subcontractor
that, if taken or not taken by [***], would constitute such a breach by [***]) under this Agreement; or (b) the negligence or
reckless or willful misconduct of [***] or its permitted subcontractors in connection with the Licensed Products or the
performance of the Services, except (with regards to both (a) and (b) above) to the extent that Losses arise or result from (x)
TransAct’s breach of any representation, warranty, covenant, or obligation of TransAct under this Agreement; or (y) the
negligence or reckless or willful misconduct of TransAct in connection with the Licensed Products or the Services.

8.2                    Indemnification  by  TransAct.    TransAct  shall  defend,  indemnify,  and  hold  harmless  [***]  and  its  officers,
directors,  employees,  agents,  contractors,  successors,  and  assigns  (each,  a  “[***]  Indemnitee”)  from  and  against  any  and  all
Losses incurred by the [***] Indemnitee resulting from any Action by a third party that arises out of or results from, or is alleged
to arise out of or result from (a) TransAct’s breach of any representation, warranty, covenant, or obligation of TransAct under this
Agreement; or (b) the negligence or reckless or willful misconduct of TransAct in connection with the Licensed Products or the
Services, except (with regards to both (a) and (b) above) to the extent that Losses arise or result from (x) [***]’s breach of any
representation,  warranty,  covenant,  or  obligation  of  [***]  under  this  Agreement;  or  (y)  the  negligence  or  reckless  or  willful
misconduct of [***] in connection with the Licensed Products or the Services.

11

8.3                    Indemnification  Procedure.    The  Party  seeking  indemnification  hereunder  (the  “Indemnified  Party”)  will
promptly  notify  the  other  Party  (the  “Indemnifying  Party”)  in  writing  of  any  Action  for  which  it  seeks  to  be  indemnified
pursuant to Section 8 and cooperate with Indemnifying Party in the defense of such Action at the Indemnifying Party’s cost and
expense (provided that the Indemnifying Party shall not be required to compensate the Indemnified Party for its personnel’s time
spent providing such cooperation).  The Indemnifying Party shall immediately take control of the defense and investigation of
such  Action  and  shall  employ  counsel  reasonably  acceptable  to  the  Indemnified  Party  to  handle  and  defend  the  same,  at  the
Indemnifying Party’s sole cost and expense.  The Indemnifying Party shall not settle any Action without the Indemnified Party’s
prior written consent, unless such settlement is limited to monetary damages fully paid by the Indemnifying Party and does not
include any admission of liability or equitable remedy.  An Indemnified Party’s failure to give prompt notice under this Section
8.3  will  not  relieve  the  Indemnifying  Party  of  its  obligations  hereunder  except  to  the  extent  that  the  Indemnifying  Party  can
demonstrate  that  it  has  been  materially  prejudiced  as  a  result  of  such  failure.    The  Indemnified  Party  may  participate  in  and
observe the proceedings at its own cost and expense with counsel of its own choosing.

8.4          Infringement Remedy.  If any of the Licensed Products, or any component thereof, other than any proprietary
materials of TransAct, is found to be infringing or if any use of any Licensed Products or any component thereof is enjoined,
threatened to be enjoined, or otherwise the subject of an infringement claim (collectively, an “Infringement Claim”), [***] shall,
at [***]’s sole cost and expense, do one of the following as determined by [***]: (i) procure for TransAct and its customers the
right  to  use  the  infringing  Licensed  Products,  (ii)  replace  the  infringing  Licensed  Products  with  a  non-infringing,  functionally
equivalent one, (iii) suitably modify any infringing Licensed Products so that it is non-infringing, or (iv) refund to TransAct a
pro-rata  portion  of  any  Monthly  Fees  paid  to  [***]  with  respect  to  the  period  remaining  after  the  date  of  such  Infringement
Claim.  The remedies set forth in this Section 8.4 are in addition to, and not in lieu of, all other remedies that may be available to
TransAct under this Agreement or otherwise, including TransAct’s right to be indemnified for such Actions.

8.5          Disclaimer; Limitation.

(a)          EXCEPT AS SET FORTH BELOW, IN NO EVENT SHALL EITHER PARTY BE LIABLE UNDER THIS
AGREEMENT TO THE OTHER PARTY FOR ANY SPECIAL, CONSEQUENTIAL, PUNITIVE, INCIDENTAL, OR
INDIRECT DAMAGES, HOWEVER CAUSED, ON ANY THEORY OF LIABILITY, AND WHETHER OR NOT THAT
PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.  THESE LIMITATIONS SHALL APPLY
NOTWITHSTANDING ANY FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY.

(b)          EXCEPT AS SET FORTH BELOW, IN NO EVENT SHALL EITHER PARTY’S AGGREGATE LIABILITY
ARISING OUT OF OR RELATED TO THIS AGREEMENT, WHETHER ARISING OUT OF OR RELATED TO BREACH OF
CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, EXCEED SEVEN HUNDRED FIFTY THOUSAND
DOLLARS ($750,000).

12

(c)          The limitations described in this Section 8.5 will not apply to: (i) claims of a breach of [***]’s or TransAct’s obligations
under Section 6 (Confidential Information); (ii) claims of infringement of a third party’s intellectual property rights; (iii) [***]’s
or TransAct’s indemnification obligations under this Agreement; (iv) claims arising out of, in connection with or resulting from
the misuse or appropriation of Confidential Information or any Licensed Products by either Party; (v) claims relating to property
damage or personal injury; or (vi) either Party’s intentional misconduct that is tortious or criminal, or committed with the
knowledge that such misconduct was reasonably certain to materially damage the other Party.

8.6          Mutual Warranties.  Each Party represents and warrants to the other Party as follows:

(a)          it is duly organized, validly existing, and in good standing as a corporation or other entity as represented

herein under the laws of its jurisdiction of incorporation or organization;

(b)          it has the full right, power, and authority to enter into this Agreement, to grant the rights and licenses

granted hereunder, and to perform its obligations hereunder;

(c)          the execution of this Agreement by its representative whose signature is set forth at the end hereof has

been duly authorized by all necessary action of the party;

(d)          the execution, delivery and performance of its obligations hereunder will not violate any contractual or

other legal obligation of [***] or any rights of any third parties, and

(e)          when executed and delivered by both Parties, this Agreement will constitute the legal, valid, and binding

obligation of such party, enforceable against such party in accordance with its terms.

8.7          [***] Warranties.  [***] represents and warrants to TransAct as follows:

(a)          [***] shall perform the Services in a timely, professional and workmanlike manner, using a high degree
of skill, care, consistent with standards for performance of the Services consistent with industry best practices and agreed to by
the Parties in this Agreement (including the attachments).

(b)          The Licensed Products shall materially conform to all relevant specifications, and be free of material or
frequent defects, for a period of ten (10) years from delivery to TransAct.  [***] agrees to correct promptly any such Licensed
Products not in compliance with this warranty.

(c)          The Licensed Products comply with, and [***] is in compliance with, and will perform all Services in
compliance with, all applicable laws, rules and regulations, including all applicable data protection and privacy laws with respect
to any data of TransAct  customers,  including,  without  limitation,  the  European  Union’s  Data  Protection  Directive  (95/46/EC),
Directive on Privacy and Electronic Communications (2002/58/EC), General Data Protection Regulation (2016/679).

13

(d)                    [***] owns  all  proprietary  rights,  including  any  patent,  copyright,  trade  secret,  trademark  and  other
proprietary rights, in and to the Licensed Products and has all requisite rights to grant the licenses to TransAct contemplated in
this Agreement.

(e)          The Licensed Products do not and will not infringe any Third-Party Rights.

(f)          The Licensed Products shall not contain any viruses, worms, trap doors, timers, clocks, counters, time
locks,  time  bombs,  logic  bombs,  Trojan  horses  or  other  limiting  code,  design,  instruction  or  routines  which  is  designed,  or
intended  to  do  any  of  the  following  either  automatically  or  without  the  intentional  action  of  TransAct:  (i)  altering,  deleting  or
interfering with any data, information, software or subsystems; (ii) damaging, destroying, disabling, suspending the operation of,
or altering the operation of the Licensed Products or other software or components thereof; or (iii) causing the Licensed Products
or other software or components thereof to become inoperable or otherwise incapable of being used in the full manner for which
they were provided under this Agreement.

(g)          The Licensed Products will be, and as installed in the TransAct operating environment (or any successor
thereto)  and  used  in  accordance  with  the  Documentation  will  function  in  all  respects  in  conformity  with  this  Agreement
(including the attachments) and the specifications and Documentation for the Licensed Products; and any media on which any
Software is delivered will be free of damage or defect in design, material, and workmanship, and will remain so under ordinary
use  as  contemplated  by  this  Agreement  and  the  specifications  and,  with  respect  to  the  Software  component  thereof,  the
Documentation therefor.

(h)          [***] will have production-ready versions of the individual applications that comprise the BOHA!

Solution listed on Exhibit C available for resale to TransAct customers not later than the dates indicated on Exhibit C unless
[***] notifies TransAct in advance that despite reasonable best efforts an individual application will not be ready by the date
specified on Exhibit C, in which case both Parties shall mutually agree upon a reasonable extension of such date for such
application to be ready.

9.          Term and Termination.

9.1          Term.  Unless otherwise terminated as specified herein, the term of this Agreement will commence on the Effective
Date and will continue through December 31, 2031 (this initial term and all renewal terms, if any, collectively, the “Term”).  This
Agreement shall continue in full force and effect for additional one-year terms thereafter unless either Party gives not less than
ninety (90) days written notice of termination prior to expiration of the then-effective Term.

9.2          Termination for Breach.  Either Party may cancel or terminate this Agreement, without liability, by giving written notice
of breach or default if the other (a) becomes insolvent, unable to pay its debts when due, or the subject of bankruptcy proceedings
not terminated within thirty (30) days of any filing; or makes a general assignment for the benefit of creditors; or if a receiver is
appointed for substantially all of its property; or (b) breaches or defaults on any of its obligations under this Agreement and fails
to cure such breach or default within forty five (45) days after receipt of written notice specifying the nature of such breach or
default.

14

9.3          Effect of Termination.  Upon termination of this Agreement for any reason, both Parties agree to: (a) return to the other
Party or destroy all copies of any Confidential Information received from the other Party in connection with this Agreement
(provided that each Party may retain such copies of Confidential Information as are resident on any electronic back-ups of its
systems, provided further that any such Confidential Information so retained remains subject to the provisions of non-disclosure
and non-use set forth in Section 6); (b) [***] agrees to provide reasonable cooperation and assistance to TransAct in transitioning
the Services to an alternate service provider for compensation on a time and materials basis; (c) should TransAct receive fees
from existing customers after this Agreement has been terminated or expires [***] shall support those customers as long as [***]
is compensated with its share of Monthly Fees under Section 4.1; and (d) [***] will promptly refund to TransAct any unrepaid
amount of the Base Fee should TransAct terminate this Agreement under Section 9.2 (Termination for Breach) above.  Except for
non-payment of amounts due hereunder, no expiration or termination of this Agreement will affect TransAct’s rights in any of the
Licensed Products so long as TransAct customers continue to use the Licensed Products and the related Monthly Fees are paid to
[***].  Should TransAct terminate this Agreement for reasons other than Section 9.2 (Termination for Breach), then at the time if
there are any Base Fees still due and outstanding to TransAct they will be forfeited.   Termination of this Agreement by either
Party will be without prejudice to that Party’s other rights and remedies hereunder.  The following Sections, and any other right
or obligation of the Parties in this Agreement that, by its nature, should survive termination or expiration of this Agreement, shall
survive the expiration or termination of this Agreement: Section 2.2 (Maintenance and Support); Section 4.1(c) (Monthly Fees);
Section 6 (Confidential Information); Section 7 (Intellectual Property Rights); Section 8 (Indemnification; Limitation of Liability;
Warranties); and Section 10 (Miscellaneous).

10.          Miscellaneous.

10.1          Effect of Bankruptcy.  All rights and licenses granted by [***] under this Agreement (including, without limitation, all
rights and licenses to the Licensed Products) and the Escrow Agreement (as defined below) are and will be deemed to be rights
and licenses to “intellectual property”, and all Licensed Products are and will be deemed to be “embodiment(s) of intellectual
property” for purposes of, and as such terms are used in and interpreted under, Section 365(n) of the United States Bankruptcy
Code (the “Code”) (11 U.S.C. § 365(n)).  The non-bankrupt or insolvent Party shall have the right to exercise all rights and
elections under the Code and all other applicable bankruptcy, insolvency and similar laws with respect to this Agreement and the
subject matter hereof with respect to the other Party. 

10.2          Escrow.  In order to facilitate the agreements of the Parties hereunder and to provide continuity of services
contemplated by this Agreement to any TransAct Active Customers or TransAct Active Prospects, the Parties agree to promptly
and in good faith enter into a source code escrow agreement (the “Escrow Agreement”) with a recognized escrow firm, on
standard and commercially reasonable terms and conditions, with respect to the Software and Documentation licensed under this
Agreement, including, but not limited to, the escrow release conditions set forth on Schedule B. 

15

TransAct shall be responsible for the costs of maintaining such source code escrow, including the fees of the agent thereunder. 
The Parties agree to maintain such Escrow Agreement for the Term.  In connection therewith, [***] represents and warrants that
it shall store with such escrow firm the Software source code (including all project files required to build both the server and
client components of the BOHA! Solution) and the accompanying Documentation.  [***] represents and warrants that it shall
keep such escrow up-to-date with the current Software source code and Documentation (new escrow deposits at least once each
calendar quarter, unless there have not been any material changes to the Software source code or Documentation during such
quarter).

10.3          Governing Law.  This Agreement shall be governed by, and construed and interpreted in accordance with, the laws of
the State of Connecticut without regard to conflict of laws principles.  Any claim or controversy arising out of or relating to this
Agreement shall be brought exclusively in federal or state court located in Hartford, Connecticut.

10.4          Waiver.  No failure or delay on the part of any Party in exercising any right hereunder, irrespective of the length of
time for which such failure or delay shall continue, will operate as a waiver of, or impair, any such right.  No single or partial
exercise of any right hereunder shall preclude any other or further exercise thereof or the exercise of any other right.  No waiver
of any right hereunder will be effective unless given in a signed writing.

10.5          Further Assurances.  Each Party to this Agreement will, at the request of the other Party and without charge (provided
that the cost to the providing Party is reasonable under the circumstances), execute and deliver all such further instruments and
documents as may be reasonably requested to further confirm, carry out and otherwise accomplish the intent and purpose of this
Agreement.

10.6          Severability.  If any provision of this Agreement is held to be invalid, illegal or unenforceable in any jurisdiction, such
provision shall be deemed amended to conform to applicable laws so as to be valid and enforceable, or, if it cannot be so
amended without materially altering the intention of the Parties, it shall be stricken, and the remainder of this Agreement shall
remain in full force and effect.

10.7          Notices.  All notices, requests, consents, claims, demands, waivers and other communications hereunder shall be in
writing and shall be deemed to have been given: (a) when delivered by hand; (b) when received by the addressee if sent by a
nationally recognized overnight courier (receipt requested); (c) on the date sent by facsimile or e-mail of a PDF document (with
confirmation of receipt) if sent during normal business hours of the recipient, and on the next Business Day if sent after normal
business hours of the recipient; or (d) on the third day after the date mailed, by certified or registered mail, return receipt
requested, postage prepaid.  Such communications must be sent to the respective Parties at the following addresses (or at such
other address for a party as shall be specified in a notice given in accordance with this Section 10.7).

16

If to [***]:

[***]

If to TransAct:

TransAct Technologies Incorporated
One Hamden Center
2319 Whitney Avenue, Suite 3B
Hamden, CT 06518
Tel: (203) 859-6800
Fax: (203) 949-9048
E-Mail: sdemartino@transact-tech.com

10.8          Subcontractors.  [***] may use subcontractors in its reasonable discretion to provide certain Services and development
of Licensed Products.  Notwithstanding any subcontracting of Services or development of Licensed Products, [***] shall not be
relieved of its performance or obligations under this Agreement.  [***] shall be solely responsible for each subcontractor’s full
and timely performance, and the acts and omissions of each subcontractor shall be deemed and treated as the acts and omissions
of [***] itself.  [***] shall also be solely responsible for compensating any subcontractors engaged by [***].

10.9          Headings.  The section headings are intended for reference only and do not affect the meaning or interpretation of this
Agreement.

10.10          Timing of Services.  [***] acknowledges that with respect to [***]’s obligations hereunder that prompt and timely
performance of all such obligations in accordance with this Agreement is required.

10.11          Binding Effect.  This Agreement shall be binding upon and shall inure to the benefit of the Parties and their respective
heirs, successors, representatives and assigns.

10.12          Force Majeure.  Each Party hereto shall be excused from default or delay in the performance of its obligations
hereunder, if and to the extent that such default or delay is: (i) caused by an act of God, or other causes beyond its reasonable
control including, but not limited to, fires, riots, accident, explosion, flood, or storm.  The operation of the preceding sentence
shall not, however, relieve a Party from its obligation to meet the time schedules required herein unless the Party shall have taken
reasonable precautions to anticipate and avoid the occurrence of the force majeure event and upon its occurrence shall have used
all commercially reasonable efforts to ameliorate or eliminate its effect.  In no event shall any postponement of either Party’s
obligations hereunder as a result of a force majeure event exceed the period of time that the force majeure had an effect on such
Party.  If a delay or interruption of performance by either Party resulting from a force majeure event exceeds thirty (30) days,
then the other Party may terminate this Agreement by delivering written notice of termination specifying the date of termination,
even though such event does not constitute a breach of this Agreement.

10.13          Assignment.  Neither this Agreement, nor any of the rights or obligations hereunder, may be assigned or delegated by
[***] without the prior written consent of TransAct, which consent shall not be unreasonably withheld.  For purposes of the
foregoing, a change in control or ownership (whether resulting from a merger, sale or otherwise) of [***], shall be deemed an
assignment restricted hereunder.  TransAct may assign or otherwise transfer this Agreement to an affiliate of TransAct or in
connection with any merger, consolidation, or reorganization involving TransAct (regardless of whether TransAct is the surviving
or disappearing entity), or a sale of all or substantially all of TransAct’s assets or business relating to this Agreement to a third
party.  Any assignment or delegation in violation of the foregoing shall be null and void.

17

10.14          Entire Agreement.  This Agreement sets forth the entire agreement and understanding of the Parties relating to the
subject matter herein and merges all prior discussions between them.  No modification of or amendment to this Agreement shall
be effective unless in writing signed by the Parties.

10.15          Non-Solicitation of Employees. During the Term of this Agreement and for twelve (12) months after any expiration
or termination of this Agreement, neither Party shall, without the prior written consent of the other, solicit or hire any person
employed by the other or formerly employed by the other within the preceding six months (for clarification, general
advertisements shall not be considered solicitation of persons).

[signature page follows]

18

IN WITNESS WHEREOF the Parties have entered into this Agreement as of the Effective Date.

[***]

TRANSACT TECHNOLOGIES INCORPORATED

By:          _/s/ [***]_______________________

By:          __/s/ Steven A. DeMartino_________

Name:          __[***]________________________

Name:          __Steven A. DeMartino___________

Title:          __President & CEO______________

Title:          __President and CFO_____________

19

 
 
 
 
 
 
 
 
 
 
 
[1] [Insert general description of [***] Applications’ functionality, etc.]

[2]  The Software shall be compatible with the following TransAct products:

EXHIBIT A

a. AccuDate XL2e (Android)

203 dpi printing
Android Lollipop (v5.x)
XGA, 1024 x 768 and has a 4:3 aspect ratio
56 mm print head  (= 448 dots/raster line)

i.
ii.
iii.
iv.
v. Maximum label width = 59mm
b. AccuDate TXL / Project Nome (Android)

300 dpi printing
Android 8

i.
ii.
iii. WXGA, 1280 x 800 with a 16:10 aspect ratio.
iv.
v. Maximum label width = 80mm

73.15 mm print head (= 864 dots/raster line)

EXHIBIT B

[***]

EXHIBIT C

[***]

Customer Support

Schedule A

Bug Classifications and Expected Response Times
The following sections define the SLA for 3 bug levels with their respective definitions provided.

HIGH

A problem that severely impacts the use of the software in a production environment, such as the inability to print labels or other
parts of the standard workflow.  The situation halts TransAct’s customer’s use of the product in its business operations and no
procedural workaround exists.

First response: Acknowledgement of issue within 2 hours (resolution ETA may be unknown.)
Follow-up responses: Every 12 hours until resolved

MEDIUM

A problem where the software is functioning but TransAct’s customer’s use in a production environment is severely reduced,
such as a label not printing correctly, a menu update not loading, or a problem with the web portal that impacts menu creation or
device management.  The situation is causing a high impact to portions of TransAct’s customer’s business operations and no
procedural workaround exists.

First response: Acknowledgement of issue within 24 regular business hours (resolution ETA may be unknown.)
Follow-up responses: Every 24 hours until resolved

LOW

A problem that involves partial, non-critical loss of use of the software or a function thereof such as the inability to view media
content on the terminal, or the label designer not placing objects where required in the web portal.  For production environments,
there is a medium-to-low impact on TransAct’s customer’s business, but your business continues to function, including by using a
procedural workaround.

First response: Acknowledgement of issue within 48 regular business hours
Follow-up responses: When resolved

NOTE

The use of the term “software” in the definitions above includes both the Android application, as well as the Web Portal
and other associated apps.

Service Levels

System Uptime SLA

This section addresses [***]’s responsibilities for system uptime.  As part of this, [***] will make available a web page where
TransAct’s customers can check uptime for the month and current status.

UPTIME

Availability Standard. “Available” means the Hosted Services are available and operable for remote electronic access and use by
Transact and its customers.  Excluding Scheduled Downtime and Third Party Outages, [***] shall make the Hosted Services
available in the following monthly uptime percentages (the “Monthly Uptime Percentages”) measured in total minutes during
the applicable month.

(i)

(ii)

[***] commits to a monthly uptime of 97.75% (or 120 minutes of permitted downtime)

In case of special large contracts (between TransAct and its customers), [***] will work with Transact to address any
special SLA requirements the TransAct customer has.

“Scheduled Downtime” means all scheduled outages, in whole or in part, for maintenance and support, provided that

(i)

[***] shall notify Transact at least 5 days in advance of all scheduled outages,

(ii)

No such scheduled outage shall last longer than one hour or occur more frequently than once a week, and

(iii)

The are scheduled between the hours of 11:00 p.m. and 7:00 am (US EST).

“Third Party Outages” means periods of downtime caused, in whole or in part, by

(i)

(ii)

Transact, its customers or any of their respective employees, agents, or affiliates, or

Internet or other network traffic problems which are completely outside of the control of [***] and cannot be
mitigated by [***].  An example of network traffic problems completely outside of the control of [***] is the Transact
Identity that will be provided by Transact.

Source Code Escrow Release Conditions:

Schedule B

•          [***] publicly announces its intention to cease its ongoing business operations or such intention or actual cessation of
business is reported by the news media;
•          [***] publicly announces its intention to cease providing, or refuses to provide to TransAct, maintenance or other support
of the Software substantially on the terms and conditions described in the Agreement;
•          [***] makes a general assignment for the benefit of its creditors;
•          [***] is unable or admits in writing its inability to pay its debts as they become due;
•          [***] is dissolved, insolvent, bankrupt or the subject of receivership;
•          [***] authorizes, applies for, or consents to the appointment of a trustee or liquidator of all or a substantial part of its
assets or has proceedings seeking such appointment commenced against it which are not dismissed within sixty (60) days of such
commencement;
•          [***] files a voluntary petition under title 11 of the United States Code or under any bankruptcy, insolvency, or any similar
law of any jurisdiction or has proceedings under any such law instituted against it, which, if such proceedings are instituted
against [***], are not terminated within sixty (60) days of such commencement;
•          Any substantial part of [***]'s property is or becomes subject to any levy, seizure, assignment or sale for or by any
creditor or governmental agency without being released or satisfied within sixty (60) days thereafter;
•          TransAct terminates the Agreement pursuant to Section 9.2(b) thereof;
•          [***] transfers of all or substantially all of its assets to a third party except in connection with a continuation of [***]'s
business;
•          Joint written instructions from [***] and TransAct.

[***] Certain information in this document has been excluded pursuant to Item (601)(b)(10) of Regulation S-K because it
is not material and would likely cause competitive harm to the registrant if publicly disclosed.

AMENDMENT NO. 1 TO MASTER LICENSE AGREEMENT

This Amendment No. 1 to Master License Agreement, dated as of February 22, 2019 (this "Amendment") is dated as of

May 5th, 2019 (the “Amendment Effective Date”) by and between TransAct Technologies Incorporated, having an address at
One Hamden Center, 2319 Whitney Avenue, Suite 3B, Hamden, Connecticut 06518, USA (“TransAct”) and [***], each a “Party”
and collectively the “Parties.”

BACKGROUND

A.          The Parties have entered into a Master License Agreement, dated as of February 22, 2019 (as amended or

otherwise modified from time to time, the "Existing Agreement");

B.          TransAct proposed to enter into an agreement with [***] pursuant to which TransAct will provide the BOHA!

MTO Labeling application to [***] subject to certain customized service levels;

C.          The Parties desire to amend the Existing Agreement to reflect certain changes to the Existing Agreement on the

terms and subject to the conditions set forth herein; and

D.          Pursuant to Section 10.14 of the Existing Agreement, amendments to the Existing Agreement must be in writing

and signed by the Parties.

NOW, THEREFORE, in consideration of the mutual covenants and promises contained herein, the Parties, intending to be

legally bound, agree as follows:

1.          Definitions. Capitalized terms used and not defined in this Amendment have the respective meanings assigned to them in the Existing

Agreement.

2.          Amendments to the Existing Agreement. As of the Amendment Effective Date, the Existing Agreement is hereby amended or

modified as follows:

(a)

Section 2.2 of the Existing Agreement is hereby amended by inserting immediately following the words "[***]
shall offer such product support 24 hours per day, seven days per week, as described in Section 2.6." the words "The Parties may
provide, in any amendment to or modification of Schedule A, for specific mutually agreed remedies in the event of a breach of
Schedule A."

(b)

Schedule A of the Existing Agreement is hereby amended by adding the following provision at the end of the

portion of such Schedule A called “UPTIME” under “Service Levels”:

“Availability Standard for [***]

Notwithstanding the availability provisions set forth above, with respect to TransAct’s provision of the BOHA! MTO Labeling
application to [***] pursuant to a written agreement between TransAct and [***], [***] shall make the Hosted Services available, as
measured over the course of each calendar month, at least 99.95% of the time between the hours of 6:00 AM to 9:00 PM (Eastern time)
Monday through Friday during weekdays (Monday through Friday) (the “[***] Uptime Requirements”).  In the event that under any
such agreement with [***], TransAct is required to pay any penalties or credits to [***] (whether by direct payment or setoff against
amounts owed by [***] to TransAct) as a result of [***]’s breach of the [***] Uptime Requirements (“[***] Credits”), TransAct shall
have the right to setoff [***] of the amount of such [***] Credits against amounts owed by TransAct to [***] under this Agreement.”

3.          Effect of Amendment. Except as expressly provided in this Amendment, all of the terms and provisions of the Existing Agreement

are and will remain in full force and effect and are hereby ratified and confirmed by the Parties. Without limiting the generality of the foregoing, the
amendments contained herein will not be construed as an amendment to any other provision of the Existing Agreement. On and after the Effective Date,
each reference in the Existing Agreement to "this Agreement," "the Agreement," "hereunder," "hereof," "herein," or words of like import will mean and be
a reference to the Existing Agreement as amended by this Amendment.

4.          Miscellaneous.

(a)

This Amendment shall be governed by, and construed and interpreted in accordance with, the laws of the State of

Connecticut without regard to conflict of laws principles.

(b)

(c)

This Amendment shall inure to the benefit of and be binding upon each of the Parties and each of their respective

permitted successors and permitted assigns.

The headings in this Amendment are for reference only and do not affect the interpretation of this Amendment.

(d)

This Amendment may be executed in counterparts, each of which is deemed an original, but all of which constitute
one and the same agreement. Delivery of an executed counterpart of this Amendment electronically or by facsimile shall be effective
as delivery of an original executed counterpart of this Amendment.

(e)

This Amendment constitutes the sole and entire agreement between the Parties with respect to the subject matter
contained herein, and supersedes all prior and contemporaneous understandings, agreements, representations, and warranties, both
written and oral, with respect to such subject matter.

IN WITNESS WHEREOF, the Parties have executed this Amendment as of the Amendment Effective Date.

[***]

TRANSACT TECHNOLOGIES INCORPORATED

By:          _/s/ [***]_______________________

Name:          _[***]_________________________

Title:          _President & CEO________________

By:          _/s/ Steven A. DeMartino__________

Name:          _Steven A. DeMartino____________

Title:          _President and CFO______________

 
 
 
 
 
 
 
 
 
 
 
 
 
 
[***] Certain information in this document has been excluded pursuant to Item (601)(b)(10) of Regulation S-K because it
is not material and would likely cause competitive harm to the registrant if publicly disclosed.

AMENDMENT NO. 2 TO MASTER LICENSE AGREEMENT

This Amendment No. 2 to Master License Agreement, dated as of February 22, 2019 (this "Amendment") is dated as of
August 15, 2019 (the “Amendment Effective Date”) by and between TransAct Technologies Incorporated, having an address
at One Hamden Center, 2319 Whitney Avenue, Suite 3B, Hamden, Connecticut 06518, USA (“TransAct”) and [***], each a
“Party” and collectively the “Parties.”

BACKGROUND

A.          The Parties have entered into a Master License Agreement, dated as of February 22, 2019, as amended by an

Amendment No. 1 thereto, dated May 5, 2019 (as amended or otherwise modified from time to time, the "Existing Agreement");

B.          TransAct and [***] are parties to a certain Loan and Security Agreement, dated as of August 15, 2019 (the
“Loan Agreement”) pursuant to which TransAct has agreed to make certain advances of funds to [***] as set forth therein;

C.          The Loan Agreement requires that the Existing Agreement be amended to provide for a right of setoff by

TransAct against amounts due to [***] under the Existing Agreement in certain events as described therein;

D.          The Parties desire to amend the Existing Agreement to reflect certain changes to the Existing Agreement on the

terms and subject to the conditions set forth herein; and

E.          Pursuant to Section 10.14 of the Existing Agreement, amendments to the Existing Agreement must be in writing

and signed by the Parties.

NOW, THEREFORE, in consideration of the mutual covenants and promises contained herein, and for other good and

valuable consideration, the receipt and sufficiency of which are hereby acknowledged and accepted, the Parties, intending to be
legally bound, agree as follows:

1.          Definitions. Capitalized terms used and not defined in this Amendment have the respective meanings assigned to them in the Existing

Agreement.

2.          Amendments to the Existing Agreement. As of the Amendment Effective Date, the Existing Agreement is hereby amended to

add a new Section 4.7 to read entirely as follows:

“4.7          Right of Setoff.  TransAct and [***] are parties to a certain Loan and Security Agreement, dated as of August 15, 2019 (the

“Loan Agreement”) pursuant to which TransAct has agreed to make certain advances of funds to [***] as set forth therein.  In the event that
[***] has not repaid the Obligations (as defined in the Loan Agreement) in full within thirty (30) days of the Maturity Date (as defined in the Loan
Agreement) TransAct shall be entitled to setoff the amount of such unpaid Obligations from time to time against any amounts otherwise payable to
[***] hereunder, including, without limitation, the Monthly Fees and White Label Fees (“Setoff Amounts”), and to retain such amounts setoff as
payment of such Obligations, in which case any amounts which are setoff by Transact shall automatically be credited towards the amounts of the
Obligations otherwise owed and payable by [***] under the Loan Agreement and such amounts shall be deemed repaid by [***] under the Loan
Agreement.  TransAct shall provide [***] a written record of any Setoff Amounts describing the source and amount of such Setoff Amounts
promptly following such setoff.  The setoff rights of TransAct under this Section 4.7 shall terminate automatically on the earlier of (i) the closing
of the Transaction (as defined in the Loan Agreement), and (ii) such time as the Obligations have been paid to TransAct in full pursuant to the
terms of the Loan Agreement (other than contingent indemnification obligations for which no claim has been made).

3.          Effect of Amendment. Except as expressly provided in this Amendment, all of the terms and provisions of the Existing Agreement

are and will remain in full force and effect and are hereby ratified and confirmed by the Parties. Without limiting the generality of the foregoing, the
amendments contained herein will not be construed as an amendment to any other provision of the Existing Agreement. On and after the Effective Date,
each reference in the Existing Agreement to "this Agreement," "the Agreement," "hereunder," "hereof," "herein," or words of like import will mean and be
a reference to the Existing Agreement as amended by this Amendment.

4.          Miscellaneous.

(a)

This Amendment shall be governed by, and construed and interpreted in accordance with, the laws of the State of

Connecticut without regard to conflict of laws principles.

(b)

(c)

permitted successors and permitted assigns.

This Amendment shall inure to the benefit of and be binding upon each of the Parties and each of their respective

The headings in this Amendment are for reference only and do not affect the interpretation of this Amendment.

(d)

This Amendment may be executed in counterparts, each of which is deemed an original, but all of which constitute
one and the same agreement. Delivery of an executed counterpart of this Amendment electronically or by facsimile shall be effective
as delivery of an original executed counterpart of this Amendment.

(e)

Except as provided in the Loan Agreement, this Amendment constitutes the sole and entire agreement between the

Parties with respect to the subject matter contained herein, and supersedes all prior and contemporaneous understandings,
agreements, representations, and warranties, both written and oral, with respect to such subject matter.

[signature page follows]

IN WITNESS WHEREOF, the Parties have executed this Amendment as of the Amendment Effective Date.

[***]

TRANSACT TECHNOLOGIES INCORPORATED

By:          _/s/ [***]_______________________

By:          _/s/ Steven A. DeMartino__________

Name:          _[***]_________________________

Name:          _Steven A. DeMartino____________

Title:          _President & CEO_______________

Title:          _President and CFO______________

 
 
 
 
 
 
 
 
 
 
 
 
 
[***] Certain information in this document has been excluded pursuant to Item (601)(b)(10) of Regulation S-K because it
is not material and would likely cause competitive harm to the registrant if publicly disclosed.

THIRD AMENDMENT
TO
MASTER LICENSE AGREEMENT

This Third Amendment to Master License Agreement (this “Third Amendment”) is made and entered into as of September 8,
2020 (the “Third Amendment Effective Date”), by and between [***], and TransAct Technologies Incorporated (“TransAct”).

WHEREAS,  [***]  and  TransAct  previously  entered  into  that  certain  Master  License  Agreement,  fully  executed  as  of
February 22, 2019 (the “Original Agreement”) and amended by an Amendment No. 1 dated May 5, 2019 and by an Amendment
No. 2 dated August 15, 2019; and

WHEREAS, the Original Agreement had pricing set at specified levels, and [***] and TransAct now wish to modify the

pricing of some of the licensed products.

NOW, THEREFORE, in consideration of the premises and for other good and valuable consideration, the receipt and

sufficiency of which are hereby acknowledged, [***] and TransAct agree as set forth in this Third Amendment.

1.

Exhibit B of the Original Agreement is hereby deleted in its entirety and replaced with the following:

[***]

* [***] and TransAct will review this pricing 18 months from the Third Amendment Effective Date and will work together in good faith to adjust pricing
to a mutually agreeable level if either party believes a change is necessary

2.

3.

All other terms and provisions of the Original Agreement are hereby ratified, adopted and reaffirmed and shall remain in
full force and legal effect, except only those which are explicitly changed by this Third Amendment.  To the extent that
there is a conflict between the terms and provisions of the Original Agreement and this Third Amendment, the terms and
provisions of this Third Amendment shall govern for purposes of the subject matter of this Third Amendment only.

This Third Amendment and the Original Agreement constitute the entire understanding and agreement, and supersede any
and all prior or contemporaneous representations, understandings, and agreements, whether oral or written, between [***]
and  TransAct  relating  to  the  subject  matter  of  this  Third  Amendment  and  the  Original  Agreement.    This  Third
Amendment may be executed in counterparts, each of which shall be deemed an original and all of which together shall
constitute one and the same document.

IN WITNESS WHEREOF, [***] and TransAct, by their duly authorized representatives, have executed this Third Amendment as
of the Third Amendment Effective Date.

[***]
/s/ [***]
Authorized Signatory
[***]
Name
President and CEO
Title

TransAct Technologies Incorporated
/s/ Steven A. DeMartino
Authorized Signatory
Steven A. DeMartino
Name
President and CFO
Title

Exhibit 10.25

[***] Certain information in this document has been excluded pursuant to Item (601)(b)(10) of Regulation S-K because it
is not material and would likely cause competitive harm to the registrant if publicly disclosed.

MASTER DEVELOPMENT AND LICENSE AGREEMENT

This Master Development and License Agreement (this “Agreement”), dated as of July 20th, 2018 (the “Effective Date”)
by and between TransAct Technologies Incorporated, having an address at One Hamden Center, 2319 Whitney Avenue, Suite
3B, Hamden, CT 06518, USA (“TransAct”) and [***] (“Developer”), each a “Party” and collectively the “Parties.”

BACKGROUND

A.          Developer is engaged in the business of providing software development and related services and work product;

and

B.          TransAct desires to retain Developer to provide the software development and related services and work product
described  herein  from  time  to  time  in  separately  executed  Statements  of  Work,  and  Developer  desires  to  provide  the  same  to
TransAct, each on the terms and conditions set forth herein.

NOW THEREFORE, in consideration of the mutual covenants and promises contained herein, the Parties, intending to be

legally bound, agree as follows:

1.          Services.

1.1          Statement(s) of Work.  TransAct hereby engages Developer, and Developer accepts such engagement, to develop
Software (as defined below) and provide services to TransAct as set forth in the initial Statement of Work attached hereto as
Exhibit A (with the exhibits thereto, the “Statement of Work”), which Exhibit is hereby made a part of this Agreement as if fully
included herein.  Additional statements of work entered into pursuant to this Agreement may also be referred to herein as
“Statements of Work.”  The services to be provided by Developer as set forth in a Statement of Work are hereinafter referred to
as the “Services.”  The Parties may agree on additional Statements of Work from time to time.  No Statement of Work shall be
effective unless signed by duly authorized representatives of both Parties.  Any such additional statement of work shall be made a
part of this Agreement as if fully included herein and shall be subject to the terms of this Agreement.

1.2          Software.  For purposes of this Agreement, “Software” shall mean the computer programs, including programming
tools, scripts, and routines that Developer develops or otherwise provides under this Agreement (regardless of whether performed
domestically or abroad and regardless of whether performed before or after execution of this Agreement or the applicable
Statement of Work) as described more fully in each Statement of Work, including all updates, upgrades, new versions, new
releases, enhancements, improvements, and other modifications made or provided thereto.

1.3          Documentation.  Prior to or concurrently with the delivery of any Software hereunder, Developer shall provide TransAct
complete and accurate user manuals, operating manuals,

1

and other instructions, specifications, documents and materials, in any form or media, that describe the components, features,
requirements, and other aspects of the Software, including any functionality, testing, operation or use thereof (the
“Documentation”) for such Software.  Documentation shall include all such information as may be reasonably necessary for the
effective installation, testing, use, support, and maintenance of the applicable Software by TransAct and its customers, including
the effective configuration, integration, and systems administration of the Software and performance of all other functions set
forth in the Software specifications.  Unless otherwise agreed in writing, Developer shall provide all Documentation in both hard
copy and electronic form, in such formats and media as are set forth in the relevant Statement of Work, or as TransAct may
otherwise reasonably request.  “Work Product” means the Software and the Documentation.

1.4          Open-Source Components.  Developer shall not include in any Software, and operation of all Software in accordance
with its specifications and Documentation shall not require the use of, any software component that is subject to any open source
copyright license agreement, including software available under the GNU Affero General Public License (AGPL), GNU General
Public License (GPL), GNU Lesser General Public License (LGPL), Mozilla Public License (MPL), Apache License, BSD
licenses, or any other license that is approved by the Open Source Initiative, other than as may be specifically described in a
Statement of Work for such Software, and for which the relevant open source license(s) are included in such Statement of Work. 
Developer shall provide TransAct with a complete, machine-readable copy of the source code for any approved open source
components in accordance with the terms of the Open Source License(s) therefor at no cost to TransAct.  To the extent any open
source software components are provided for in a Statement of Work or other written permission issued by TransAct, Developer
shall assure that any such Software, including any source code, complies with all attribution and other requirements and meets
available exceptions set forth in any applicable open source license agreement such that the Software, including any source code,
remains “closed source.”

1.5          Developer Personnel.  Developer is solely responsible for all of its employees and sub-contractors (if permitted pursuant
to Section 10.8) (the “Developer Personnel”) and for the payment of their compensation, including, if applicable, withholding of
income taxes, and the payment and withholding of social security and other payroll taxes, unemployment insurance, workers
compensation insurance and disability benefits.  If TransAct assigns any of its employees to contribute to the development of any
Work Product, TransAct shall be responsible for the payment of such TransAct employees’ compensation, including, if
applicable, withholding of income taxes, and the payment and withholding of social security and other payroll taxes,
unemployment insurance, workers compensation insurance and disability benefits.

1.6          Change Orders.  The Parties may change the scope of the Services, Work Product and other matters specified in a
Statement of Work only by a written amendment executed by authorized representatives of both Parties (“Change Order”).  If
any Change Order would, in the reasonable judgment of either Party, result in substantial additional expenses or substantial cost
savings, then the Parties shall meet to discuss, in good faith, an increase or reduction, as the case may be, in fees under such
Statement of Work.

1.7          Standard of Performance.  Developer will be responsible for overall management and performance of the Services. 
Developer will design, develop, create, test, deliver, configure,

2

integrate, customize, and otherwise provide and make fully operational Work Product as described in each Statement of Work on
a timely and professional basis in accordance with all terms, conditions, and specifications set forth in this Agreement and such
Statement of Work.  The Developer Personnel will perform the Services in a timely, professional and workmanlike manner, using
the degree of skill, care, and judgment consistent with customarily accepted good business practices and otherwise in accordance
with all standards for performance of the Services established by TransAct in each Statement of Work.  All Services and Work
Product provided under any Statement of Work will be subject to TransAct’s review and approval in accordance with the terms
contained herein.  In addition to the warranty obligations contained herein, any claim made in good faith by TransAct regarding
the deficiency of the Services or Work Product, shall be resolved by Developer repairing the deficiency of the Services or Work
Product at no additional cost to TransAct.

1.8          Acceptance Testing.  Unless otherwise set forth in the applicable Statement of Work, the procedures in this Section will
apply for all TransAct acceptances contemplated in connection with Work Product hereunder or any Services for which the
applicable Statement of Work contemplates acceptance testing.  For any Work Product, or portion thereof presented for
acceptance by TransAct, Developer will provide to TransAct all relevant documents, deliverables and other information that is
reasonably necessary for TransAct to make its evaluation.  TransAct shall, upon receipt of a Work Product that Developer
designates as “final,” have thirty (30) business days to complete acceptance testing thereof (the “Acceptance Period”).  If
TransAct determines that such Work Product does not conform to the specifications and any acceptance criteria set forth in the
applicable Statement of Work, TransAct shall notify Developer in writing outlining each deficiency and failure to comply with
the Statement of Work and Developer shall, within twenty (20) business days after receipt of written notification of TransAct’s
non-acceptance, repair the deficiency.  A Work Product shall be deemed accepted by TransAct if written notification of
TransAct’s non-acceptance is not received by Developer within the Acceptance Period.  Notwithstanding the foregoing,
TransAct’s acceptance of a Work Product shall in no way limit the performance and warranty obligations of Developer as
identified in Section 1.7 and Section 8.

1.9          Access to Works-in-Process.  Developer will deliver all Work Product, and provide access to all works-in-process, to
TransAct as set forth in each applicable Statement of Work and if not so set forth, upon the written request of TransAct.

2.          Training, Maintenance and Support.

2.1          Training.  Developer shall provide TransAct and its designees with such training as set forth in the applicable Statement
of Work.  Unless expressly provided in any Statement of Work, all training shall be provided at no additional charge to Transact,
it being acknowledged and agreed that the fees include full consideration therefor.

2.2          Maintenance and Support.  Developer offers product support 24 hours per day, seven days per week, without additional
charge.  Developer agrees to provide TransAct with such support services (as described in more detail in the Statement of Work
set forth in Exhibit A hereto) with respect to the Software and Work Product for ten (10) years from acceptance of the Software. 
The Parties acknowledge and agree that Developer is not responsible for direct support of the customers of TransAct.

3

3.          Independent Contractors; No Partnership.

3.1          Independent Contractors.  This Agreement is intended to create an independent contractor relationship between the
Parties for purposes of Federal, state and local law.  The Parties understand and agree that Developer Personnel will be: (a) the
employees or subcontractors of Developer only, and Developer alone will determine the terms and conditions of such
employment or engagement; and (b) hired, paid, supervised, directed, controlled, promoted or demoted, terminated, engaged and
otherwise managed solely by Developer.

3.2          No Partnership.  Nothing in this Agreement will be construed or implied to create a relationship of agency, partners,
affiliates, joint employers, or joint venturers.  Neither Party will have the power or authority to act for the other in any manner or
to create obligations or debts which would be binding on the other.  Neither Party will be responsible for any obligation of the
other or be responsible for any act or omission of the other.

4.          Compensation; Expenses; Taxes.

4.1          Fees.  The Services and Work Product will be provided either on a flat fee basis or on a time and materials basis and
will be charged at the rates set out in the applicable Statement of Work.  All rates, charges and/or fees for any and all Work
Product, deliverables and/or Services performed by Developer must be listed in a Statement of Work.  Any attempt to alter rates,
charges and other fees in any document other than in a Change Order shall be void and non-binding on TransAct.

4.2          Expenses.  Unless otherwise specified, the Developer’s expenses will be included in the fees charged by Developer, as
set forth in Statements of Work. Notwithstanding the foregoing, TransAct shall reimburse Developer for any actual travel or other
transportation-related expenses that (i) Developer incurs in performing the Services or developing Work Product, and (ii)
TransAct has pre-approved in writing.  Any such reimbursable expenses shall be subject to TransAct’s reimbursement policies in
effect from time to time.

4.3          Taxes.  All fees set forth herein are exclusive of taxes.  Developer shall be responsible for all sales, use, VAT, gross
receipts, real estate, personal property and any other similar taxes, duties, and charges of any kind imposed by any federal, state,
or local governmental entity on any amounts payable by TransAct hereunder, other than any taxes imposed on, or with respect to,
TransAct’s income.  Developer will indemnify and hold harmless TransAct for any loss or damage (including without limitation
any penalties and interest) sustained because of Developer’s failure to pay such taxes.

5.          Payment Terms.

5.1          Invoices.  Unless otherwise stated in the Statement of Work, Developer shall issue invoices within thirty (30) days
following the end of the period covered by each applicable invoice.  The length of such billing period will be as specified in the
applicable Statement of Work or, if none is specified, a billing period shall be defined as a calendar month.  Developer shall
submit each invoice in both hard copy and electronic format, via such delivery means and to such address as are specified by
TransAct in writing from time to time.  No term or condition of any invoice shall be binding upon TransAct, and TransAct hereby
rejects any terms inconsistent with or additional to the terms and conditions of this Agreement.  Except as otherwise set forth in a
Statement of Work, TransAct will pay all undisputed amounts owed to Developer within thirty (30) days’ receipt of the invoices.

4

5.2          Disputed Amounts.  TransAct may withhold from payment any amount disputed by TransAct in good faith, pending
resolution of the dispute, provided that TransAct: (a) timely pays all amounts not subject to dispute; (b) notifies Developer of the
dispute prior to the due date, specifying in such notice (i) the amount in dispute, and (ii) the reason for the dispute; (c) works with
Developer in good faith to resolve the dispute promptly; and (d) promptly pays any amount determined to be due by resolution of
the dispute.  Developer shall continue performing its obligations in accordance with the applicable Statement of Work
notwithstanding any such dispute or actual or alleged nonpayment that is the subject of the dispute, pending its resolution.

5.3          Right of Set-off.  Without prejudice to any other right or remedy it may have, TransAct reserves the right to set-off at
any time any amount owing to it by Developer against any amount payable by TransAct to Developer under this Agreement.

6.          Confidential Information.

6.1          Definition.  “Confidential Information” shall mean confidential or other proprietary information that is disclosed by
one Party (the “Disclosing Party”) to the other Party (the “Receiving Party”) under this Agreement or relates to the Work
Product or the Services, including without limitation, product specifications and documentation, financial data, business and
product plans, each Party’s software source code, and other confidential business information.  Without limitation, data and
information concerning customers of TransAct (including, without limitation, (i) data entered by TransAct customers on
TransAct terminals and hosted by Developer, and (ii) information regarding how TransAct’s customers use TransAct-supplied
terminals) constitutes Confidential Information of TransAct.  Confidential Information shall not include information which the
Receiving Party can demonstrate: (a) is or becomes public knowledge without any action by, or involvement of the Receiving
Party; (b) is disclosed by the Receiving Party with the prior written approval of the Disclosing Party; (c) was previously known to
the Receiving Party without an obligation of confidence; (d) is independently developed by the Receiving Party without use of
the Confidential Information; or (e) was acquired by the Receiving Party from a third party which is not, under an obligation of
confidence with respect to such information.

6.2          Restrictions.  As a condition to being provided with any disclosure of or access to Confidential Information, the
Receiving Party shall (a) not access or use Confidential Information other than as necessary to exercise its rights or perform its
obligations under and in accordance with this Agreement; (b) except as may be permitted by and subject to its compliance with
Section 6.4, not disclose or permit access to Confidential Information other than to its employees, officers, directors, consultants,
legal advisors and permitted subcontractors (collectively, “Representatives”) who (i) need to know such Confidential
Information for the performance of their obligations under and in accordance with this Agreement; (ii) have been informed of the
confidential nature of the Confidential Information and their obligations under Section 6; and (iii) are bound by written
confidentiality and restricted use obligations at least as protective of the Confidential Information as the terms set forth in Section
6; (c) safeguard the Confidential Information from unauthorized use, access or disclosure using at least the degree of care it uses
to protect its own sensitive information and in no event less than a reasonable degree of care; and (d) ensure its Representatives’
compliance with, and be responsible and liable for any of its Representatives’ noncompliance with, the terms of Section 6.

5

6.3          Duration.  The Receiving Party shall continue such confidential treatment of Confidential Information for a period of
five (5) years from the date of termination, expiration or cancellation of this Agreement.  Notwithstanding the foregoing, trade
secrets of the Disclosing Party will remain Confidential Information for so long as they remain trade secrets under applicable law.

6.4          Compelled Disclosures.  If the Receiving Party or any of its Representatives is compelled by applicable law to disclose
any Confidential Information then, to the extent legally permitted, the Receiving Party shall: (a) promptly, and prior to such
disclosure, notify the Disclosing Party in writing of such requirement so that the Disclosing Party can seek a protective order or
other remedy, or waive its rights under Section 6.2; and (b) provide reasonable assistance to the Disclosing Party in opposing
such disclosure or seeking a protective order or other limitations on disclosure.  If the Disclosing Party waives compliance or,
after providing the notice and assistance required under this Section, the Receiving Party remains required by law to disclose any
Confidential Information, the Receiving Party shall disclose only that portion of the Confidential Information that the Disclosing
Party is legally required to disclose and, upon the Receiving Party’s request, shall use commercially reasonable efforts to obtain
assurances from the applicable court or other presiding authority that such Confidential Information will be afforded confidential
treatment.

7.          Intellectual Property Rights.

7.1          Work Product.

(a)          The Work Product shall be delivered in a form and format acceptable to TransAct.  Work Product shall be owned solely
and exclusively by Developer (other than any Work Product components that contain Confidential Information of TransAct,
which shall remain proprietary to TransAct), subject to the license set forth below.  Work Product includes, without limitation, the
Software, Documentation and all deliverables provided under any Statement of Work.  Notwithstanding the foregoing, any
ancillary works to the Work Product (such as applications that run on the Software platform) created by TransAct shall belong
exclusively to TransAct.

(b)          Developer shall not design, develop or provide to TransAct any Work Product that infringes upon or violates the rights
of any person or entity, including rights relating to defamation, privacy, publicity, contract, patent, copyright, trademark, trade
secret or other intellectual property rights (collectively, “Third-Party Rights”).  If Developer becomes aware of any such
possible violation or infringement, Developer shall immediately so notify TransAct in writing and correct the issue.

6

7.2          License Grant.

(a)          In exchange for the payments set forth in Statements of Work, Developer hereby grants to TransAct a perpetual,
worldwide, irrevocable, fully-paid, exclusive (as set forth in an applicable Statement of Work), transferable, royalty-free right and
license to, and to sublicense third parties to, make, have made, use, sell, offer for sale, export, import, execute, reproduce,
distribute, display, perform and exploit the Work Product, including any enhancements thereto.  For purposes of clarification,
TransAct shall have the right to create its own applications, or use third party applications, on TransAct’s devices in connection
with the Software.

(b)          In the event that a Statement of Work specifies that a Work Product shall be TransAct-branded or “white labeled,”
TransAct hereby grants to Developer a perpetual, revocable, worldwide, fully-paid, non-exclusive, non-transferable, royalty-free
right and license to use the TransAct name and trademarks solely for the purposes of white labeling Work Product.  Subject to
this clause (b), TransAct retains all right, title and interest in the TransAct name and trademarks.

8.          Indemnification; Limitation of Liability; Warranties.

8.1          Indemnification by Developer.  Developer shall defend, indemnify, and hold harmless TransAct and its officers,
directors, employees, agents, contractors, successors, and assigns (each, a “TransAct Indemnitee”) from and against any and all
losses, damages, deficiencies, claims, actions, judgments, settlements, interest, awards, penalties, fines, costs, or expenses of
whatever kind, including reasonable attorneys’ fees (together, “Losses”) incurred by the TransAct Indemnitee resulting from any
claim, action, cause of action, demand, suit, arbitration, inquiry, audit, notice of violation, proceeding, litigation, citation,
summons, subpoena, or investigation of any nature, civil, criminal, administrative, regulatory, or other, whether at law, in equity,
(each an “Action”) by a third party that arises out of or results from, or is alleged to arise out of or result from (a) Developer’s
breach of any representation, warranty, covenant, or obligation of Developer (including any action or failure to act by any
permitted subcontractor that, if taken or not taken by Developer, would constitute such a breach by Developer) under this
Agreement; or (b) the negligence or reckless or willful misconduct of Developer or its permitted subcontractors in connection
with the Work Product or the performance of the Services, except (with regards to both (a) and (b) above) to the extent that
Losses arise or result from (x) TransAct’s breach of any representation, warranty, covenant, or obligation of TransAct under this
Agreement; or (y) the negligence or reckless or willful misconduct of TransAct in connection with the Work Product or the
Services.

8.2          Indemnification Procedure.  TransAct will promptly notify Developer in writing of any Action for which it seeks to be
indemnified pursuant to Section 8 and cooperate with Developer in the defense of such Action at Developer’s cost and expense
(provided that Developer shall not be required to compensate TransAct for its personnel’s time spent providing such
cooperation).  Developer shall immediately take control of the defense and investigation of such Action and shall employ counsel
reasonably acceptable to TransAct to handle and defend the same, at Developer’s sole cost and expense.  Developer shall not
settle any Action without TransAct’s prior written consent, unless such settlement is limited to monetary damages fully paid by
Developer and does not include any admission of liability or equitable remedy.  TransAct’s failure to give prompt notice under
this Section 8.2 will not relieve Developer of its obligations hereunder except to the extent that Developer can demonstrate that it
has been materially prejudiced as a result of such failure.  TransAct may participate in and observe the proceedings at its own
cost and expense with counsel of its own choosing.

7

8.3          Infringement Remedy.  If any of the Work Product, or any component thereof, other than any proprietary materials of
TransAct, is found to be infringing or if any use of any Work Product or any component thereof is enjoined, threatened to be
enjoined, or otherwise the subject of an infringement claim, Developer shall, at Developer’s sole cost and expense (i) procure for
TransAct the right to use the infringing Work Product, (ii) replace the infringing Work Product with a non-infringing, functionally
equivalent one, (iii) suitably modify the infringing Work Product so that it is non-infringing, or (iv) accept return of the infringing
Work Product and refund a pro-rata portion (based on a five-year straight line depreciation commencing upon delivery) of any
fees paid by TransAct to Developer with respect to such Work Product and all other affected Work Products.  The remedies set
forth in this Section 8.3 are in addition to, and not in lieu of, all other remedies that may be available to TransAct under this
Agreement or otherwise, including TransAct’s right to be indemnified for such Actions.

8.4          Indemnification by TransAct.  TransAct shall defend, indemnify, and hold harmless Developer and its officers,
directors, employees, agents, contractors, successors, and assigns (each, a “Developer Indemnitee”) from and against any and all
Losses incurred by the Developer Indemnitee resulting from any Action by a third party that arises out of or results from, or is
alleged to arise out of or result from (a) TransAct’s breach of any representation, warranty, covenant, or obligation of TransAct
under this Agreement; or (b) the negligence or reckless or willful misconduct of TransAct in connection with the Work Product or
the Services, except (with regards to both (a) and (b) above) to the extent that Losses arise or result from (x) Developer’s breach
of any representation, warranty, covenant, or obligation of Developer under this Agreement; or (y) the negligence or reckless or
willful misconduct of Developer in connection with the Work Product or the Services.

8.5          Disclaimer; Limitation.

(a)          EXCEPT AS SET FORTH BELOW, IN NO EVENT SHALL EITHER PARTY BE LIABLE UNDER THIS
AGREEMENT OR ANY STATEMENT OF WORK TO THE OTHER PARTY FOR ANY SPECIAL, CONSEQUENTIAL,
PUNITIVE, INCIDENTAL, OR INDIRECT DAMAGES, HOWEVER CAUSED, ON ANY THEORY OF LIABILITY, AND
WHETHER OR NOT THAT PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.  THESE
LIMITATIONS SHALL APPLY NOTWITHSTANDING ANY FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED
REMEDY.

(b)          EXCEPT AS SET FORTH BELOW, IN NO EVENT SHALL EITHER PARTY’S AGGREGATE LIABILITY
ARISING OUT OF OR RELATED TO THIS AGREEMENT OR ANY STATEMENT OF WORK, WHETHER ARISING OUT
OF OR RELATED TO BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHERWISE, EXCEED
SEVEN HUNDRED FIFTY THOUSAND DOLLARS ($750,000).

(c)          The limitation described in this Section 8.5 will not apply to: (i) claims of a breach of Developer’s obligations under
Section 6 (Confidential Information); (ii) claims of infringement of a third party’s intellectual property rights; (iii) Developer’s
indemnification obligations under this Agreement; (iv) claims arising out of, in connection with or resulting from Developer’s
misuse or appropriation of TransAct’s Confidential Information or any Work Product; (v) claims relating to property damage or
personal injury; or (vi) either Party’s intentional misconduct that is tortious or criminal, or committed with the knowledge that
such misconduct was reasonably certain to materially damage the other Party.

8

8.6          Mutual Warranties.  Each Party represents and warrants to the other Party as follows:

(a)          it is duly organized, validly existing, and in good standing as a corporation or other entity as represented herein under
the laws of its jurisdiction of incorporation or organization;

(b)          it has the full right, power, and authority to enter into this Agreement, to grant the rights and licenses granted hereunder,
and to perform its obligations hereunder;

(c)          the execution of this Agreement by its representative whose signature is set forth at the end hereof has been duly
authorized by all necessary action of the party;

(d)          the execution, delivery and performance of its obligations hereunder will not violate any contractual or other legal
obligation of Developer or any rights of any third parties, and

(e)          when executed and delivered by both Parties, this Agreement will constitute the legal, valid, and binding obligation of
such party, enforceable against such party in accordance with its terms.

8.7          Developer Warranties.  Developer represents and warrants to TransAct as follows:

(a)          Developer shall perform the Services in accordance with the applicable Statement of Works and in a timely, professional
and workmanlike manner, using a high degree of skill, care, consistent with standards for performance of the Services established
by TransAct and agreed to by the Parties in each Statement of Work.

(b)          The Work Product shall materially conform to all relevant specifications, and be free of material or frequent defects, for
a period of ten (10) years from delivery to TransAct.  Developer agrees to correct promptly any such Work Product not in
compliance with this warranty.

(c)          Developer is in compliance with, and will perform all Services in compliance with, all applicable laws, rules and
regulations.

(d)          Except as otherwise expressly set forth in a Statement of Work, the Work Product is and will be the original work of
Developer or its permitted subcontractors.

(e)          The Work Product does not and will not infringe any Third-Party Rights.

(f)          The Work Product shall not contain any viruses, worms, trap doors, timers, clocks, counters, time locks, time bombs,
logic bombs, Trojan horses or other limiting code, design, instruction or routines which is designed, or intended to do any of the
following either automatically or without the intentional action of TransAct: (i) altering, deleting or interfering with any data,
information, software or subsystems; (ii) damaging, destroying, disabling, suspending the operation of, or altering the operation
of the Work Product or other software or components thereof; or (iii) causing the Work Product or other software or components
thereof to become inoperable or otherwise incapable of being used in the full manner for which they were provided under this
Agreement.

9

(g)          The Work Product will be, and as installed in the TransAct operating environment (or any successor thereto) and used in
accordance with the Documentation will function in all respects in conformity with this Agreement, the applicable Statement of
Work and the specifications and Documentation therefor; and any media on which any Software is delivered will be free of
damage or defect in design, material, and workmanship, and will remain so under ordinary use as contemplated by this
Agreement, the applicable Statement of Work and the specifications and, with respect to the Software component thereof, the
Documentation therefor.

9.          Term and Termination.

9.1          Term.  Unless otherwise terminated as specified herein, the term of this Agreement will commence on the Effective
Date and will continue through December 31, 2021 (this initial term and all renewal terms, if any, collectively, the “Term”).  This
Agreement shall continue in full force and effect for additional one-year terms thereafter unless either Party gives not less than
ninety (90) days written notice of termination prior to expiration of the then-effective Term.  This Agreement shall continue to
govern any outstanding Statements of Work until their expiration or termination.

9.2          Termination for Breach.  Either Party may cancel or terminate the affected Statement of Work(s) or this Agreement as a
whole, without liability, by giving written notice of breach or default if the other (a) becomes insolvent, unable to pay its debts
when due, or the subject of bankruptcy proceedings not terminated within thirty (30) days of any filing; or makes a general
assignment for the benefit of creditors; or if a receiver is appointed for substantially all of its property; or (b) breaches or defaults
on any of its obligations under this Agreement and fails to cure such breach or default within thirty (30) days after receipt of
written notice specifying the nature of such breach or default.  Notwithstanding the foregoing, in the event that a breach by
TransAct relates to non-payment under a specific Statement of Work, Developer’s termination rights under this Section 9.2 shall
extend only to the Statement of Work affected by such breach.

9.3          Effect of Termination.  Upon termination of this Agreement for any reason, Developer agrees to immediately
discontinue performance under all Statements of Work.  Upon termination for any reason of a Statement of Work or this
Agreement in its entirety, Developer agrees to: (a) return to TransAct all copies of any Confidential Information received from
TransAct in connection with the terminated agreement(s); (b) deliver to TransAct all Work Product and all works-in-process
related to the applicable Statement(s) of Work; (c) provide reasonable cooperation and assistance to TransAct in transitioning the
Services to an alternate service provider; and (d) on a pro rata basis, repay all amounts, if any, paid in advance for any Services or
Work Product that have not been provided.  Except for non-payment of amounts due hereunder, no expiration or termination of
this Agreement will affect TransAct’s rights in any of the Work Product.  Termination of this Agreement by either Party will be
without prejudice to that Party’s other rights and remedies hereunder.  The following Sections shall survive the expiration or
termination of this Agreement: Section 2.2 (Maintenance and Support); Section 6 (Confidential Information); Section 7
(Intellectual Property Rights); Section 8 (Indemnification; Limitation of Liability; Warranties); and Section 10 (Miscellaneous).

10

10.          Miscellaneous.

10.1          Effect of Developer Bankruptcy.  All rights and licenses granted by Developer under this Agreement (including,
without limitation, all rights and licenses to the Work Product) are and will be deemed to be rights and licenses to “intellectual
property”, and all Work Product is and will be deemed to be “embodiment(s) of intellectual property” for purposes of, and as
such terms are used in and interpreted under, Section 365(n) of the United States Bankruptcy Code (the “Code”) (11 U.S.C. §
365(n)).  TransAct shall have the right to exercise all rights and elections under the Code and all other applicable bankruptcy,
insolvency and similar laws with respect to this Agreement and the subject matter hereof.  Without limiting the generality of the
foregoing, Developer acknowledges and agrees that, if Developer or its estate shall become subject to any bankruptcy or similar
proceeding, or Developer otherwise ceases to conduct its business in the ordinary course:

(a)          subject to TransAct’s rights of election, all rights and licenses granted to TransAct under this Agreement will continue
subject to the terms and conditions of this Agreement, and will not be affected, even by Developer’s rejection of this Agreement;
and

(b)          TransAct shall be entitled to a complete duplicate of (or complete access to, as appropriate) all such intellectual property
and embodiments of intellectual property, and the same, if not already in TransAct’s possession, shall be promptly delivered to
TransAct, unless Developer elects to and does in fact continue to perform all of its obligations under this Agreement.

(c)          Unless Developer elects to and does in fact continue to perform all of its obligations under this Agreement, Developer
automatically grants TransAct a perpetual, worldwide, irrevocable, fully-paid, non-exclusive, transferable, royalty-free right and
license to use, modify, create derivative works of, operate, sublicense, sell, offer for sale, export, import, execute, reproduce,
distribute, display, perform and exploit all such intellectual property and embodiments of intellectual property.

10.2          Escrow.  In order to facilitate delivery of intellectual property as set forth in Section 10.1 (Effect of Developer
Bankruptcy) of this Agreement and Section 7 (Hosting) of the Statement of Work attached hereto as Exhibit A, the Parties agree
to promptly and in good faith enter into a source code escrow agreement with a recognized escrow firm, on standard and
commercially reasonable terms and conditions, with respect to the Software and Documentation licensed under this Agreement. 
The Parties agree to maintain such escrow agreement for the Term.  In connection therewith, Developer represents and warrants
that it shall store with such escrow firm the Software source code (including all project files required to build both the server and
client components of the [***] solution) and the accompanying Documentation.  Developer represents and warrants that it shall
keep such escrow up-to-date with the current Software source code and Documentation (new escrow deposits at least once each
calendar quarter, unless there have not been any material changes to the Software source code or Documentation during such
quarter).

11

10.3          Governing Law.  This Agreement shall be governed by, and construed and interpreted in accordance with, the laws of
the State of New York without regard to conflict of laws principles.  Any claim or controversy arising out of or relating to this
Agreement shall be brought exclusively in federal or state court located in New York, New York.

10.4          Waiver.  No failure or delay on the part of any Party in exercising any right hereunder, irrespective of the length of
time for which such failure or delay shall continue, will operate as a waiver of, or impair, any such right.  No single or partial
exercise of any right hereunder shall preclude any other or further exercise thereof or the exercise of any other right.  No waiver
of any right hereunder will be effective unless given in a signed writing.

10.5          Further Assurances.  Each Party to this Agreement will, at the request of the other Party and without charge (provided
that the cost to the providing Party is reasonable under the circumstances), execute and deliver all such further instruments and
documents as may be reasonably requested to further confirm, carry out and otherwise accomplish the intent and purpose of this
Agreement.

10.6          Severability.  If any provision of this Agreement is held to be invalid, illegal or unenforceable in any jurisdiction, such
provision shall be deemed amended to conform to applicable laws so as to be valid and enforceable, or, if it cannot be so
amended without materially altering the intention of the Parties, it shall be stricken, and the remainder of this Agreement shall
remain in full force and effect.

10.7          Notices.  All notices, requests, consents, claims, demands, waivers and other communications hereunder shall be in
writing and shall be deemed to have been given: (a) when delivered by hand; (b) when received by the addressee if sent by a
nationally recognized overnight courier (receipt requested); (c) on the date sent by facsimile or e-mail of a PDF document (with
confirmation of receipt) if sent during normal business hours of the recipient, and on the next Business Day if sent after normal
business hours of the recipient; or (d) on the third day after the date mailed, by certified or registered mail, return receipt
requested, postage prepaid.  Such communications must be sent to the respective parties at the following addresses (or at such
other address for a party as shall be specified in a notice given in accordance with this Section 10.7).

If to Developer:

[***]

If to TransAct:

TransAct Technologies Incorporated
One Hamden Center
2319 Whitney Avenue, Suite 3B
Hamden, CT 06518
Tel: (203) 859-6800
Fax: (203) 949-9048
E-Mail: dblock@TransAct-tech.com

with a copy to:  sdemartino@transact-tech.com

12

10.8          Subcontractors.  TransAct agrees that Developer will subcontract to [***] certain Services and development of Work
Product described in the Statement of Work set forth in Exhibit A hereto.  Except as set forth above, Developer shall not
subcontract this Agreement, any Statement of Work or any Services or Work Product to be provided hereunder to any third party
without: (a) the prior written consent of TransAct, which may be withheld at its sole discretion, and (b) the prior written
agreement of the proposed subcontractor to be bound by the provisions of this Agreement.  Notwithstanding any subcontracting,
Developer shall not be relieved of its performance or obligations under this Agreement or any Statement of Work.  Developer
shall be solely responsible for each subcontractor’s full and timely performance, and the acts and omissions of each subcontractor
shall be deemed and treated as the acts and omissions of Developer itself.  Developer shall also be solely responsible for
compensating any subcontractors.

10.9          Headings.  The section headings are intended for reference only and do not affect the meaning or interpretation of this
Agreement.

10.10          Time of the Essence.  Developer acknowledges that time is of the essence with respect to Developer’s obligations
hereunder and agrees that prompt and timely performance of all such obligations in accordance with this Agreement and each
Statement of Work is strictly required.

10.11          Binding Effect.  This Agreement shall be binding upon and shall inure to the benefit of the Parties and their respective
heirs, successors, representatives and assigns.

10.12          Force Majeure.  Each Party hereto shall be excused from default or delay in the performance of its obligations
hereunder, if and to the extent that such default or delay is: (i) caused by an act of God, or other causes beyond its reasonable
control including, but not limited to, fires, riots, accident, explosion, flood, or storm.  The operation of the preceding sentence
shall not, however, relieve a Party from its obligation to meet the time schedules required herein unless the Party shall have taken
reasonable precautions to anticipate and avoid the occurrence of the force majeure event and upon its occurrence shall have used
all commercially reasonable efforts to ameliorate or eliminate its effect.  In no event shall any postponement of either Party’s
obligations hereunder as a result of a force majeure event exceed the period of time that the force majeure had an effect on such
Party.  If a delay or interruption of performance by either Party resulting from a force majeure event exceeds thirty (30) days,
then the other Party may terminate this Agreement and/or any Applicable Statement of Work by delivering written notice of
termination specifying the date of termination, even though such event does not constitute a breach of this Agreement or any
Statement of Work.

10.13          Order of Precedence.  In the event of a conflict between the terms and conditions in this Agreement and any
Statement of Work, the terms and conditions of this Agreement shall control, except to the extent that specific language in
Statement of Work executed by TransAct expressly states that it supersedes particular language in this Agreement.

13

10.14          Assignment.  Neither this Agreement, any Statement of Work, nor any of the rights or obligations hereunder or
thereunder, may be assigned or delegated by Developer without the prior written consent of TransAct, which consent shall not be
unreasonably withheld.  Any assignment or delegation in violation of the foregoing shall be null and void.  For purposes of the
foregoing, a change in control or ownership (whether resulting from a merger, sale or otherwise), shall be deemed an assignment
restricted hereunder.

10.15          Entire Agreement.  This Agreement sets forth the entire agreement and understanding of the Parties relating to the
subject matter herein and merges all prior discussions between them.  No modification of or amendment to this Agreement shall
be effective unless in writing signed by the Parties.

10.16          Non-Solicitation. During the term of this Agreement and for twelve (12) months after any expiration or termination
of this Agreement, neither Party shall, without the prior written consent of the other, solicit or hire any person employed by the
other or formerly employed by the other within the preceding six months (for clarification, general advertisements shall not be
considered solicitation of persons).

14

IN WITNESS WHEREOF the Parties have entered into this Agreement as of the Effective Date.

[***]

TRANSACT TECHNOLOGIES INCORPORATED

By:          _/s/ [***]________________________

Name:          _[***]__________________________

Title:          _President & CEO________________

By:          _/s/ Steven A. DeMartino___________

Name:          _Steven A. DeMartino_____________

Title:          _President and CFO_______________

15

 
 
 
 
 
 
 
 
 
 
 
 
[***]

EXHIBIT A

Statement of Work

16

EXHIBIT 21

TransAct Technologies

Subsidiaries of the Company

as of December 31, 2020

 Name
TransAct.com, Inc.
TransAct Technologies (Macau) Limited
TransAct Technologies (United Kingdom) Limited

Jurisdiction of Incorporation
United States - Delaware
Macau
United Kingdom

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT

Exhibit 23.1

We consent to the incorporation by reference in the Registration Statement of Transact Technologies Incorporated on Form S-8 (File Nos. 333-203184, 333-132624, 333-
170515,  333-221514  and  333-248054)  and  Form  S-3  (File  No.  333-248055)  of  our  report  dated  March  12,  2021, with  respect  to  our  audit  of  the  consolidated  financial
statements  of Transact Technologies Incorporated as of December 31, 2020 and for the year ended December 31, 2020, which report is included in this Annual Report on

Form 10-K of Transact Technologies Incorporated for the year ended December 31, 2020.

/s/ Marcum LLP

Marcum LLP
Hartford, CT

March 12, 2021

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Exhibit 23.2

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (333-248055) and Form S-8 (Nos. 333-248054, 333-
221514, 333-203184, 333-170515, and 333-132624) of TransAct Technologies Incorporated of our report dated March 16, 2020 relating to the financial
statements, which appears in this Form 10‑K.

/s/ PricewaterhouseCoopers LLP

Hartford, Connecticut

March 12, 2021

RULE 13a-14(a) CERTIFICATION OF CHIEF EXECUTIVE OFFICER
IN ACCORDANCE WITH SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

Exhibit 31.1

I, Bart C. Shuldman, certify that:

1.

I have reviewed this Annual Report on Form 10-K of TransAct Technologies Incorporated;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light  of  the  circumstances  under  which  such  statements  were  made,  not  misleading  with  respect  to  the  period  covered  by  this
report;

3. Based  on  my  knowledge,  the  financial  statements,  and  other  financial  information  included  in  this  report,  fairly  present  in  all  material  respects  the

financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The  registrant’s  other  certifying  officer  and  I  are  responsible  for  establishing  and  maintaining  disclosure  controls  and  procedures  (as  defined  in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))
for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;

(b) Designed  such  internal  control  over  financial  reporting,  or  caused  such  internal  control  over  financial  reporting  to  be  designed  under  our
supervision, to provide reasonable  assurance  regarding  the  reliability  of  financial  reporting  and  the  preparation  of  financial  statements  for
external purposes in accordance with generally accepted accounting principles;

(c) Evaluated  the  effectiveness  of  the  registrant’s  disclosure  controls  and  procedures  and  presented  in  this  report  our  conclusions  about  the

effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent
fiscal  quarter  (the  registrant's  fourth  fiscal  quarter  in  the  case  of  an  annual  report)  that  has  materially  affected,  or  is  reasonably  likely  to
materially affect, the registrant’s internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the

registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All  significant  deficiencies  and  material  weaknesses  in  the  design  or  operation  of  internal  control  over  financial  reporting  which  are

reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any  fraud,  whether  or  not  material,  that  involves  management  or  other  employees  who  have  a  significant  role  in  the  registrant's  internal

control over financial reporting.

Date:  March 12, 2021

/s/ Bart C. Shuldman
Bart C. Shuldman
Chairman and Chief Executive Officer

 
 
 
 
 
RULE 13a-14(a) CERTIFICATION OF CHIEF FINANCIAL OFFICER
IN ACCORANCE WITH SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

Exhibit 31.2

I, Steven A. DeMartino, certify that:

1.

I have reviewed this Annual Report on Form 10-K of TransAct Technologies Incorporated;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light  of  the  circumstances  under  which  such  statements  were  made,  not  misleading  with  respect  to  the  period  covered  by  this
report;

3. Based  on  my  knowledge,  the  financial  statements,  and  other  financial  information  included  in  this  report,  fairly  present  in  all  material  respects  the

financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The  registrant’s  other  certifying  officer  and  I  are  responsible  for  establishing  and  maintaining  disclosure  controls  and  procedures  (as  defined  in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))
for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;

(b) Designed  such  internal  control  over  financial  reporting,  or  caused  such  internal  control  over  financial  reporting  to  be  designed  under  our
supervision, to provide reasonable  assurance  regarding  the  reliability  of  financial  reporting  and  the  preparation  of  financial  statements  for
external purposes in accordance with generally accepted accounting principles;

(c) Evaluated  the  effectiveness  of  the  registrant’s  disclosure  controls  and  procedures  and  presented  in  this  report  our  conclusions  about  the

effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent
fiscal  quarter  (the  registrant's  fourth  fiscal  quarter  in  the  case  of  an  annual  report)  that  has  materially  affected,  or  is  reasonably  likely  to
materially affect, the registrant’s internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the

registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All  significant  deficiencies  and  material  weaknesses  in  the  design  or  operation  of  internal  control  over  financial  reporting  which  are

reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any  fraud,  whether  or  not  material,  that  involves  management  or  other  employees  who  have  a  significant  role  in  the  registrant's  internal

control over financial reporting.

Date:  March 12, 2021

/s/ Steven A. DeMartino
Steven A. DeMartino
President, Chief Financial Officer, Treasurer and Secretary

 
 
 
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Exhibit 32

In connection with the Annual Report of TransAct Technologies Incorporated (the “Company”) on Form 10-K for the period ending December 31, 2020, as
filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company, certify, pursuant to
18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The  information  contained  in  the  Report  fairly  presents,  in  all  material  respects,  the  financial  condition  and  results  of  operations  of  the

Company.

Date:  March 12, 2021

/s/ Bart C. Shuldman
Bart C. Shuldman
Chairman and Chief Executive Officer

Date: March 12, 2021

/s/ Steven A. DeMartino
Steven A. DeMartino
President, Chief Financial Officer, Treasurer and Secretary